bcr_patient_barcode,additional_studies,gender,vital_status,days_to_birth,days_to_death,days_to_last_followup,race_list,tissue_source_site,patient_id,bcr_patient_uuid,age_at_initial_pathologic_diagnosis,year_of_initial_pathologic_diagnosis,person_neoplasm_cancer_status,lymph_node_examined_count,anatomic_neoplasm_subdivisions,menopause_status,breast_carcinoma_progesterone_receptor_status,her2_immunohistochemistry_level_result,margin_status,lab_procedure_her2_neu_in_situ_hybrid_outcome_type,breast_carcinoma_estrogen_receptor_status,lab_proc_her2_neu_immunohistochemistry_receptor_status,number_of_lymphnodes_positive_by_he,tissue_prospective_collection_indicator,tissue_retrospective_collection_indicator,er_level_cell_percentage_category,progesterone_receptor_level_cell_percent_category,stage_event_pathologic_stage,stage_event_tnm_categories,os_time,wsi_filename
TCGA-BH-A0HX,,FEMALE,0,-19900,NO,829,WHITE,BH,A0HX,3b01d064-8c00-4972-9f07-407eac8e7534,54,2008,TUMOR FREE,24,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft Lower Inner QuadrantLeft Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,2,NO,YES,80-89%,50-59%,Stage IIB,T2N1aM0,829,TCGA-BH-A0HX-01Z-00-DX1.44EBA39E-383D-4820-915E-4E5FDA1D43DA.svs
TCGA-AR-A0TS,,FEMALE,0,-17141,NO,1138,WHITE,AR,A0TS,972447aa-4332-47e7-bddd-2eb699dbb664,46,2006,,16,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,2,NO,YES,,,Stage IIB,T2N1M0,1138,TCGA-AR-A0TS-01Z-00-DX1.2DB81A2E-16C1-4EE0-8175-65FA46768277.svs
TCGA-BH-A0DH,,FEMALE,0,-23366,NO,1156,WHITE,BH,A0DH,491b6364-1223-474f-816f-e248c8c841e2,63,2007,TUMOR FREE,28,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Positive,,Positive,Negative,3,NO,YES,90-99%,40-49%,Stage IIB,T2N1aM0,1156,TCGA-BH-A0DH-01Z-00-DX1.968AA1FD-068C-4B90-8C95-85BF2EFC3E3F.svs
TCGA-BH-A1FG,,FEMALE,1,-32295,577,NO,WHITE,BH,A1FG,d4e7426c-9739-4585-9114-e564b13c7c02,88,1998,,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Negative,,NO,YES,,,Stage I,T1cNXM0,577,TCGA-BH-A1FG-01Z-00-DX1.DA665FB6-9DD9-4B18-A925-2EFD9BC4C43B.svs
TCGA-D8-A1XB,,FEMALE,0,-22976,NO,201,WHITE,D8,A1XB,d2694b09-7844-4496-865c-5d3d8cd03330,62,2010,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,YES,NO,,,Stage IIB,T2N1aM0,201,TCGA-D8-A1XB-01Z-00-DX2.B262C269-F22B-4306-8195-079C0874EF8E.svs
TCGA-AR-A1AO,,FEMALE,0,-17332,NO,1325,WHITE,AR,A1AO,623befd6-0ca4-4a6c-9cf5-d9385c3b718f,47,2006,TUMOR FREE,39,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Positive,Negative,2,NO,YES,,,Stage IIA,T1N1M0,1325,TCGA-AR-A1AO-01Z-00-DX1.244DEE5B-0896-452F-A14D-E290260A9D8F.svs
TCGA-S3-AA10,,FEMALE,0,-24075,NO,241,BLACK OR AFRICAN AMERICAN,S3,AA10,23C31C2E-336C-4878-A476-CF8D811B4875,65,2013,TUMOR FREE,4,RightRight Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,241,TCGA-S3-AA10-01Z-00-DX1.C0468882-0DD8-4FC5-8C2F-E18BE8000F69.svs
TCGA-AQ-A04J,,FEMALE,0,-16615,NO,160,WHITE,AQ,A04J,9938ce5c-e74e-446e-a932-f096f85cc3b1,45,2009,TUMOR FREE,20,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i+)M0,160,TCGA-AQ-A04J-01Z-00-DX1.6A4E16D4-2696-4E5F-BCA8-708556FC3A8C.svs
TCGA-A8-A08A,,FEMALE,0,-32750,NO,30,,A8,A08A,7fe4670d-4626-459d-869b-ab15f478c6a7,89,2007,TUMOR FREE,,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage I,T1cN0M0,30,TCGA-A8-A08A-01Z-00-DX1.3BB777A0-8652-4483-8DD6-8EB88AB0A8EF.svs
TCGA-A8-A076,,FEMALE,0,-24230,NO,1642,,A8,A076,23dabeef-8e3c-44bc-9a12-a9522d17be5c,66,2006,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,1642,TCGA-A8-A076-01Z-00-DX1.BAAC4F9C-0C04-42FB-95F4-D765305089B8.svs
TCGA-AN-A0FX,,FEMALE,0,-19309,NO,10,WHITE,AN,A0FX,13b860c3-8048-4dc9-9eb0-7480bc660837,52,2010,TUMOR FREE,12,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Positive,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A0FX-01Z-00-DX1.C9656600-F823-4044-972B-7059B39FC539.svs
TCGA-D8-A27R,,FEMALE,0,-15122,NO,29,WHITE,D8,A27R,0b23b5fe-6c7e-4297-bc55-f93fcb830ac4,41,2011,TUMOR FREE,11,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,11,YES,NO,,,Stage IIIC,T2N3aM0,29,TCGA-D8-A27R-01Z-00-DX1.F6E2FD1C-0666-4788-8D95-A76D15907270.svs
TCGA-AC-A2BM,,FEMALE,0,-15212,NO,1162,BLACK OR AFRICAN AMERICAN,AC,A2BM,8159FF7B-89F4-411A-9B9C-491F1CB3EB34,41,2005,TUMOR FREE,13,Left Upper Inner Quadrant,,Positive,,Negative,Negative,Positive,,1,NO,YES,60-69%,10-19%,Stage IIB,T2N1aMX,1162,TCGA-AC-A2BM-01Z-00-DX1.162A9FA9-6E61-48BF-B0A5-C6C7640ABD9B.svs
TCGA-B6-A0RT,,FEMALE,0,-14374,NO,2721,WHITE,B6,A0RT,4bf50455-9ab7-4521-a791-089f66d3b877,39,1996,TUMOR FREE,23,Right Upper Outer QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Negative,,Close,,Negative,,1,NO,YES,,,Stage IIIA,T3N1M0,2721,TCGA-B6-A0RT-01Z-00-DX1.6C2BA663-D61B-404B-B62C-B81747B6A3AC.svs
TCGA-E2-A106,,FEMALE,0,-12528,NO,1555,ASIAN,E2,A106,87e09544-eddb-473b-8617-212407ce644e,34,2006,TUMOR FREE,16,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Close,Negative,Positive,Equivocal,1,NO,YES,90-99%,80-89%,Stage IB,T1cN1miM0,1555,TCGA-E2-A106-01Z-00-DX1.A8D49C06-3C93-48A6-87F8-86D646BEA28C.svs
TCGA-AO-A0JB,,FEMALE,0,-18561,NO,1150,WHITE,AO,A0JB,3ea9412b-429e-4dcf-90cd-c53be06885a1,50,2007,TUMOR FREE,14,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft Lower Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,0,Negative,,Positive,Negative,1,NO,YES,90-99%,60-69%,Stage IIIA,T3N1aM0,1150,TCGA-AO-A0JB-01Z-00-DX1.250FE098-345B-4981-9236-0519E1C9058E.svs
TCGA-A2-A0YM,,FEMALE,0,-24831,NO,662,WHITE,A2,A0YM,5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c,67,2008,TUMOR FREE,5,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,662,TCGA-A2-A0YM-01Z-00-DX1.A48B4C96-2CC5-464C-98B7-F0F92AE56533.svs
TCGA-BH-A18H,,FEMALE,0,-23065,NO,0,WHITE,BH,A18H,878f975b-94fd-4d69-b7e7-1ed3ac2ee438,63,2010,,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Equivocal,Positive,Positive,0,NO,YES,,,Stage IA,T1bN0M0,0,TCGA-BH-A18H-01Z-00-DX1.4EC9108F-04C2-4B28-BD74-97A414C9A536.svs
TCGA-BH-A1F2,,FEMALE,1,-19701,959,NO,WHITE,BH,A1F2,6a2972e3-cca9-47e5-aac0-b770f2399eeb,53,1999,TUMOR FREE,19,Left,,Positive,,,,Positive,Positive,6,NO,YES,,,Stage IIIB,T4bN1bM0,959,TCGA-BH-A1F2-01Z-00-DX1.17E2FD6F-0DCF-425B-864B-21ADCDAE734B.svs
TCGA-AR-A24Z,,FEMALE,0,-20900,NO,1574,WHITE,AR,A24Z,9fefbe7c-f66a-4940-843e-285cb7b392c1,57,2006,,8,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,1574,TCGA-AR-A24Z-01Z-00-DX1.C88AFF18-A8E4-426A-BEA3-70566DE39C46.svs
TCGA-D8-A141,,FEMALE,0,-14626,NO,113,WHITE,D8,A141,42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b,40,2010,,15,Right,Indeterminate (neither Pre or Postmenopausal),Positive,1+,Negative,,Positive,Negative,1,YES,NO,,,,T1cN1M0,113,TCGA-D8-A141-01Z-00-DX1.10F6EEB2-C920-43FF-B5A7-B5A651CBDBE3.svs
TCGA-BH-A0E2,,FEMALE,0,-18152,NO,376,BLACK OR AFRICAN AMERICAN,BH,A0E2,8ace3b8c-f23e-48a9-a137-9e046bd9549b,49,2009,TUMOR FREE,26,Right Upper Inner QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,4,NO,YES,90-99%,<10%,Stage IIIA,T2N2aM0,376,TCGA-BH-A0E2-01Z-00-DX1.5F6FA19C-D59F-45BE-80CE-F738CAB1EF0B.svs
TCGA-E2-A10B,,FEMALE,0,-24577,NO,748,WHITE,E2,A10B,f801aeed-dc43-49d7-a319-84c8851979d9,67,2007,TUMOR FREE,28,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Close,Negative,Positive,Equivocal,2,NO,YES,,,Stage IIB,T2N1aM0,748,TCGA-E2-A10B-01Z-00-DX1.148CFC4B-EE65-4A7E-918F-10C72F37CB0F.svs
TCGA-AR-A0TU,,FEMALE,0,-13039,NO,360,,AR,A0TU,dfe6db17-cf45-488e-bd3c-b8433d7343ca,35,2006,TUMOR FREE,4,Right Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,360,TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069.svs
TCGA-EW-A1P6,,FEMALE,0,-23485,NO,312,WHITE,EW,A1P6,ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb,64,2010,TUMOR FREE,25,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Close,,Positive,Negative,2,NO,YES,90-99%,90-99%,Stage IIB,T2N1aM0,312,TCGA-EW-A1P6-01Z-00-DX1.A8024C26-6336-4858-88FD-5679795899BA.svs
TCGA-3C-AALK,,FEMALE,0,-19074,NO,1217,BLACK OR AFRICAN AMERICAN,3C,AALK,C31900A4-5DCD-4022-97AC-638E86E889E4,52,2011,TUMOR FREE,2,Right,,Positive,,Close,,Positive,Positive,0,NO,YES,70-79%,80-89%,Stage IA,T1cN0 (i+)M0,1217,TCGA-3C-AALK-01Z-00-DX1.4E6EB156-BB19-410F-878F-FC0EA7BD0B53.svs
TCGA-A8-A07I,,FEMALE,0,-25263,NO,426,,A8,A07I,566792ae-f853-4a47-856d-f02cdcfcb18a,69,2009,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIIA,T2N2aM0,426,TCGA-A8-A07I-01Z-00-DX1.37E7BB2E-8210-4216-B75F-0FD06D6C9AE3.svs
TCGA-BH-A0DO,,FEMALE,0,-28529,NO,525,WHITE,BH,A0DO,d3d4d709-ab34-4617-aa8c-51a3d0a3efe6,78,2009,TUMOR FREE,2,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,525,TCGA-BH-A0DO-01Z-00-DX1.1684557E-A5D4-4828-B2D5-FA899993A019.svs
TCGA-E2-A1L9,,FEMALE,0,-14868,NO,388,WHITE,E2,A1L9,5ea18514-51ad-4844-abea-15e82f0b10c9,40,2009,TUMOR FREE,2,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,NO,YES,80-89%,80-89%,Stage IIA,T1cN1miM0,388,TCGA-E2-A1L9-01Z-00-DX1.F2CC1036-8EEE-4664-962E-541B8ACB10DE.svs
TCGA-GM-A2DH,,FEMALE,0,-21344,NO,1286,WHITE,GM,A2DH,5700C1B3-922A-4401-8AB8-89028908D696,58,2007,TUMOR FREE,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,0,NO,YES,<10%,<10%,Stage I,T1cN0 (i+)M0,1286,TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989.svs
TCGA-E2-A9RU,,FEMALE,0,-32873,NO,0,BLACK OR AFRICAN AMERICAN,E2,A9RU,6F18F96E-C0C9-4CC4-9FB2-CBA8949D5402,90,2013,TUMOR FREE,22,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Positive,Equivocal,12,NO,YES,70-79%,,Stage IIIC,T2N3aMX,0,TCGA-E2-A9RU-01Z-00-DX1.A06BE284-B9DC-4B45-A202-A9D027AEEDD9.svs
TCGA-E9-A1QZ,,FEMALE,0,-22397,NO,0,WHITE,E9,A1QZ,b6b932ce-6856-4d94-9e6c-16dfbe51906f,61,2011,TUMOR FREE,19,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-E9-A1QZ-01Z-00-DX1.CDAECCA9-4F09-491F-A975-B775D47E46F0.svs
TCGA-A1-A0SD,,FEMALE,0,-21793,NO,437,WHITE,A1,A0SD,c462e422-eb8d-4daf-9897-2a9c6cbd783a,59,2005,,3,Left,,Positive,,Positive,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0M0,437,TCGA-A1-A0SD-01Z-00-DX1.DB17BFA9-D951-42A8-91D2-F4C2EBC6EB9F.svs
TCGA-D8-A1XR,,FEMALE,0,-20488,NO,168,WHITE,D8,A1XR,70f34c5c-3671-44c8-9469-99f9786efec1,56,2010,TUMOR FREE,7,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,2,YES,NO,,,Stage IIB,T2N1aM0,168,TCGA-D8-A1XR-01Z-00-DX2.A103FB8B-4397-4DD4-8587-90A736407484.svs
TCGA-GI-A2C9,,FEMALE,0,-21534,NO,711,BLACK OR AFRICAN AMERICAN,GI,A2C9,9F6BE944-83DE-42AB-8738-F0022F475E61,58,2003,TUMOR FREE,4,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IIB,T3N0MX,711,TCGA-GI-A2C9-01Z-00-DX1.90181423-51ED-41FE-9B8F-973A67793D4F.svs
TCGA-LL-A6FR,,FEMALE,0,-18520,NO,118,BLACK OR AFRICAN AMERICAN,LL,A6FR,1347C23D-8D6E-4C15-9461-640249838C96,50,2013,TUMOR FREE,1,RightRight Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Negative,Equivocal,0,YES,NO,,<10%,Stage IIA,T2N0 (i-)MX,118,TCGA-LL-A6FR-01Z-00-DX1.107010FD-8EDD-406D-B4DE-DEC9E85576FF.svs
TCGA-BH-A0AZ,,FEMALE,0,-17465,NO,867,WHITE,BH,A0AZ,518f231c-f5f9-4a39-a97b-7fd5666d3e50,47,2008,TUMOR FREE,13,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIIA,T3N1acM0 (i+),867,TCGA-BH-A0AZ-01Z-00-DX1.E20051E8-DEEF-48E5-B519-40777DDBC96B.svs
TCGA-AN-A0AL,,FEMALE,0,-15286,NO,198,WHITE,AN,A0AL,3e9f93c0-aa79-4b4c-bd6c-b3325912362a,41,2010,TUMOR FREE,5,Left Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIIB,T4N0M0,198,TCGA-AN-A0AL-01Z-00-DX1.D9E446A3-175F-4242-AFC1-78FFE3FC9AC4.svs
TCGA-A2-A0EV,,FEMALE,0,-29285,NO,545,WHITE,A2,A0EV,7032ec9c-e96b-4642-a7b6-d0aee7a3add2,80,2008,TUMOR FREE,6,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,Negative,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IA,T1cN0 (i-)M0,545,TCGA-A2-A0EV-01Z-00-DX1.EA8C5594-BA4F-47A8-949B-D536E00E62C9.svs
TCGA-BH-A1FM,,FEMALE,1,-16289,1388,NO,WHITE,BH,A1FM,7eb18190-5a41-4637-9783-f81bbde499e4,44,1998,,10,Right Upper Outer Quadrant,,Negative,,,,Positive,,8,NO,YES,,,Stage IIIA,T2N2M0,1388,TCGA-BH-A1FM-01Z-00-DX1.860C5169-FE2B-43A6-A13D-E736374303DD.svs
TCGA-A8-A06Z,,FEMALE,0,-30984,NO,31,,A8,A06Z,2399caeb-ead2-4003-af38-809db4ac2e2b,84,2007,,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T3N0M0,31,TCGA-A8-A06Z-01Z-00-DX1.2BC8B71D-E01B-4CC1-B5E7-09BB54A5E1F8.svs
TCGA-A8-A07O,,FEMALE,0,-18870,NO,304,,A8,A07O,cf9db1af-17f0-490e-8139-142bd704763a,51,2009,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,,NO,YES,,,Stage IIA,T2N0M0,304,TCGA-A8-A07O-01Z-00-DX1.3D657129-F2A7-4BC1-A910-805FBDCE2212.svs
TCGA-E9-A243,,FEMALE,0,-19035,NO,43,WHITE,E9,A243,d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f,52,2011,TUMOR FREE,10,Right Upper Inner Quadrant,Peri (6-12 months since last menstrual period),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0 (i-)M0,43,TCGA-E9-A243-01Z-00-DX1.9A3B34E5-25EF-4243-8680-FABF2F1CCDA9.svs
TCGA-AO-A03O,,FEMALE,1,-25362,2483,NO,BLACK OR AFRICAN AMERICAN,AO,A03O,1111fb30-46ce-4722-98da-ec9ba2323d90,69,2002,TUMOR FREE,17,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,2483,TCGA-AO-A03O-01Z-00-DX1.054BBC89-69F4-4311-814D-E343472CD2C0.svs
TCGA-BH-A1F5,,FEMALE,1,-22842,2712,NO,WHITE,BH,A1F5,e663954c-05a8-479a-a623-400c1eb5efc6,62,2002,TUMOR FREE,4,Right,,Positive,,,,Positive,Negative,1,NO,YES,,,Stage IIA,T1cN1aM0,2712,TCGA-BH-A1F5-01Z-00-DX1.9A1AA3BB-80B1-473D-B075-8D65A94C4E0B.svs
TCGA-B6-A0IJ,,FEMALE,0,-15625,NO,5383,BLACK OR AFRICAN AMERICAN,B6,A0IJ,2c86c3ea-d926-4d39-a5ae-39ece4774287,42,1995,TUMOR FREE,27,Right Upper Outer QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,0,NO,YES,,,Stage IIB,T3N0 (i-)M0,5383,TCGA-B6-A0IJ-01Z-00-DX1.BF2E062F-06DA-4CA8-86C4-36674C035CAA.svs
TCGA-E2-A15A,,FEMALE,0,-16750,NO,502,WHITE,E2,A15A,73ccc949-01b7-48d3-a7c4-c4bcd261672a,45,2009,TUMOR FREE,19,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,13,NO,YES,,,Stage IIIC,T2N3aM0,502,TCGA-E2-A15A-01Z-00-DX1.B9D22735-FE9F-46D9-84E6-0C71A1BF84D6.svs
TCGA-BH-A0HN,,FEMALE,0,-24731,NO,516,WHITE,BH,A0HN,a68a3361-48b4-4bd0-999d-b4cc3d43eb4a,67,2009,TUMOR FREE,2,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,0,NO,YES,90-99%,90-99%,Stage IA,T1cN0 (i-)M0,516,TCGA-BH-A0HN-01Z-00-DX1.4997F641-C593-41F6-82ED-6A0E4EFA55F3.svs
TCGA-E2-A10A,,FEMALE,0,-15085,NO,352,WHITE,E2,A10A,4da7abaf-ac7a-41c0-8033-5780a398545c,41,2007,WITH TUMOR,3,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Positive,0,NO,YES,,,Stage IIB,T3N0 (i-)M0,352,TCGA-E2-A10A-01Z-00-DX1.98B19EF1-0DAE-4DC6-8B0E-963CFABC6724.svs
TCGA-A8-A09R,,FEMALE,0,-30196,NO,273,,A8,A09R,cb0a2055-2168-4454-8755-47dd613db36f,82,2009,TUMOR FREE,,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T2N1M0,273,TCGA-A8-A09R-01Z-00-DX1.392580F3-0CE5-4EDB-91CF-814AAD0DB649.svs
TCGA-C8-A1HK,,FEMALE,0,,NO,7,ASIAN,C8,A1HK,52c35691-efca-42f5-a03e-02c9f872275c,53,2010,TUMOR FREE,8,Right,Peri (6-12 months since last menstrual period),Negative,3+,Negative,,Negative,Positive,,YES,NO,,,Stage IIB,T2N1M0,7,TCGA-C8-A1HK-01Z-00-DX1.A15F452B-1260-4106-86D1-05F00082F0CE.svs
TCGA-D8-A27R,,FEMALE,0,-15122,NO,29,WHITE,D8,A27R,0b23b5fe-6c7e-4297-bc55-f93fcb830ac4,41,2011,TUMOR FREE,11,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,11,YES,NO,,,Stage IIIC,T2N3aM0,29,TCGA-D8-A27R-01Z-00-DX2.31F47D8F-DFD7-42AE-BBBA-7DBBA12FA97D.svs
TCGA-A2-A25B,,FEMALE,0,-14454,NO,258,BLACK OR AFRICAN AMERICAN,A2,A25B,eadf8482-e60e-4307-adb7-d5c3b9fa6cae,39,2010,TUMOR FREE,8,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Close,Negative,Positive,Equivocal,2,YES,NO,90-99%,10-19%,Stage IIB,T2N1M0,258,TCGA-A2-A25B-01Z-00-DX1.58D7BEDE-5558-4A9E-A95E-DDF24C9267EF.svs
TCGA-AR-A0U3,,FEMALE,0,-21755,NO,2317,WHITE,AR,A0U3,c5f00132-1c6b-4337-af6f-596c652665cc,59,2004,,4,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,NO,YES,10-19%,,Stage IIB,T2N1M0,2317,TCGA-AR-A0U3-01Z-00-DX1.9BB87F9D-459F-4A18-B591-29822EA5AE18.svs
TCGA-E2-A1BD,,FEMALE,0,-19627,NO,317,WHITE,E2,A1BD,0e1d0d46-7a7b-4538-95dd-b9fc20a15aec,53,2010,TUMOR FREE,1,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,317,TCGA-E2-A1BD-01Z-00-DX1.A2AFF7AD-ED47-43E4-87FE-62882BAEB8DA.svs
TCGA-A8-A08G,,FEMALE,0,-14976,NO,607,,A8,A08G,719082cc-1ebe-4a51-a659-85a59db1d77d,41,2009,TUMOR FREE,,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,607,TCGA-A8-A08G-01Z-00-DX1.C3BB7FEC-91B7-4B45-8DFC-36CABCC0FD57.svs
TCGA-E2-A1LS,,FEMALE,0,-16887,NO,239,WHITE,E2,A1LS,91a2f2af-e4b1-4a0b-ab20-6a36ce63c533,46,2010,TUMOR FREE,5,Right Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,0,NO,YES,,,Stage IA,T1cN0M0,239,TCGA-E2-A1LS-01Z-00-DX1.9a43a58a-df40-4375-8456-ef0071bc9eb9.svs
TCGA-A2-A0CY,,FEMALE,0,-23229,NO,1288,WHITE,A2,A0CY,757df7b0-4774-4493-98bf-999ded9ac86e,63,2006,TUMOR FREE,22,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,1,NO,YES,90-99%,10-19%,Stage IIB,T2N1M0,1288,TCGA-A2-A0CY-01Z-00-DX1.8815F011-317B-4BB7-A48F-64EABD0E558B.svs
TCGA-A7-A5ZW,,FEMALE,0,-17529,NO,134,BLACK OR AFRICAN AMERICAN,A7,A5ZW,523E24A2-51B9-4658-BE2F-42E5FCCEBB17,47,2012,TUMOR FREE,1,Right Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Positive,1+,Negative,,Positive,Negative,1,YES,NO,90-99%,80-89%,Stage IIA,T1cN1aM0,134,TCGA-A7-A5ZW-01Z-00-DX1.5F571EE3-A1A3-4604-BE89-1A46E0EC508B.svs
TCGA-C8-A131,,FEMALE,0,-29966,NO,14,ASIAN,C8,A131,c49e3b18-fd88-48f4-8b01-300692ceb367,82,2010,TUMOR FREE,8,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,4,YES,NO,,,Stage IIIA,T2N2M0,14,TCGA-C8-A131-01Z-00-DX1.5CB27A29-9951-40B9-B4DB-26A4D2EA89B8.svs
TCGA-D8-A1JE,,FEMALE,0,-22683,NO,57,WHITE,D8,A1JE,115bc72c-116f-40c1-be9b-e3dd7650efae,62,2010,TUMOR FREE,10,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,3,YES,NO,,,Stage IIA,T1cN1aM0,57,TCGA-D8-A1JE-01Z-00-DX2.CCF3DFEF-E851-425A-BCD0-0F7B377A00BC.svs
TCGA-C8-A132,,FEMALE,0,-20471,NO,13,ASIAN,C8,A132,89e867de-d30e-4bfc-a453-0a76309dabd5,56,2010,TUMOR FREE,4,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,1,YES,NO,,,Stage IIB,T2N1M0,13,TCGA-C8-A132-01Z-00-DX1.6CCE1FE0-BB4B-4046-BAF0-43AA110B2EBE.svs
TCGA-A2-A3XW,,FEMALE,0,-15670,NO,1209,BLACK OR AFRICAN AMERICAN,A2,A3XW,C02699B5-580A-4D55-971E-F4692B2CCE57,42,2009,TUMOR FREE,18,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,Negative,Positive,Negative,3,YES,NO,90-99%,,Stage IIB,T2N1aM0,1209,TCGA-A2-A3XW-01Z-00-DX1.45F5F36F-5503-4A38-AF37-E526915A8DBE.svs
TCGA-D8-A1JA,,FEMALE,0,-21918,NO,18,WHITE,D8,A1JA,9ced0c70-c46c-4f98-8f48-840defe4b8b1,60,2010,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,,YES,NO,<10%,,,T4bNXM0,18,TCGA-D8-A1JA-01Z-00-DX1.BD43F94A-D5A8-490E-AED4-5F3AB24080FA.svs
TCGA-E9-A227,,FEMALE,0,-15602,NO,24,WHITE,E9,A227,89a8da07-4487-47c6-8d3c-442a87e4f632,42,2011,WITH TUMOR,17,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Positive,,Positive,Negative,1,YES,NO,90-99%,80-89%,Stage IIB,T2N1M0,24,TCGA-E9-A227-01Z-00-DX1.823062BF-3444-489B-AF91-AAD4ECAA1DC7.svs
TCGA-B6-A0RI,,FEMALE,0,-16138,NO,6796,WHITE,B6,A0RI,bfd55808-dddd-44c3-97d7-41600497b992,44,1992,WITH TUMOR,15,Right Upper Outer QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,6,NO,YES,,,Stage IIIB,T4bN1bM0,6796,TCGA-B6-A0RI-01Z-00-DX1.E39951A4-AC6A-4B07-851B-F35CB86D79AA.svs
TCGA-A2-A0SW,,FEMALE,1,-30085,1365,NO,WHITE,A2,A0SW,991e1427-3c01-423d-abfd-4584302ca72c,82,2006,WITH TUMOR,15,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Positive,,4,NO,YES,40-49%,<10%,Stage IV,T2N2M1,1365,TCGA-A2-A0SW-01Z-00-DX1.E1EA0407-B831-4D75-826E-80B82B821797.svs
TCGA-D8-A1JJ,,FEMALE,0,-19966,NO,274,WHITE,D8,A1JJ,f7ab565c-83b5-4988-b9be-8a46f65dca8c,54,2010,TUMOR FREE,1,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IIA,T2N0M0,274,TCGA-D8-A1JJ-01Z-00-DX1.a986b48f-b295-4d7a-b778-ce829cdf9c38.svs
TCGA-E9-A1NH,,FEMALE,0,-26221,NO,0,WHITE,E9,A1NH,b2aac45b-2073-4c7a-adb9-769a4fdcc111,71,2011,TUMOR FREE,5,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,3,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-E9-A1NH-01Z-00-DX1.20FF11B7-DAF0-41C2-B7C5-449BA5268EC0.svs
TCGA-AQ-A04L,,FEMALE,0,-17759,NO,3359,WHITE,AQ,A04L,78582fbc-dcc7-48ae-9f95-5271c9bc5b72,48,2001,TUMOR FREE,2,Right,Peri (6-12 months since last menstrual period),Negative,3+,Negative,,Positive,Positive,0,NO,YES,60-69%,,Stage IIA,T2N0 (i-)MX,3359,TCGA-AQ-A04L-01Z-00-DX1.F35BF4DD-896A-43C2-8DA6-C67945C003BE.svs
TCGA-BH-A0B1,,FEMALE,0,-24315,NO,1148,WHITE,BH,A0B1,b4e4fea2-b802-4a86-923e-3fcbd3c708fe,66,2007,TUMOR FREE,15,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,NO,YES,90-99%,40-49%,Stage IIB,T2N1aM0,1148,TCGA-BH-A0B1-01Z-00-DX1.CC60D284-04FB-4B73-90AA-FCE9185DADB6.svs
TCGA-E2-A15C,,FEMALE,0,-22583,NO,497,WHITE,E2,A15C,da840a22-8d30-4682-bbd0-8fa87bd40528,61,2009,TUMOR FREE,4,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage I,T1cN0M0,497,TCGA-E2-A15C-01Z-00-DX1.26E13415-1D37-43C7-9EBB-4411BE7FCE10.svs
TCGA-E2-A109,,FEMALE,0,-23521,NO,1172,WHITE,E2,A109,f0787165-6f58-4d67-b510-928eea2c4882,64,2007,,6,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,1172,TCGA-E2-A109-01Z-00-DX1.FCF5E9FC-F9FE-4F5F-96DD-5628E2609BEF.svs
TCGA-LL-A441,,FEMALE,0,-22772,NO,91,BLACK OR AFRICAN AMERICAN,LL,A441,69FC24FC-CFE2-487A-935F-1A954B30B709,62,2012,TUMOR FREE,4,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IA,T1cN0MX,91,TCGA-LL-A441-01Z-00-DX1.33B13078-BB14-4C42-88A6-7460AD2BCD00.svs
TCGA-C8-A275,,FEMALE,0,-20774,NO,1,ASIAN,C8,A275,ce887e90-0660-4f44-a3a4-b3b894cb7eda,56,2010,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,,YES,NO,,,Stage IIA,T1N1M0,1,TCGA-C8-A275-01Z-00-DX1.44D27E67-4DD6-4893-B38A-01E48F5A358A.svs
TCGA-A8-A096,,FEMALE,0,-26723,NO,0,,A8,A096,d7cac141-9269-4733-83ce-e1bc0b503254,73,2009,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,0,TCGA-A8-A096-01Z-00-DX1.FCECFB0D-4E02-4C69-A0FE-7D6C7F9FEB07.svs
TCGA-S3-A6ZH,,FEMALE,0,-10832,NO,263,BLACK OR AFRICAN AMERICAN,S3,A6ZH,EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6,29,2013,TUMOR FREE,21,LeftLeft Upper Outer Quadrant,,Positive,2+,Negative,Negative,Positive,Equivocal,14,YES,NO,90-99%,80-89%,Stage IIIC,T3N3aMX,263,TCGA-S3-A6ZH-01Z-00-DX1.E728FF79-4921-436F-BFF5-5B782C0EEB9A.svs
TCGA-BH-A0H9,,FEMALE,0,-25289,NO,1247,WHITE,BH,A0H9,0f64edec-0f1f-4025-8a53-75f9534f7828,69,2007,TUMOR FREE,1,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,30-39%,Stage IIA,T2N0 (i-)M0,1247,TCGA-BH-A0H9-01Z-00-DX1.8AE869C6-5C78-4D52-AC8B-5B6FD5FD91AA.svs
TCGA-A7-A0CH,,FEMALE,0,-29104,NO,162,WHITE,A7,A0CH,9de678e5-67ed-4453-a98b-7ac351d5d0f1,79,2009,TUMOR FREE,2,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0 (i-)M0,162,TCGA-A7-A0CH-01Z-00-DX1.48ADDD0B-527A-404C-B794-7D7D35BF861F.svs
TCGA-AN-A0FD,,FEMALE,0,-26007,NO,196,WHITE,AN,A0FD,c6086936-7544-4da0-8c0c-114166848483,71,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,0,NO,YES,80-89%,10-19%,Stage IIA,T2N0M0,196,TCGA-AN-A0FD-01Z-00-DX1.8970DBBA-7D43-4C2E-B14A-6D21F1EF3425.svs
TCGA-A7-A4SE,,FEMALE,0,-20080,NO,371,BLACK OR AFRICAN AMERICAN,A7,A4SE,DBF6F981-15CC-40AD-91AC-A66360405FBD,54,2011,TUMOR FREE,3,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,371,TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6.svs
TCGA-AQ-A54N,,FEMALE,0,-18741,NO,78,BLACK OR AFRICAN AMERICAN,AQ,A54N,58090433-D8D1-4499-A235-810C3E9D5B74,51,2011,TUMOR FREE,1,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,YES,NO,,,Stage IIA,T2N0M0,78,TCGA-AQ-A54N-01Z-00-DX1.E53271E9-AFD2-4071-9B1E-CD05F63B8136.svs
TCGA-A8-A09C,,FEMALE,0,-25355,NO,31,,A8,A09C,80f3f48a-cc21-415c-b181-c77e7ba1c563,69,2009,,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,,Negative,Positive,Negative,,NO,YES,,,Stage X,T2N0MX,31,TCGA-A8-A09C-01Z-00-DX1.19E0C0E9-0ED6-4E3A-95FE-A5778F5DDBCD.svs
TCGA-E9-A244,,FEMALE,0,-19778,NO,21,WHITE,E9,A244,a4c59287-1ad5-46a5-8040-e591e6ce064f,54,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0 (i-)M0,21,TCGA-E9-A244-01Z-00-DX1.4FDAA892-9DBF-4E5D-89F3-2A84C8AC8F0A.svs
TCGA-BH-A0BJ,,FEMALE,0,-15027,NO,660,WHITE,BH,A0BJ,d6f911b5-e895-43f8-8f86-0ac2f1bc6fae,41,2008,TUMOR FREE,18,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,2,NO,YES,90-99%,70-79%,Stage IIB,T2N1aM0,660,TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B.svs
TCGA-A2-A0CV,,FEMALE,0,-15289,NO,1870,ASIAN,A2,A0CV,ad7fcc89-82a3-48aa-8461-581c1a857677,41,2005,TUMOR FREE,18,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,4,NO,YES,90-99%,90-99%,Stage IIB,T2N1aM0,1870,TCGA-A2-A0CV-01Z-00-DX1.B02D017A-61CD-45FE-BB31-705CD127DDAB.svs
TCGA-AN-A0FZ,,FEMALE,0,-16533,NO,10,WHITE,AN,A0FZ,8240c4ae-f878-4882-aa07-7857c7ac52cf,45,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,,Positive,Positive,1,NO,YES,,,Stage IIIA,T2N2M0,10,TCGA-AN-A0FZ-01Z-00-DX1.9555AF11-3A0D-4FE3-AE91-09DA77B175CA.svs
TCGA-A2-A04Q,,FEMALE,0,-17660,NO,2179,WHITE,A2,A04Q,b5fba77b-1f50-4e71-95b2-566afba4bdd7,48,2004,TUMOR FREE,3,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,<10%,<10%,Stage IA,T1N0 (i-)M0,2179,TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4.svs
TCGA-B6-A0I8,,FEMALE,1,-17073,749,NO,WHITE,B6,A0I8,6e6408d6-6c48-4dfc-9f1c-28b7386e87b4,46,1992,WITH TUMOR,0,Right Upper Inner QuadrantRight,Indeterminate (neither Pre or Postmenopausal),,,,,,,,NO,YES,,,Stage X,T1NXM0,749,TCGA-B6-A0I8-01Z-00-DX1.E576652B-C3F6-4A01-83BC-6DD154C75605.svs
TCGA-A8-A08F,,FEMALE,0,-21641,NO,549,,A8,A08F,0a017f15-1c6b-45e7-8d55-e0a71df1b2e8,59,2008,TUMOR FREE,,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIC,T2N3aM0,549,TCGA-A8-A08F-01Z-00-DX1.9D2222F6-1425-46FD-BC94-728EF835FAC2.svs
TCGA-B6-A0WZ,,FEMALE,0,-18584,NO,3941,BLACK OR AFRICAN AMERICAN,B6,A0WZ,08740d7f-5a5e-4dfa-bd48-7fbf228a7a28,50,1996,TUMOR FREE,21,Right Upper Inner QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,11,NO,YES,,,Stage II,T2N1bM0,3941,TCGA-B6-A0WZ-01Z-00-DX1.6CFB236E-36F5-43D6-8DE3-C4ECBD3C14C6.svs
TCGA-AR-A1AN,,FEMALE,0,-16974,NO,1330,WHITE,AR,A1AN,43029932-feb0-4658-97fa-645c1e775009,46,2006,TUMOR FREE,5,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,0,NO,YES,70-79%,70-79%,Stage IIA,T2N0M0,1330,TCGA-AR-A1AN-01Z-00-DX1.1118F9FE-6DF2-4496-B102-D3A10D332EC0.svs
TCGA-B6-A0X4,,FEMALE,1,-22688,860,NO,WHITE,B6,A0X4,4e42fdc5-2a8b-49e9-87ef-6db7a6692d08,62,1996,WITH TUMOR,21,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,2,NO,YES,,,Stage IIB,T2N1bM0,860,TCGA-B6-A0X4-01Z-00-DX1.4B7914DE-3436-4D69-9BC6-F6419D3CC518.svs
TCGA-AC-A5EH,,FEMALE,0,-27964,NO,63,BLACK OR AFRICAN AMERICAN,AC,A5EH,D13FB44B-291B-4EA4-920C-142DAA8D1989,76,2012,TUMOR FREE,14,Left Upper Outer Quadrant,,Negative,,Negative,,Positive,Negative,1,YES,NO,20-29%,,Stage IIB,T2N1miMX,63,TCGA-AC-A5EH-01Z-00-DX1.DF59B26B-379F-4047-B7AE-4493810D30A0.svs
TCGA-C8-A12N,,FEMALE,0,-21428,NO,0,ASIAN,C8,A12N,b8a615f9-d19b-4b09-8ec8-0674e5c648cd,58,2010,TUMOR FREE,10,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0 (i-)M0,0,TCGA-C8-A12N-01Z-00-DX1.8E50110E-A6C0-496F-B44E-7190096C113E.svs
TCGA-D8-A1JG,,FEMALE,0,-22878,NO,187,WHITE,D8,A1JG,7f2a63e6-64d5-4be1-9814-e8416fc9e688,62,2010,TUMOR FREE,1,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,YES,NO,,,Stage IIA,T2N0M0,187,TCGA-D8-A1JG-01Z-00-DX1.BA6D5CC7-3A9B-4D17-A86A-B159D345A216.svs
TCGA-A7-A26H,,FEMALE,0,-26423,NO,65,WHITE,A7,A26H,dddd8e2f-e540-418a-b02e-698d18a12c14,72,2011,,5,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Positive,Positive,Equivocal,0,YES,NO,90-99%,,Stage IIA,T1N1aM0,65,TCGA-A7-A26H-01Z-00-DX1.3344CFD3-5A19-4B01-BEB2-AB89F83FD53A.svs
TCGA-E2-A153,,FEMALE,0,-18875,NO,586,WHITE,E2,A153,be9bf36a-12e1-4386-addf-1686dc8b49de,51,2009,TUMOR FREE,15,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,3,NO,YES,,,Stage IIB,T2N1aM0,586,TCGA-E2-A153-01Z-00-DX1.CA994467-E541-4131-A9FC-DCD9944F29C4.svs
TCGA-A8-A09M,,FEMALE,0,-27455,NO,457,,A8,A09M,626b4ff0-2188-4a14-aac8-6703c624917f,75,2009,TUMOR FREE,,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIC,T2N3aM0,457,TCGA-A8-A09M-01Z-00-DX1.E2CEA8B5-C86D-4873-BE67-359FBEECCA09.svs
TCGA-A8-A08Z,,FEMALE,0,-28003,NO,1217,,A8,A08Z,d7808cbc-4b8c-467b-b2c3-f48d05b9ecab,76,2004,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,,T4bN3aM0,1217,TCGA-A8-A08Z-01Z-00-DX1.D0AADCA6-C27C-4FB8-89C1-94B5901146E7.svs
TCGA-BH-A0B3,,FEMALE,0,-19479,NO,1203,WHITE,BH,A0B3,18eb4dfc-556f-4bf3-a411-4780209ed1e0,53,2007,TUMOR FREE,29,Right Upper Inner QuadrantRight Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,2,NO,YES,,,Stage IIB,T2N1aM0,1203,TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55.svs
TCGA-A2-A0EY,,FEMALE,0,-22872,NO,485,WHITE,A2,A0EY,d67cd793-2931-429a-9084-2f3c4c8be7ad,62,2009,TUMOR FREE,23,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,Positive,Positive,Positive,1,NO,YES,60-69%,<10%,Stage IIB,T2N1aM0,485,TCGA-A2-A0EY-01Z-00-DX1.2F2428B3-0767-48E0-AC22-443C244CBD16.svs
TCGA-B6-A0IG,,FEMALE,1,-18433,4456,NO,WHITE,B6,A0IG,34ab0cb8-bf19-4cbb-b4eb-3c45ee5aa60b,50,1994,WITH TUMOR,16,Left,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,4,NO,YES,,,Stage IIB,T2N1bM0,4456,TCGA-B6-A0IG-01Z-00-DX1.4238CB6E-0561-49FD-9C49-9B8AEAFC4618.svs
TCGA-EW-A1OW,,FEMALE,0,-21465,NO,464,BLACK OR AFRICAN AMERICAN,EW,A1OW,f55dd73d-8c36-440b-84e5-9aae53107775,58,2009,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0MX,464,TCGA-EW-A1OW-01Z-00-DX1.97888686-EBB6-4B13-AB5D-452F475E865B.svs
TCGA-A8-A09Q,,FEMALE,0,-30528,NO,761,,A8,A09Q,09c2bc35-c21f-4aa4-ac30-0d8db02ad811,83,2008,WITH TUMOR,,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Positive,Negative,Positive,Negative,,NO,YES,,,Stage IIIB,T4bN2aM0,761,TCGA-A8-A09Q-01Z-00-DX1.C7240AFB-5971-4577-812C-A255C249001A.svs
TCGA-A2-A0CM,,FEMALE,1,-14969,754,NO,BLACK OR AFRICAN AMERICAN,A2,A0CM,eb2dbb4f-66b6-4525-8323-431970f7a64e,40,2003,WITH TUMOR,1,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,754,TCGA-A2-A0CM-01Z-00-DX1.AC4901DE-4B6D-4185-BB9F-156033839828.svs
TCGA-PL-A8LX,,FEMALE,0,-12840,NO,5,BLACK OR AFRICAN AMERICAN,PL,A8LX,FE2CD610-AA52-4789-AC62-7683281BB22F,35,2013,WITH TUMOR,,LeftLeft Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,YES,NO,,,Stage IV,T4N1aM1,5,TCGA-PL-A8LX-01A-01-DX1.9646D69F-A764-4246-9243-67A63006DE96.svs
TCGA-E9-A1R3,,FEMALE,0,-25693,NO,64,WHITE,E9,A1R3,4922cddc-575c-4b8a-8245-ce5f6876760c,70,2010,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,10,YES,NO,,,Stage IIIC,T2N3M0,64,TCGA-E9-A1R3-01Z-00-DX1.779642c7-b3b0-4ff2-af97-201d4bcfc197.svs
TCGA-OL-A66P,,FEMALE,0,-27489,NO,58,BLACK OR AFRICAN AMERICAN,OL,A66P,F81AC8A2-4CE6-439E-B027-1C0BFC88CEAA,75,2013,,2,Right,,Negative,,Negative,Negative,Negative,,,NO,YES,,,Stage IIA,T2N0MX,58,TCGA-OL-A66P-01Z-00-DX1.5ADD0D6D-37C6-4BC9-8C2B-64DB18BE99B3.svs
TCGA-AC-A62X,,FEMALE,0,-26627,NO,34,BLACK OR AFRICAN AMERICAN,AC,A62X,5B2A4F11-CA46-4974-9420-59B4820920BF,72,2013,TUMOR FREE,10,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,,0,YES,NO,<10%,,Stage IIA,T2N0MX,34,TCGA-AC-A62X-01Z-00-DX1.36FDC9AA-4EBE-40E6-92C2-8471049171A4.svs
TCGA-B6-A0IK,,FEMALE,1,-23150,571,NO,WHITE,B6,A0IK,0491063c-14a7-4104-8002-1459126332f3,63,1994,WITH TUMOR,14,Left,Indeterminate (neither Pre or Postmenopausal),Negative,,Positive,,Negative,,1,NO,YES,,,Stage IIIB,T4N1M0,571,TCGA-B6-A0IK-01Z-00-DX1.1640DB44-4AC0-4A34-9E21-4673C4289A99.svs
TCGA-A2-A0T5,,FEMALE,0,-14503,NO,321,WHITE,A2,A0T5,36d77496-99f8-4911-ba7c-89fae32662aa,39,2009,TUMOR FREE,4,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0 (i-)M0,321,TCGA-A2-A0T5-01Z-00-DX1.128C288B-B357-439B-A8D4-8E7DEBF73E4E.svs
TCGA-E2-A14Z,,FEMALE,0,-23682,NO,518,WHITE,E2,A14Z,d7ce6b79-f7c0-481e-9dbd-6273f01c9786,64,2009,WITH TUMOR,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,518,TCGA-E2-A14Z-01Z-00-DX1.A1344A78-1842-4578-8CDE-921E50656891.svs
TCGA-OL-A5RV,,FEMALE,0,-15820,NO,733,BLACK OR AFRICAN AMERICAN,OL,A5RV,1D38D356-D126-4476-94D0-26616B9375B1,43,2011,TUMOR FREE,29,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Negative,Positive,,20,NO,YES,90-99%,90-99%,Stage IIIC,T2N3MX,733,TCGA-OL-A5RV-01Z-00-DX1.920AC243-1DAC-4854-BEB6-1CBCC950F26B.svs
TCGA-BH-A18I,,FEMALE,0,-19489,NO,220,WHITE,BH,A18I,9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58,53,2010,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Positive,,Positive,Positive,1,NO,YES,,,Stage IIA,T1cN1acM0 (i+),220,TCGA-BH-A18I-01Z-00-DX1.EE699DE3-EBF4-4AB4-8319-9911F027FA18.svs
TCGA-BH-A0DK,,FEMALE,0,-18237,NO,423,WHITE,BH,A0DK,f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad,49,2009,TUMOR FREE,3,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,0,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,423,TCGA-BH-A0DK-01Z-00-DX1.0CFED53C-BAD9-4E35-B12F-57E64F3FEF1C.svs
TCGA-D8-A1JL,,FEMALE,0,-26484,NO,265,WHITE,D8,A1JL,aa4244a8-0454-4247-a1c3-357fd51746fa,72,2010,TUMOR FREE,11,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,265,TCGA-D8-A1JL-01Z-00-DX1.FE3F0C6B-F98A-4036-BF9A-25A8CC66B1FD.svs
TCGA-BH-A18Q,,FEMALE,1,-20675,1692,NO,WHITE,BH,A18Q,db4bc6aa-2e7d-4bcb-8519-a455f624d33b,56,2001,,25,Left,,Negative,,Negative,Negative,Negative,Positive,2,NO,YES,,,Stage IIB,T2N1bM0,1692,TCGA-BH-A18Q-01Z-00-DX1.E89E49C7-D62A-4408-A3D9-19E79FCB249E.svs
TCGA-BH-A0E6,,FEMALE,0,-25408,NO,293,WHITE,BH,A0E6,6c0066e3-96df-4870-bcd3-98cda64082e9,69,2009,TUMOR FREE,1,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,,,Stage IA,T1cN0 (i-)M0,293,TCGA-BH-A0E6-01Z-00-DX1.44DFEFB4-FA05-4246-8D6B-55BA8C3275DB.svs
TCGA-B6-A0WY,,FEMALE,1,-14778,3461,NO,WHITE,B6,A0WY,f475d460-75cd-4fe9-aa54-c90be12b4ef8,40,1996,WITH TUMOR,21,Left Lower Inner QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Positive,,3,NO,YES,,,Stage IIIA,T3N1bM0,3461,TCGA-B6-A0WY-01Z-00-DX1.FA103E02-3BDC-47DC-BA6E-59FCC58866D1.svs
TCGA-D8-A1XL,,FEMALE,0,-12668,NO,319,WHITE,D8,A1XL,2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c,34,2010,TUMOR FREE,13,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,2,YES,NO,,,Stage IIB,T2N1aMX,319,TCGA-D8-A1XL-01Z-00-DX1.FDF07020-8F40-4C00-9023-E5F40E0D8A7C.svs
TCGA-AO-A12D,,FEMALE,0,-15774,NO,1948,WHITE,AO,A12D,2fe854b4-bac9-4801-9a1c-ee99388e8082,43,2005,TUMOR FREE,16,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,Positive,Negative,Positive,1,NO,YES,<10%,<10%,Stage IIA,T1cN1aM0,1948,TCGA-AO-A12D-01Z-00-DX1.BA006BAD-5C6E-4099-BC99-3888E69F506E.svs
TCGA-LL-A5YN,,FEMALE,0,-16884,NO,111,BLACK OR AFRICAN AMERICAN,LL,A5YN,EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C,46,2013,,5,RightRight Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Equivocal,0,YES,NO,90-99%,90-99%,Stage IIA,T2N0 (i-)M0,111,TCGA-LL-A5YN-01Z-00-DX1.F221939B-3680-4B95-93A9-BE8599550E87.svs
TCGA-BH-A0E0,,FEMALE,0,-14175,NO,134,WHITE,BH,A0E0,20e8106b-1290-4735-abe4-7621e08e3dc8,38,2009,TUMOR FREE,21,Left Upper Outer QuadrantLeft Lower Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,10,NO,YES,,,Stage IIIC,T3N3aM0,134,TCGA-BH-A0E0-01Z-00-DX1.01E88024-83DF-4282-ABAF-F4E35807DA06.svs
TCGA-BH-A0EI,,FEMALE,0,-18741,NO,743,WHITE,BH,A0EI,22b35927-1c3f-4f98-ba42-deafc56b677a,51,2008,TUMOR FREE,2,Right,Peri (6-12 months since last menstrual period),Positive,,Negative,,Positive,Negative,2,NO,YES,,,Stage IIA,T1cN1aM0,743,TCGA-BH-A0EI-01Z-00-DX1.929E126A-C9F8-4240-BF00-B6C4A57B7FF6.svs
TCGA-A8-A08C,,FEMALE,0,-24017,NO,608,,A8,A08C,78e1da41-127c-4e9c-aaaa-77a0d94c31d0,65,2008,TUMOR FREE,,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,608,TCGA-A8-A08C-01Z-00-DX1.0602211C-1098-4711-AA41-8F56B11DB36F.svs
TCGA-E2-A1BC,,FEMALE,0,-23168,NO,297,,E2,A1BC,d8492ebd-3d94-4a4b-8de7-386526691cc2,63,2010,TUMOR FREE,4,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Positive,,Positive,Negative,0,NO,YES,,,Stage IA,T1cN0M0,297,TCGA-E2-A1BC-01Z-00-DX1.FD19F2F8-497F-4D7D-97C6-271DC6B75173.svs
TCGA-BH-A0DS,,FEMALE,0,-25944,NO,78,WHITE,BH,A0DS,fb57c598-b45b-478a-9d34-ca1f050d5b7c,71,2010,TUMOR FREE,14,Right Upper Inner QuadrantRight Lower Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,8,NO,YES,70-79%,70-79%,Stage IIIA,T2N2aM0,78,TCGA-BH-A0DS-01Z-00-DX1.38E82A1F-21B9-4B97-A304-15B886EA68A0.svs
TCGA-A2-A25F,,FEMALE,0,-24319,NO,114,WHITE,A2,A25F,c836951b-3ffb-4e20-8504-0eccb7d50dd4,66,2011,TUMOR FREE,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Negative,Negative,0,YES,NO,,<10%,Stage IIA,T2N0 (i-)M0,114,TCGA-A2-A25F-01Z-00-DX1.87499CD4-E41C-46B1-AAF3-5CE881F2B8BC.svs
TCGA-D8-A140,,FEMALE,0,-22900,NO,27,WHITE,D8,A140,2585edbd-3488-4100-a4ab-a161252a31ee,62,2010,,15,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,1,YES,NO,,<10%,Stage IIB,T2N1aM0,27,TCGA-D8-A140-01Z-00-DX2.0C0A62BB-1FB8-47D8-8FAF-112D221F18BE.svs
TCGA-BH-A0BD,,FEMALE,0,-17275,NO,554,WHITE,BH,A0BD,b379bfb8-284e-4300-8325-85cfd6809cb8,47,2009,TUMOR FREE,9,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,2,NO,YES,,,Stage IIA,T1cN1aM0,554,TCGA-BH-A0BD-01Z-00-DX1.CD4A6FC2-BA8C-4E30-972A-E6CD1BEAD8AD.svs
TCGA-LL-A8F5,,FEMALE,0,-22544,NO,189,BLACK OR AFRICAN AMERICAN,LL,A8F5,E1786E78-AC46-46FD-8CE0-8F7456E46082,61,2013,,3,RightRight Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,0,YES,NO,20-29%,<10%,Stage IIA,T2N0 (i-)MX,189,TCGA-LL-A8F5-01Z-00-DX1.7579425E-1425-4160-A9DD-3D50F4C5428D.svs
TCGA-E9-A1R5,,FEMALE,0,-23116,NO,42,WHITE,E9,A1R5,23c21dea-3713-408f-ba56-f7c586e9f206,63,2011,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IA,T1cN0M0,42,TCGA-E9-A1R5-01Z-00-DX1.b870d5eb-6259-4b49-86e4-569a9e32ecd5.svs
TCGA-E2-A10E,,FEMALE,0,-23684,NO,418,WHITE,E2,A10E,dc15a8ae-991e-421c-bc70-70e94f79dd17,64,2008,TUMOR FREE,21,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,,,Stage IIA,T1cN1aM0,418,TCGA-E2-A10E-01Z-00-DX1.C45030A9-CC1A-4BA7-8F62-872619C5AD5E.svs
TCGA-A2-A259,,FEMALE,0,-25666,NO,1286,BLACK OR AFRICAN AMERICAN,A2,A259,3fc3755d-a3f8-4e2c-813f-ff124f2a75c1,70,2007,TUMOR FREE,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Close,Negative,Positive,Negative,0,NO,YES,90-99%,80-89%,Stage I,T1cN0 (i-)M0,1286,TCGA-A2-A259-01Z-00-DX1.7289CD72-CB74-41D4-B4AC-4EA5FDFEC666.svs
TCGA-E2-A15D,,FEMALE,0,-17224,NO,316,WHITE,E2,A15D,c85f080a-1075-41df-959f-1b514a11b3c4,47,2009,TUMOR FREE,4,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,316,TCGA-E2-A15D-01Z-00-DX1.AA5AF847-3635-4BAF-AAC3-BADB4A1B2CB1.svs
TCGA-BH-A0DI,,FEMALE,0,-23327,NO,673,WHITE,BH,A0DI,27ba717a-5cd8-440a-9345-4ae086f6efca,63,2009,TUMOR FREE,28,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,3,NO,YES,,,Stage IIB,T2N1aM0,673,TCGA-BH-A0DI-01Z-00-DX1.6A42D535-8842-4C36-8299-A40E9E56759D.svs
TCGA-GM-A2DN,,FEMALE,0,-21288,NO,2352,WHITE,GM,A2DN,56BBD282-B88D-4730-9242-AB97D08DC83A,58,2004,TUMOR FREE,9,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0 (i-)M0,2352,TCGA-GM-A2DN-01Z-00-DX1.593003B0-BA87-486B-B472-D6B85867D54D.svs
TCGA-A2-A3XZ,,FEMALE,0,-16978,NO,973,BLACK OR AFRICAN AMERICAN,A2,A3XZ,FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0,46,2009,TUMOR FREE,3,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,,Negative,Positive,0,NO,YES,,,Stage I,T1cN0M0,973,TCGA-A2-A3XZ-01Z-00-DX1.B7A1344E-7015-4A21-B3D4-EB760161BE7C.svs
TCGA-AC-A23E,,FEMALE,0,-18500,NO,72,WHITE,AC,A23E,e7bae6e7-f779-449d-92b9-66996041e00d,50,2010,TUMOR FREE,2,Right,,Positive,,Negative,,Positive,,1,,,30-39%,80-89%,Stage IIB,T2N1MX,72,TCGA-AC-A23E-01Z-00-DX1.F12A5A87-72CF-42F8-A6EC-8E7FAD80B1F7.svs
TCGA-BH-A0HU,,FEMALE,0,-19216,NO,392,WHITE,BH,A0HU,dc657ca8-98e8-4ec4-a513-1b848be0e85d,52,2009,TUMOR FREE,1,Right Upper Outer QuadrantRight,Peri (6-12 months since last menstrual period),Positive,1+,Negative,,Positive,Negative,0,NO,YES,40-49%,40-49%,Stage IA,T1cN0 (i-)M0,392,TCGA-BH-A0HU-01Z-00-DX1.73B38904-E4F8-4F45-BD75-A27EC833B6DE.svs
TCGA-AR-A1AR,,FEMALE,1,-18482,524,NO,WHITE,AR,A1AR,eda6d2d5-4199-4f76-a45b-1d0401b4e54c,50,2007,TUMOR FREE,14,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,5,NO,YES,,,Stage IIIA,T1N2M0,524,TCGA-AR-A1AR-01Z-00-DX1.E7B7F6F0-9CC0-4D4F-8C9F-443A74D2BE40.svs
TCGA-C8-A12O,,FEMALE,0,-18506,NO,0,ASIAN,C8,A12O,83f26720-007c-42c9-a7de-7484bf8afa89,50,2010,TUMOR FREE,10,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0 (i-)M0,0,TCGA-C8-A12O-01Z-00-DX1.A77E552B-7B69-45B7-B341-A03571F2A06C.svs
TCGA-AN-A0FF,,FEMALE,0,-11929,NO,172,WHITE,AN,A0FF,d5cab7f5-e4f1-40ee-a0c8-4c8004c1c9a0,32,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,0,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IA,T1bN0M0,172,TCGA-AN-A0FF-01Z-00-DX1.A23982C3-E0EB-4DB2-84EE-26E0005E3F66.svs
TCGA-AO-A128,,FEMALE,0,-22340,NO,2877,WHITE,AO,A128,016caf42-4e19-4444-ab5d-6cf1e76c4afa,61,2002,TUMOR FREE,15,Right Lower Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,Negative,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,2877,TCGA-AO-A128-01Z-00-DX1.4E6BFFBC-87AD-4ED4-959D-FEB5545400BE.svs
TCGA-E2-A14N,,FEMALE,0,-13743,NO,1350,WHITE,E2,A14N,752ad011-79e0-494f-9868-98bf6feb28f8,37,2007,TUMOR FREE,38,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Negative,Negative,1,NO,YES,,,Stage IIB,T2N1M0,1350,TCGA-E2-A14N-01Z-00-DX1.15F5644F-CA9F-4688-B56E-BCC00CA4769B.svs
TCGA-D8-A1JU,,FEMALE,0,-18733,NO,106,WHITE,D8,A1JU,af2a8e2f-2ae1-48bc-bba5-0e2c077c4e48,51,2010,TUMOR FREE,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IA,T1cN0M0,106,TCGA-D8-A1JU-01Z-00-DX1.355D93B4-E69E-417C-B3D1-3E1AAF1E02FE.svs
TCGA-S3-AA15,,FEMALE,0,-18659,NO,209,BLACK OR AFRICAN AMERICAN,S3,AA15,E783E518-C1E5-4EAC-8EAF-E2D65CCD9692,51,2013,TUMOR FREE,13,RightRight Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,2,YES,NO,,,Stage IIB,T2N1acM0 (i+),209,TCGA-S3-AA15-01Z-00-DX2.915A4F90-25CB-4535-99C7-D0D0CFC90412.svs
TCGA-3C-AALI,,FEMALE,0,-18538,NO,3801,BLACK OR AFRICAN AMERICAN,3C,AALI,55262FCB-1B01-4480-B322-36570430C917,50,2003,TUMOR FREE,15,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Positive,1,NO,YES,<10%,<10%,Stage IIB,T2N1aM0,3801,TCGA-3C-AALI-01Z-00-DX1.F6E9A5DF-D8FB-45CF-B4BD-C6B76294C291.svs
TCGA-BH-A42V,,FEMALE,0,-15158,NO,272,BLACK OR AFRICAN AMERICAN,BH,A42V,57CF380D-AB52-467F-B9AE-740B2F84C820,41,2012,TUMOR FREE,3,Left Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Positive,,Positive,Negative,1,YES,NO,,,Stage IB,T1cN1miM0,272,TCGA-BH-A42V-01Z-00-DX1.B6D78256-05D1-45FA-826A-1B8554D60B7D.svs
TCGA-A2-A04R,,FEMALE,0,-13483,NO,2365,BLACK OR AFRICAN AMERICAN,A2,A04R,f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5,36,2004,TUMOR FREE,1,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,60-69%,80-89%,Stage IA,T1N0 (i-)M0,2365,TCGA-A2-A04R-01Z-00-DX1.BE3661A3-A2A0-4248-B7D5-D8986E529B6C.svs
TCGA-AN-A0FW,,FEMALE,0,-24692,NO,11,WHITE,AN,A0FW,e112b452-8850-4353-bfed-0dbdc243290b,67,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Indeterminate,1+,Negative,,Positive,Negative,2,NO,YES,,,Stage IIIA,T2N2M0,11,TCGA-AN-A0FW-01Z-00-DX1.5EEDFC71-6ABE-4189-8C45-2127403A8F04.svs
TCGA-D8-A1JF,,FEMALE,0,-29199,NO,96,WHITE,D8,A1JF,dcd5e079-813a-4c1a-b320-0931468d2bbc,79,2010,TUMOR FREE,25,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,8,YES,NO,,,Stage IIIA,T1cN2aM0,96,TCGA-D8-A1JF-01Z-00-DX1.224EDA43-F822-4A88-814A-BA7D4C60F8CC.svs
TCGA-D8-A1Y2,,FEMALE,0,-26021,NO,73,WHITE,D8,A1Y2,c7d7a770-23c0-4310-ab48-1f6152dc2849,71,2011,TUMOR FREE,7,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Indeterminate,0,YES,NO,,<10%,Stage IIA,T2N0MX,73,TCGA-D8-A1Y2-01Z-00-DX2.A563ABFE-18DE-4D78-BB66-9CD18D3CBE3A.svs
TCGA-BH-A0H5,,FEMALE,0,-16719,NO,1080,WHITE,BH,A0H5,cab38ea8-4555-413c-b81e-4621aac4ef85,45,2008,TUMOR FREE,1,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,0,NO,YES,,,Stage I,T1cN0 (i-)M0,1080,TCGA-BH-A0H5-01Z-00-DX1.28F24D4D-EE80-4EDA-BC30-A194E22FD61C.svs
TCGA-AO-A0J4,,FEMALE,0,-15052,NO,294,BLACK OR AFRICAN AMERICAN,AO,A0J4,a9b7d7fe-be31-4f71-afee-c1bfdf511888,41,2009,TUMOR FREE,4,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IA,T1cN0 (i-)M0,294,TCGA-AO-A0J4-01Z-00-DX1.2EFC978E-8DF5-4254-9598-C0910B17C5C8.svs
TCGA-D8-A1X5,,FEMALE,0,-29734,NO,171,WHITE,D8,A1X5,eb93df3d-9e25-4e4c-9a5d-350f296e5acf,81,2010,TUMOR FREE,16,Right Upper Outer QuadrantRight Lower Inner QuadrantRight Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,14,YES,NO,,,Stage IIIC,T2N3aMX,171,TCGA-D8-A1X5-01Z-00-DX1.81B10B43-0D99-44D0-A245-D652041B8FEE.svs
TCGA-E2-A15F,,FEMALE,0,-23660,NO,469,WHITE,E2,A15F,ec77a23d-84f5-47e4-bf2a-fa1c03baf3db,64,2009,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage I,T1cN0M0,469,TCGA-E2-A15F-01Z-00-DX1.F022214A-3F0C-4DA4-A0EE-735D27480A45.svs
TCGA-BH-A1EY,,FEMALE,1,-28940,538,NO,WHITE,BH,A1EY,0741b5db-4405-42ba-b63a-c6ee4f341480,79,2000,WITH TUMOR,12,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,538,TCGA-BH-A1EY-01Z-00-DX1.25C3DE1F-C702-4959-8DFA-69EF78AD9307.svs
TCGA-C8-A12Y,,FEMALE,0,,NO,0,ASIAN,C8,A12Y,298a1710-deb4-4064-a0f2-da32d43aa217,44,2010,TUMOR FREE,9,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-C8-A12Y-01Z-00-DX1.A15CB3E2-E145-4C75-8FEA-1DD503CD7C20.svs
TCGA-AN-A0FY,,FEMALE,0,-20347,NO,10,WHITE,AN,A0FY,de75d0b9-0f47-4732-8df5-05c350cfcd32,55,2010,TUMOR FREE,11,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,,,Stage IA,T1cN0M0,10,TCGA-AN-A0FY-01Z-00-DX1.25F5E2A1-F92C-4FE1-BD90-0CDDE50DC066.svs
TCGA-A2-A04Y,,FEMALE,0,-19533,NO,764,WHITE,A2,A04Y,9ce7ce09-4409-4fa3-9f78-b2b24716f860,53,2008,TUMOR FREE,13,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,1,NO,YES,90-99%,10-19%,Stage IIB,T2N1miM0,764,TCGA-A2-A04Y-01Z-00-DX1.4DC97AD6-4806-4A3A-A998-FD36F93590A4.svs
TCGA-EW-A1IY,,FEMALE,0,-14122,NO,258,ASIAN,EW,A1IY,5ff12cbe-a3e0-4ce6-8452-12b984a1baaf,38,2009,TUMOR FREE,6,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage I,T1cN0MX,258,TCGA-EW-A1IY-01Z-00-DX1.3FD00274-C2CD-491A-915B-23FD535A4723.svs
TCGA-A8-A06Q,,FEMALE,0,-23164,NO,31,,A8,A06Q,281f70c5-876f-44b3-84fb-f2302f85e74c,63,2007,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIA,T3N2M0,31,TCGA-A8-A06Q-01Z-00-DX1.622AC6E4-DB1A-4C8D-8185-52D4FD1F30B4.svs
TCGA-BH-A1FU,,FEMALE,1,-16174,1688,NO,WHITE,BH,A1FU,c348a9b3-c901-4384-a222-144387bac0c5,44,1997,WITH TUMOR,5,Right Upper Outer Quadrant,,Negative,,,,Negative,,0,NO,YES,,,Stage IA,T1cN0M0,1688,TCGA-BH-A1FU-01Z-00-DX1.3D195750-8C9E-48C6-92EC-44AC6AB56267.svs
TCGA-A8-A093,,FEMALE,0,-22373,NO,546,,A8,A093,02f5ae33-a563-4ecb-9e33-dfa500a44931,61,2009,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,546,TCGA-A8-A093-01Z-00-DX1.1C8056D1-11CD-482D-9A23-3A9D1B4E63F0.svs
TCGA-B6-A0RE,,FEMALE,0,-22449,NO,6435,BLACK OR AFRICAN AMERICAN,B6,A0RE,08da7c4c-3067-4bcf-9d7a-78566df72e69,61,1989,TUMOR FREE,14,Right Upper Outer QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,,0,NO,YES,,,Stage X,TXN0 (i-)M0,6435,TCGA-B6-A0RE-01Z-00-DX1.8933BDB4-EF8D-41FA-9A50-05BB3AB976E5.svs
TCGA-AO-A12B,,FEMALE,0,-23150,NO,2359,WHITE,AO,A12B,f6ed684f-ee7a-496c-80d5-6eacd494d16a,63,2004,TUMOR FREE,2,Right Upper Inner QuadrantRight Lower Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0 (i-)M0,2359,TCGA-AO-A12B-01Z-00-DX1.B215230B-5FF7-4B0A-9C1E-5F1658534B11.svs
TCGA-E2-A105,,FEMALE,0,-28855,NO,1163,WHITE,E2,A105,b0bcb829-cee0-4247-bb75-093a5bea89ee,79,2007,TUMOR FREE,1,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,,Positive,Equivocal,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,1163,TCGA-E2-A105-01Z-00-DX1.192813F9-2D7B-40C7-88D9-BFA939D43FEE.svs
TCGA-OL-A5S0,,FEMALE,0,-24139,NO,298,BLACK OR AFRICAN AMERICAN,OL,A5S0,43B3BF47-7313-4DFB-952A-EC0B9D48E16C,66,2012,TUMOR FREE,12,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Positive,Positive,,2,NO,YES,30-39%,,Stage IIB,T2N1aMX,298,TCGA-OL-A5S0-01Z-00-DX1.49A7AC9D-C186-406C-BA67-2D73DE82E13B.svs
TCGA-E2-A1IF,,FEMALE,0,-27341,NO,956,WHITE,E2,A1IF,718db047-9f32-48c4-98c9-515218441bca,74,2008,TUMOR FREE,4,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,956,TCGA-E2-A1IF-01Z-00-DX1.51F5B0AC-E4D6-439D-8168-34934471FA06.svs
TCGA-A8-A083,,FEMALE,0,-24746,NO,0,,A8,A083,afb9418e-91eb-4db1-aacf-12bd946c9ba0,67,2008,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T3N0M0,0,TCGA-A8-A083-01Z-00-DX1.AD121BA9-B5FA-4A03-869B-8FE2C5014CE0.svs
TCGA-A8-A091,,FEMALE,0,-22554,NO,580,,A8,A091,f39edd06-1016-4e8e-a42e-12f7e699ddc5,61,2008,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,580,TCGA-A8-A091-01Z-00-DX1.1F38CADB-A093-416E-A8A8-31E61CD730BA.svs
TCGA-AN-A0FV,,FEMALE,0,-21479,NO,10,WHITE,AN,A0FV,2e8e70f2-c781-44c2-8f12-1f8c2f536aa3,58,2010,TUMOR FREE,12,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A0FV-01Z-00-DX1.C0D02946-FCDA-472D-895D-7ACF5C96B264.svs
TCGA-AO-A1KP,,FEMALE,0,-28247,NO,2513,WHITE,AO,A1KP,3aaabc62-f5a4-4025-9b29-5adf82c86c84,77,2003,TUMOR FREE,9,Left Lower Inner QuadrantLeft Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,0,NO,YES,80-89%,40-49%,Stage IIA,T1N1M0,2513,TCGA-AO-A1KP-01Z-00-DX1.612442AB-24E2-489B-9838-7CEE82BCD605.svs
TCGA-LL-A5YO,,FEMALE,0,-18354,NO,97,BLACK OR AFRICAN AMERICAN,LL,A5YO,B8AEFC48-4A6E-4254-A57F-5F688399B582,50,2013,TUMOR FREE,1,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IA,T1bN0MX,97,TCGA-LL-A5YO-01Z-00-DX1.B5B6DFDB-1020-41FF-AA50-9C633E17DE5F.svs
TCGA-B6-A0X5,,FEMALE,1,-22380,2097,NO,BLACK OR AFRICAN AMERICAN,B6,A0X5,4e6edfe6-adcb-4c12-8ff4-38a79f5887e8,61,1995,WITH TUMOR,14,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,3,NO,YES,,,Stage IIB,T2N1bM0,2097,TCGA-B6-A0X5-01Z-00-DX1.02A9FF1E-EA20-4F2D-A2BB-427A287DE3FD.svs
TCGA-C8-A12W,,FEMALE,0,-18140,NO,7,ASIAN,C8,A12W,6adca853-1b09-47ff-814c-47b732a76d96,49,2010,TUMOR FREE,7,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIIB,T4N1M0,7,TCGA-C8-A12W-01Z-00-DX1.3727E7BB-831E-42DB-B5CB-F2D7C649290F.svs
TCGA-A8-A08S,,FEMALE,0,-25994,NO,580,,A8,A08S,2779fa01-ac93-4e80-a997-3385f72172c3,71,2008,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T1cN1M0,580,TCGA-A8-A08S-01Z-00-DX1.C0E044C2-FC3F-4E3D-A779-A725FF375F21.svs
TCGA-E9-A228,,FEMALE,0,-21294,NO,0,WHITE,E9,A228,b95eef8a-205f-4cf8-9d3c-ae51d406e1e0,58,2011,TUMOR FREE,12,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,2,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-E9-A228-01Z-00-DX1.adbeed20-3b14-44fe-a98a-3bf7cecea30a.svs
TCGA-A8-A08J,,FEMALE,1,-19266,1127,NO,,A8,A08J,68177e92-4784-45d9-af14-4ce0c00eae74,52,2005,WITH TUMOR,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Positive,Negative,Positive,Negative,,NO,YES,,,Stage IV,T4bN3M1,1127,TCGA-A8-A08J-01Z-00-DX1.4607286A-033B-4C44-8306-50DB9C596166.svs
TCGA-EW-A1OY,,FEMALE,0,-23266,NO,593,WHITE,EW,A1OY,53ff5893-7d5e-4bcb-be9c-665fa34b7824,63,2009,TUMOR FREE,1,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0MX,593,TCGA-EW-A1OY-01Z-00-DX1.42AF5C9A-A90F-4A58-B5D4-B615F8CD4333.svs
TCGA-AC-A8OP,,FEMALE,0,-26550,NO,53,BLACK OR AFRICAN AMERICAN,AC,A8OP,B9C6C069-2A2B-4CC7-A398-DC45C132D979,72,2011,TUMOR FREE,6,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Indeterminate,0,YES,NO,90-99%,10-19%,Stage IA,T1cN0 (i-)MX,53,TCGA-AC-A8OP-01Z-00-DX1.A2AF501D-7DCD-4BE7-93A4-EBCAF0C0D54E.svs
TCGA-B6-A0RM,,FEMALE,1,-21047,2373,NO,BLACK OR AFRICAN AMERICAN,B6,A0RM,151f3677-6854-4265-9126-d92c646c67ae,57,1993,TUMOR FREE,0,Left,Indeterminate (neither Pre or Postmenopausal),Positive,,,,Positive,,,NO,YES,,,Stage X,TXNXMX,2373,TCGA-B6-A0RM-01Z-00-DX1.31DE3E32-7996-4D30-BB5F-72C94409C940.svs
TCGA-AR-A0TT,,FEMALE,0,-19679,NO,1730,BLACK OR AFRICAN AMERICAN,AR,A0TT,13ca97a1-75bb-4a49-b8c3-181e5b2c9e86,53,2006,,19,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Positive,Negative,5,NO,YES,10-19%,,Stage IIIA,T2N2M0,1730,TCGA-AR-A0TT-01Z-00-DX1.127C2A4F-62AC-4E83-99DB-13519BD2949D.svs
TCGA-E2-A1LE,,FEMALE,1,-26239,879,NO,WHITE,E2,A1LE,7317E605-93BA-49A9-8743-20613B02767A,71,2008,WITH TUMOR,28,Right Upper Inner QuadrantRight Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,27,NO,YES,,,Stage IIIC,T2N3aM0,879,TCGA-E2-A1LE-01Z-00-DX1.22856B2A-FBAA-4530-AEEC-E8F77BDA7F7F.svs
TCGA-A2-A1G6,,FEMALE,0,-18514,NO,132,WHITE,A2,A1G6,295cf595-4a29-46a3-a0c5-e5f08f947031,50,2010,TUMOR FREE,9,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,4,YES,NO,,,Stage IIIA,T2N2aM0,132,TCGA-A2-A1G6-01Z-00-DX1.BCC3EC46-CEBF-4B37-BCF0-266D18170B54.svs
TCGA-LD-A9QF,,FEMALE,0,-26869,NO,266,BLACK OR AFRICAN AMERICAN,LD,A9QF,95C53ECF-D8F1-4BCB-9B1A-C9A0542939F0,73,2013,TUMOR FREE,14,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,0,YES,NO,,,Stage IA,T1cN0M0,266,TCGA-LD-A9QF-01Z-00-DX1.092108DF-1A60-459E-ACE6-5A71826A98D1.svs
TCGA-D8-A1XY,,FEMALE,0,-27106,NO,81,WHITE,D8,A1XY,0130d616-885e-4a6c-9d03-2f17dd692a05,74,2010,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,,,Positive,Positive,0,YES,NO,,,Stage IIA,T2N0MX,81,TCGA-D8-A1XY-01Z-00-DX1.AC051FB4-1D51-449B-BF2D-9DDB4382414C.svs
TCGA-AN-A0AJ,,FEMALE,0,-29131,NO,244,WHITE,AN,A0AJ,9646160a-f1f9-437b-8c7d-efb0b57bfb97,79,2010,TUMOR FREE,9,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,0,NO,YES,80-89%,40-49%,Stage IIB,T3N0M0,244,TCGA-AN-A0AJ-01Z-00-DX1.74EE47B0-FE27-44CF-9355-C738DE1BD017.svs
TCGA-AR-A0TP,,FEMALE,0,-15812,NO,2521,WHITE,AR,A0TP,ab89bb2e-da84-4116-a8cd-49aad7bbfd4d,43,2003,,5,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Positive,Negative,0,NO,YES,<10%,,Stage IIA,T2N0M0,2521,TCGA-AR-A0TP-01Z-00-DX1.58E6A3A6-D1D7-4AE5-87A5-E823F04CBB2F.svs
TCGA-A2-A1FZ,,FEMALE,0,-23055,NO,410,WHITE,A2,A1FZ,805bfe39-3695-43c2-93e4-d66d0559b89f,63,2010,TUMOR FREE,3,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,YES,NO,90-99%,90-99%,Stage IIA,T2N0 (i-)M0,410,TCGA-A2-A1FZ-01Z-00-DX1.0BAAEF41-DCA4-4677-9A27-09E990033FA6.svs
TCGA-OL-A6VO,,FEMALE,0,-15780,NO,480,BLACK OR AFRICAN AMERICAN,OL,A6VO,398FB71B-CA83-44E7-BF0D-B1CA464B0283,43,2012,TUMOR FREE,7,RightRight Lower Outer Quadrant,,Negative,,Negative,Negative,Negative,Negative,0,NO,YES,,,Stage IA,T1cN0MX,480,TCGA-OL-A6VO-01Z-00-DX1.291D54D6-EBAF-4622-BD42-97AA5997F014.svs
TCGA-D8-A143,,FEMALE,0,-18984,NO,172,WHITE,D8,A143,1c40b84e-a0e3-429f-a48c-21566cf881c0,51,2010,TUMOR FREE,11,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,172,TCGA-D8-A143-01Z-00-DX1.4697FB2F-91D5-4506-AF23-7DE304D44A3F.svs
TCGA-E2-A1LB,,FEMALE,0,-15283,NO,972,BLACK OR AFRICAN AMERICAN,E2,A1LB,fa176764-a76f-44c7-b97a-cd6d21e052be,41,2008,TUMOR FREE,25,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,,Negative,Positive,2,NO,YES,,,Stage IIB,T2N1M0,972,TCGA-E2-A1LB-01Z-00-DX1.B4AFDB08-BA09-4F6E-806E-4054B790AB8E.svs
TCGA-AO-A0JF,,FEMALE,0,-24923,NO,354,WHITE,AO,A0JF,f357fe19-5359-4662-8ce9-aa996132283b,68,2009,TUMOR FREE,14,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,2,NO,YES,90-99%,70-79%,Stage IIA,T1cN1aM0,354,TCGA-AO-A0JF-01Z-00-DX1.3277D13C-F257-4D4C-AB5C-BEBA2E1A63D8.svs
TCGA-AR-A24L,,FEMALE,0,-9706,NO,2221,WHITE,AR,A24L,de646f6a-6d50-4be2-b3cd-f17554b234df,26,2005,,12,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,10-19%,10-19%,Stage IIB,T2N1M0,2221,TCGA-AR-A24L-01Z-00-DX1.218A0AE1-D070-4A16-A277-31185F10724D.svs
TCGA-AO-A03M,,FEMALE,0,-10616,NO,1455,WHITE,AO,A03M,095c7985-3842-494f-b591-706ad1cd2133,29,2006,TUMOR FREE,2,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Negative,0,NO,YES,70-79%,60-69%,Stage I,T1cN0 (i-)M0,1455,TCGA-AO-A03M-01Z-00-DX1.9998A9A0-D0A6-48FC-80FB-AE597CB9E8AA.svs
TCGA-E9-A1R0,,FEMALE,0,-21394,NO,0,WHITE,E9,A1R0,f2da1d3f-f226-4c99-a97e-9b26f67d7a5d,58,2011,TUMOR FREE,12,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,1,YES,NO,,,Stage IIA,T1cN1M0,0,TCGA-E9-A1R0-01Z-00-DX1.187C58EA-132E-4B3C-BAD0-7F59101D5C4D.svs
TCGA-A8-A090,,FEMALE,0,-27121,NO,0,,A8,A090,f4b69043-4a67-48e3-a4d1-72a21ae2d175,74,2008,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,0,TCGA-A8-A090-01Z-00-DX1.01574070-D65E-486F-B69D-0F8E3816D057.svs
TCGA-BH-A5J0,,FEMALE,0,-23072,NO,225,BLACK OR AFRICAN AMERICAN,BH,A5J0,DB55D9D9-DD56-4CA9-B1F1-0D929697B280,63,2012,TUMOR FREE,5,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,YES,NO,,,Stage IA,T1cN0M0,225,TCGA-BH-A5J0-01Z-00-DX1.73CFBC85-8449-48FF-86F8-D4D49A90498B.svs
TCGA-BH-A0B7,,FEMALE,0,-15593,NO,1733,WHITE,BH,A0B7,214a4507-d974-4b3e-8525-7408fccc6a0f,42,2006,TUMOR FREE,17,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,,Positive,Positive,1,NO,YES,,,Stage IIB,T2N1aM0,1733,TCGA-BH-A0B7-01Z-00-DX1.6950CDDF-8A81-4B10-BFFF-BE0E33A2C6CC.svs
TCGA-D8-A1JJ,,FEMALE,0,-19966,NO,274,WHITE,D8,A1JJ,f7ab565c-83b5-4988-b9be-8a46f65dca8c,54,2010,TUMOR FREE,1,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IIA,T2N0M0,274,TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7.svs
TCGA-BH-A0BL,,FEMALE,0,-12841,NO,1340,WHITE,BH,A0BL,92b5de82-0221-4df1-8094-80f40c0bb4fa,35,2007,TUMOR FREE,2,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage I,T1cN0M0,1340,TCGA-BH-A0BL-01Z-00-DX1.D5A413B0-2141-4A6F-A671-6C5EA8641D25.svs
TCGA-A7-A26I,,FEMALE,0,-23948,NO,122,WHITE,A7,A26I,b2ecbc0f-2c30-4200-8d5e-7b95424bcadb,65,2011,,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Close,Negative,Negative,Equivocal,0,YES,NO,,,Stage IIA,T2N0M0,122,TCGA-A7-A26I-01Z-00-DX1.0077D012-BC14-4E96-84F7-A1A6A3A778DF.svs
TCGA-3C-AALJ,,FEMALE,0,-22848,NO,1228,BLACK OR AFRICAN AMERICAN,3C,AALJ,427D0648-3F77-4FFC-B52C-89855426D647,62,2011,TUMOR FREE,23,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Indeterminate,1,NO,YES,90-99%,30-39%,Stage IIB,T2N1aM0,1228,TCGA-3C-AALJ-01Z-00-DX2.62DFE56B-B84C-40F9-9625-FCB55767B70D.svs
TCGA-E2-A14O,,FEMALE,0,-27837,NO,1173,WHITE,E2,A14O,fb356957-f620-4d99-b675-1355a1d9f932,76,2008,TUMOR FREE,18,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,,,Stage IIIA,T3N1aM0,1173,TCGA-E2-A14O-01Z-00-DX1.432DB252-35D4-4B02-B0A7-39BF85A38F89.svs
TCGA-EW-A1P1,,FEMALE,0,-24923,NO,920,WHITE,EW,A1P1,f2e28af9-c40e-41c4-9e82-205cca38f26a,68,2008,WITH TUMOR,32,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,11,NO,YES,<10%,<10%,Stage IIIC,T2N3bMX,920,TCGA-EW-A1P1-01Z-00-DX1.4B670029-4B3B-4D76-8EA4-F4F29EEF9E37.svs
TCGA-BH-A0HL,,FEMALE,0,-20804,NO,72,WHITE,BH,A0HL,602083f0-18d9-48b6-a529-31e165c54b37,56,2009,TUMOR FREE,17,Right Lower Inner QuadrantRight Lower Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,90-99%,40-49%,Stage IIB,T2N1aM0,72,TCGA-BH-A0HL-01Z-00-DX1.972DE96D-51F4-4A2D-B074-8D965023DC01.svs
TCGA-BH-A0HB,,FEMALE,0,-20448,NO,806,WHITE,BH,A0HB,0c1023c0-d2ce-4940-8047-7642f1dc3965,55,2008,TUMOR FREE,2,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,30-39%,Stage IA,T1cN0 (i-)M0,806,TCGA-BH-A0HB-01Z-00-DX1.F90F7139-B804-4548-9FAF-9B475BF225EB.svs
TCGA-GM-A2DL,,FEMALE,0,-18475,NO,2763,WHITE,GM,A2DL,A76774FE-7298-4D68-A2B2-C1BAD93F0C31,50,2003,TUMOR FREE,2,Left Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage I,T1cN0 (i-)M0,2763,TCGA-GM-A2DL-01Z-00-DX1.1CE6992E-B1CE-45AB-B2EB-75338B6FEE9D.svs
TCGA-LL-A73Y,,FEMALE,0,-24647,NO,126,BLACK OR AFRICAN AMERICAN,LL,A73Y,EA645243-DF49-4466-A255-9F3D4321E357,67,2013,TUMOR FREE,1,RightRight Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Negative,0,YES,NO,,,Stage IA,T1cN0MX,126,TCGA-LL-A73Y-01Z-00-DX1.50C20931-3AA9-40B4-8A73-56B1976423A8.svs
TCGA-E9-A249,,FEMALE,0,-16689,NO,29,WHITE,E9,A249,fb3607eb-858e-4ecd-8477-95140658c6d2,45,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0 (i-)M0,29,TCGA-E9-A249-01Z-00-DX1.CA244384-FD89-44F6-8F94-A060A4C241CA.svs
TCGA-GM-A2DK,,FEMALE,0,-21198,NO,1896,WHITE,GM,A2DK,3A0775A0-61AE-43F2-B5F6-629A44355C2F,58,2005,TUMOR FREE,1,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,0,NO,YES,90-99%,<10%,Stage I,T1cN0 (i-)M0,1896,TCGA-GM-A2DK-01Z-00-DX1.4F81A585-9549-454C-8E15-2E4545795460.svs
TCGA-EW-A1PA,,FEMALE,0,-21837,NO,267,WHITE,EW,A1PA,4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6,59,2010,TUMOR FREE,13,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,NO,YES,90-99%,90-99%,Stage IIB,T2N1aM0,267,TCGA-EW-A1PA-01Z-00-DX1.03B033F8-62C0-49E1-BDEA-C5217AB3460A.svs
TCGA-A8-A06O,,FEMALE,0,-22157,NO,396,,A8,A06O,69054195-9e93-49e5-b820-69b0091cc2d4,60,2009,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage I,T1cN0M0,396,TCGA-A8-A06O-01Z-00-DX1.FA4495B2-5B13-4448-ADCB-EF5316E0955B.svs
TCGA-BH-A0GY,,FEMALE,0,-24493,NO,917,WHITE,BH,A0GY,7d9d3522-ec3b-4efe-8c8e-c0e675276ef5,67,2008,TUMOR FREE,26,Left Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,3,NO,YES,40-49%,90-99%,Stage IIA,T2N1M0,917,TCGA-BH-A0GY-01Z-00-DX1.E1AEAA36-94FA-41ED-851F-7BB11DD3C06D.svs
TCGA-AN-A0XO,,FEMALE,0,-21640,NO,375,WHITE,AN,A0XO,195b6731-6ae6-416e-a345-0eb8874a0ca2,59,2010,TUMOR FREE,12,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,2,NO,YES,,,Stage IIIA,T2N2M0,375,TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD.svs
TCGA-D8-A1Y1,,FEMALE,0,-29474,NO,116,WHITE,D8,A1Y1,38a631a1-6875-4216-a335-ee93c90a86d6,80,2010,TUMOR FREE,22,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,,,Positive,Negative,1,YES,NO,,,Stage IIIA,T3N1aMX,116,TCGA-D8-A1Y1-01Z-00-DX1.477390C8-2141-4ADD-813E-25220D2A71FC.svs
TCGA-E2-A14X,,FEMALE,0,-20105,NO,692,BLACK OR AFRICAN AMERICAN,E2,A14X,60df7543-6da5-4c75-943b-5800c1e08234,55,2009,TUMOR FREE,21,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,5,NO,YES,,,Stage IIIA,T2N2M0,692,TCGA-E2-A14X-01Z-00-DX1.24ADDA43-F127-4A6B-9AAD-2FAD982A853D.svs
TCGA-AN-A0AR,,FEMALE,0,-20152,NO,10,WHITE,AN,A0AR,ebc460c2-df88-4dc0-a2c0-aca8072b75ad,55,2010,TUMOR FREE,17,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A0AR-01Z-00-DX1.0CF1267E-C61B-4928-875E-59032F838F07.svs
TCGA-C8-A26W,,FEMALE,0,-21391,NO,7,ASIAN,C8,A26W,ff0f875f-113a-4c0f-8c0a-4259cd496e6d,58,2010,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,,Positive,Equivocal,,YES,NO,,,Stage IIB,T2N1M0,7,TCGA-C8-A26W-01Z-00-DX1.CFF07941-6CD1-4CF9-BE5F-387DA67B66CC.svs
TCGA-BH-A1EU,,FEMALE,1,-30339,1286,NO,WHITE,BH,A1EU,a1093598-d3a8-4ffe-83fc-bc7d1faff7e5,83,1999,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Negative,,NO,YES,,,Stage I,T1N0M0,1286,TCGA-BH-A1EU-01Z-00-DX1.5A0956EF-0100-47FD-9026-1994CF22D0F1.svs
TCGA-A2-A0SV,,FEMALE,1,-23126,825,NO,WHITE,A2,A0SV,ad01259b-d858-40bc-a6ba-0bb06e996afb,63,2006,WITH TUMOR,9,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,8,NO,YES,90-99%,10-19%,Stage IV,T2N2aM1,825,TCGA-A2-A0SV-01Z-00-DX1.F5645E47-3540-4753-AF5D-F5709BD8DFC1.svs
TCGA-B6-A0WV,,FEMALE,1,-24803,2417,NO,WHITE,B6,A0WV,7588a286-6935-424a-bc5f-92e24c83eb37,67,1995,TUMOR FREE,7,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,4,NO,YES,,,Stage IIB,T2N1bM0,2417,TCGA-B6-A0WV-01Z-00-DX1.A8B9E114-A8CF-4389-B47C-2E1B842F7FF9.svs
TCGA-A7-A0D9,,FEMALE,0,-13836,NO,160,WHITE,A7,A0D9,17baef7c-d97d-4b98-ab53-503ef856523d,37,2009,TUMOR FREE,1,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Positive,Negative,0,YES,NO,90-99%,<10%,Stage IIA,T2N0 (i-)M0,160,TCGA-A7-A0D9-01Z-00-DX2.66CD9ED8-223B-4AC8-AA1A-2481FB0C47B3.svs
TCGA-AR-A0U4,,FEMALE,0,-19729,NO,1684,WHITE,AR,A0U4,71f97b63-c970-44ee-98c2-e02e663d5a40,54,2006,,10,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,1684,TCGA-AR-A0U4-01Z-00-DX1.DE722DC5-859D-4866-ADCC-ED98EDBFB588.svs
TCGA-E2-A1B6,,FEMALE,0,-16370,NO,338,WHITE,E2,A1B6,e0b1bcd2-1139-44b9-98b3-67bcf92bcc39,44,2008,TUMOR FREE,5,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,338,TCGA-E2-A1B6-01Z-00-DX1.8CD458BE-C4F9-4AF3-A927-18C042E9B4B7.svs
TCGA-S3-AA11,,FEMALE,0,-24813,NO,169,BLACK OR AFRICAN AMERICAN,S3,AA11,0DD8DBC1-C48B-4E7C-B401-57101F724967,67,2013,TUMOR FREE,1,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,YES,NO,90-99%,60-69%,Stage IIA,T2N0M0,169,TCGA-S3-AA11-01Z-00-DX1.36B83B37-2928-4DB7-A04A-8D511F1183FD.svs
TCGA-E2-A1IK,,FEMALE,0,-26052,NO,519,WHITE,E2,A1IK,becedbfd-b2aa-4dde-b7f4-29e6f59ec32c,71,2009,TUMOR FREE,6,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIA,T1cN1miM0,519,TCGA-E2-A1IK-01Z-00-DX1.25C554BB-AA90-4FF4-9D68-EEC899B8A27D.svs
TCGA-AO-A12F,,FEMALE,0,-13409,NO,1471,WHITE,AO,A12F,495f9eda-b9be-4eef-bae1-766a4bfbd68e,36,2006,TUMOR FREE,17,Right Upper Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,1471,TCGA-AO-A12F-01Z-00-DX1.847C8E4F-3F37-4B1D-8E6E-ACD14391AD89.svs
TCGA-B6-A1KF,,FEMALE,0,-24891,NO,3088,WHITE,B6,A1KF,f30eb65f-fb44-4062-ac39-a38d072f655f,68,1998,TUMOR FREE,14,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,,Negative,Equivocal,2,NO,YES,,,Stage IIB,T2N1M0,3088,TCGA-B6-A1KF-01Z-00-DX1.2E08E830-4216-4CD0-9646-1F489300E11D.svs
TCGA-EW-A6SB,,FEMALE,0,-22844,NO,760,BLACK OR AFRICAN AMERICAN,EW,A6SB,5C59028F-B8FA-4811-8314-BE3EAED5F364,62,2012,TUMOR FREE,8,LeftLeft Upper Inner Quadrant,,Negative,,Negative,,Negative,Negative,0,,,,,Stage II,T2N0M0,760,TCGA-EW-A6SB-01Z-00-DX1.D56E1922-01A9-4AEE-AB95-D69447DD13EE.svs
TCGA-E9-A1R7,,FEMALE,0,-23397,NO,34,WHITE,E9,A1R7,2680da86-c977-4611-b75f-df015283c023,64,2011,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0M0,34,TCGA-E9-A1R7-01Z-00-DX1.af9ff432-440e-44ac-bc33-298f5db9a706.svs
TCGA-C8-A12Z,,FEMALE,0,-16508,NO,12,ASIAN,C8,A12Z,42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4,45,2010,TUMOR FREE,2,Right,Peri (6-12 months since last menstrual period),Negative,3+,Negative,,Negative,Positive,2,YES,NO,,,Stage IIB,T2N1M0,12,TCGA-C8-A12Z-01Z-00-DX1.22616420-7C80-42DE-9C44-0F00327681C6.svs
TCGA-A1-A0SJ,,FEMALE,0,-14383,NO,416,BLACK OR AFRICAN AMERICAN,A1,A0SJ,a2db9dd1-44d5-48b5-817c-a21a85fadb21,39,2006,TUMOR FREE,19,Left,,Positive,2+,Negative,Negative,Positive,Equivocal,3,NO,YES,70-79%,10-19%,Stage IIIA,T3N1aM0,416,TCGA-A1-A0SJ-01Z-00-DX1.C196FA66-C376-4016-86BC-3D8E745B3A51.svs
TCGA-BH-A0H7,,FEMALE,0,-23972,NO,702,WHITE,BH,A0H7,2021ed1f-dc75-4701-b8b8-1386466e4802,65,2008,TUMOR FREE,16,Right Upper Inner QuadrantRight Upper Outer QuadrantRight Lower Inner QuadrantRight Lower Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,6,NO,YES,70-79%,30-39%,Stage IIIA,T1cN2aM0,702,TCGA-BH-A0H7-01Z-00-DX1.21502FEA-DB37-4630-BA42-778DDF3A6D17.svs
TCGA-AR-A1AQ,,FEMALE,0,-18109,NO,1310,WHITE,AR,A1AQ,98e0b4de-52fc-4945-9bf5-11e29368f939,49,2007,TUMOR FREE,6,Right Upper Inner QuadrantRight Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,1310,TCGA-AR-A1AQ-01Z-00-DX1.09D5D7FC-0FA8-4176-94B2-995F44D8ED4C.svs
TCGA-AR-A24Q,,FEMALE,0,-18084,NO,2009,WHITE,AR,A24Q,28e9048a-e540-42de-a1f4-4ef894fccc4c,49,2006,,2,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,0,NO,YES,<10%,,Stage IIB,T3N0M0,2009,TCGA-AR-A24Q-01Z-00-DX1.69DC7E35-DC0D-4F20-88DA-04C25F28628C.svs
TCGA-A8-A09I,,FEMALE,0,-30711,NO,1006,,A8,A09I,1557183c-aedd-4df6-b98a-3654667f7b69,84,2008,TUMOR FREE,,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,1006,TCGA-A8-A09I-01Z-00-DX1.B738E479-8766-4766-B012-B32AC2F27533.svs
TCGA-AR-A24U,,FEMALE,0,-17523,NO,1623,WHITE,AR,A24U,241fffc8-4250-4cfa-b2e7-e68c33ae07dc,47,2006,,25,Left Upper Outer QuadrantLeft Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Positive,,Negative,Positive,2,NO,YES,,,Stage IIA,T1N1M0,1623,TCGA-AR-A24U-01Z-00-DX1.220FD0D0-0DB6-4E3C-92A0-66CD6509F0AD.svs
TCGA-A2-A0YF,,FEMALE,0,-24660,NO,289,BLACK OR AFRICAN AMERICAN,A2,A0YF,ae8c77fe-e6c8-44d5-8265-4a38c637bbef,67,2009,TUMOR FREE,1,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Positive,Negative,0,NO,YES,90-99%,<10%,Stage I,T1bN0 (i+)M0,289,TCGA-A2-A0YF-01Z-00-DX1.6166E995-0669-43D6-B9C7-FE39BCE529CF.svs
TCGA-LD-A7W5,,FEMALE,0,-19169,NO,124,BLACK OR AFRICAN AMERICAN,LD,A7W5,A06FF6AE-B0DD-4516-A75C-0DB71694B46B,52,2013,WITH TUMOR,23,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Positive,,Positive,Negative,23,YES,NO,90-99%,,Stage IIIC,T2N3aM0,124,TCGA-LD-A7W5-01Z-00-DX1.C9920081-C2FE-461E-AEF8-625D4A95BE2F.svs
TCGA-A2-A0YH,,FEMALE,0,-19596,NO,379,WHITE,A2,A0YH,298d33da-15af-48cb-b30f-eaf54e7baa43,53,2009,TUMOR FREE,28,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,5,NO,YES,80-89%,70-79%,Stage IIIA,T2N2aM0,379,TCGA-A2-A0YH-01Z-00-DX1.FBA5E711-8275-45B3-BC20-5A786EE23548.svs
TCGA-A2-A0EU,,FEMALE,0,-29144,NO,733,WHITE,A2,A0EU,c0427237-b476-4af4-b664-7bd479922ea5,79,2008,TUMOR FREE,1,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Positive,Negative,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IA,T1cN0 (i-)M0,733,TCGA-A2-A0EU-01Z-00-DX1.13335BEB-63D4-469B-A389-8A079A096129.svs
TCGA-BH-A0BP,,FEMALE,0,-27917,NO,1481,WHITE,BH,A0BP,f251cb6c-d18e-4691-9c82-24ed1ac0abf9,76,2006,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,1481,TCGA-BH-A0BP-01Z-00-DX1.63A87C1D-87FA-494D-9836-74290B5DC30D.svs
TCGA-BH-A1ET,,FEMALE,1,-20425,2520,NO,WHITE,BH,A1ET,8986a141-eae7-4157-b695-02cc6fc3b071,55,1999,TUMOR FREE,19,Left,,Positive,,,,Positive,Negative,1,NO,YES,,,Stage I,T1N0M0,2520,TCGA-BH-A1ET-01Z-00-DX1.05C126CD-CC10-44BF-9A68-6CDDE97272B2.svs
TCGA-LL-A7T0,,FEMALE,0,-25867,NO,98,BLACK OR AFRICAN AMERICAN,LL,A7T0,D8F8064F-02EF-4FED-942B-714CBE5E8455,70,2013,,4,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,1,YES,NO,90-99%,<10%,Stage IIB,T2N1aM0,98,TCGA-LL-A7T0-01Z-00-DX1.B03BBA63-ACF4-4BCA-9F2B-F631F0C6A25C.svs
TCGA-A2-A0CQ,,FEMALE,0,-22810,NO,2393,BLACK OR AFRICAN AMERICAN,A2,A0CQ,ab34a9a2-d72d-4106-94fb-118844b1b60b,62,2003,TUMOR FREE,1,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,0,NO,YES,90-99%,90-99%,Stage IA,T1N0 (i-)M0,2393,TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649.svs
TCGA-A2-A0T3,,FEMALE,0,-13680,NO,456,WHITE,A2,A0T3,058dcb78-bed1-40c3-a6c2-a0cc40065531,37,2009,TUMOR FREE,13,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Positive,Negative,Positive,Equivocal,2,NO,YES,90-99%,90-99%,Stage IB,T1cN1miM0,456,TCGA-A2-A0T3-01Z-00-DX1.5E96BC87-F4FB-4ABA-8D81-FAB7F4A80661.svs
TCGA-BH-A0BO,,FEMALE,0,-19767,NO,1085,WHITE,BH,A0BO,26573441-eedb-4364-966c-e7f803deef19,54,2007,TUMOR FREE,3,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1bN0M0,1085,TCGA-BH-A0BO-01Z-00-DX1.1A704471-FEB3-40F9-9838-3E347A18285F.svs
TCGA-C8-A1HJ,,FEMALE,0,-19629,NO,5,ASIAN,C8,A1HJ,a855c228-a263-44df-87a0-cbc32187e3f5,53,2010,TUMOR FREE,10,Right,Peri (6-12 months since last menstrual period),Negative,,Negative,,Negative,Negative,,YES,NO,,,Stage IIA,T2N0M0,5,TCGA-C8-A1HJ-01Z-00-DX1.745159F1-85E7-4CC0-B088-E1CA91916FB8.svs
TCGA-AN-A0XL,,FEMALE,0,-22341,NO,10,WHITE,AN,A0XL,4649dee3-b668-44cd-ab97-3834de3ef8f8,61,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A0XL-01Z-00-DX1.E90AA056-51DC-4A6B-96EB-A0B707496912.svs
TCGA-WT-AB41,,FEMALE,0,,NO,1550,BLACK OR AFRICAN AMERICAN,WT,AB41,E7DB08A7-B439-4230-8DC4-1B54AF4736C4,55,2010,TUMOR FREE,2,Left Upper Outer QuadrantLeft Lower Inner QuadrantLeft Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,1,NO,YES,90-99%,<10%,Stage IIB,T2N1miMX,1550,TCGA-WT-AB41.svs
TCGA-LL-A73Z,,FEMALE,0,-20118,NO,137,BLACK OR AFRICAN AMERICAN,LL,A73Z,3E637872-F5E5-49D3-BB0D-9C16B8713382,55,2013,WITH TUMOR,,LeftLeft Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,,YES,NO,10-19%,<10%,Stage IV,T1cNXM1,137,TCGA-LL-A73Z-01Z-00-DX1.C010142E-29C0-411D-9E0E-4B7D8A4C09BF.svs
TCGA-A2-A0ST,,FEMALE,0,-22922,NO,2619,WHITE,A2,A0ST,12d31787-e54d-4729-ace8-9141043c92b8,62,2003,,9,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,3,NO,YES,,,Stage IIA,T1cN1aM0,2619,TCGA-A2-A0ST-01Z-00-DX1.AE05A5DB-4861-40DE-B0F5-7955FC903A96.svs
TCGA-BH-A0C0,,FEMALE,0,-23006,NO,1270,WHITE,BH,A0C0,7875018b-91dc-4ab1-83b0-ee3883e2816e,62,2007,TUMOR FREE,35,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Equivocal,1,NO,YES,90-99%,60-69%,Stage IIA,T1cN1aM0,1270,TCGA-BH-A0C0-01Z-00-DX1.2D32D35A-EB7E-4D0E-BE5F-E56F7B930463.svs
TCGA-LL-A6FQ,,FEMALE,0,-28375,NO,80,BLACK OR AFRICAN AMERICAN,LL,A6FQ,92B842C5-F71B-4EF7-BA86-358D28E0966F,77,2013,,18,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,7,YES,NO,90-99%,80-89%,Stage IIIA,T2N2aMX,80,TCGA-LL-A6FQ-01Z-00-DX1.D4FEEC16-FC67-4C4A-A4B1-F8BA34ECBCBD.svs
TCGA-BH-A0HK,,FEMALE,0,-29751,NO,178,WHITE,BH,A0HK,24334ac1-28a3-4b61-b590-3f51e375b247,81,2010,TUMOR FREE,17,Right Upper Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Positive,Negative,2,NO,YES,70-79%,<10%,Stage IIB,T2N1M0,178,TCGA-BH-A0HK-01Z-00-DX1.019036F5-647A-4EC4-8479-F2C100291AEF.svs
TCGA-E2-A15P,,FEMALE,0,-22524,NO,315,WHITE,E2,A15P,a1674d7b-787a-45c4-bf16-1b7d0efce207,61,2010,TUMOR FREE,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,,,Stage IA,T1cN0M0,315,TCGA-E2-A15P-01Z-00-DX1.4C7F95DC-B319-4A78-8F34-8CB9166EA6A8.svs
TCGA-E2-A15H,,FEMALE,0,-13985,NO,42,WHITE,E2,A15H,5580b21a-2cdb-4777-ad79-6e06654144f5,38,2009,TUMOR FREE,4,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Positive,Positive,Equivocal,1,NO,YES,,,Stage IIA,T1cN1miM0,42,TCGA-E2-A15H-01Z-00-DX1.E3A9DFDC-204D-4F03-98D9-97BBBB74E840.svs
TCGA-A8-A094,,FEMALE,0,-27729,NO,0,,A8,A094,993103b1-e5a1-4c33-8629-be53ebc41d64,75,2009,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,0,TCGA-A8-A094-01Z-00-DX1.6750B72A-FEC7-49FA-8520-FCF101CA59AC.svs
TCGA-E9-A245,,FEMALE,0,-17363,NO,26,WHITE,E9,A245,8218119a-f68b-4ea7-9ee4-5e2edc2ae342,47,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,3,YES,NO,,,Stage IIB,T2N1M0,26,TCGA-E9-A245-01Z-00-DX1.648850D5-EB80-4FBE-8507-32313FAD1060.svs
TCGA-B6-A0I5,,FEMALE,0,-18038,NO,4550,WHITE,B6,A0I5,1a18974d-967c-4727-b42e-12ae7be66589,49,1988,TUMOR FREE,13,Right Lower Inner Quadrant,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,5,NO,YES,,,Stage IIB,T2N1bM0,4550,TCGA-B6-A0I5-01Z-00-DX1.47A30509-4BA0-4BA5-AD9B-F2C2DB701159.svs
TCGA-E9-A22A,,FEMALE,0,-27288,NO,0,WHITE,E9,A22A,4aacbc42-5ac5-4339-b9fa-c6e812084837,74,2011,TUMOR FREE,2,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,0,YES,NO,10-19%,,Stage IIA,T2N0M0,0,TCGA-E9-A22A-01Z-00-DX1.d986c9eb-2c54-4663-a54b-04c0756db6db.svs
TCGA-AR-A1AX,,FEMALE,0,-23507,NO,1103,WHITE,AR,A1AX,f72c1d69-da35-459f-8542-59bfd6c09c23,64,2007,,8,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,0,NO,YES,,70-79%,Stage I,T1N0M0,1103,TCGA-AR-A1AX-01Z-00-DX1.2389D54F-545E-499E-B392-DD731834460A.svs
TCGA-D8-A145,,FEMALE,0,-29280,NO,49,WHITE,D8,A145,4958c36f-1dc7-4f14-9dec-36e14107dbe3,80,2010,TUMOR FREE,7,Right Upper Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,YES,NO,,<10%,Stage IIA,T1cN1aM0,49,TCGA-D8-A145-01Z-00-DX2.B834BF47-1CD6-45EA-BB88-D8ECE1FDDC6A.svs
TCGA-D8-A1Y3,,FEMALE,0,-22317,NO,125,WHITE,D8,A1Y3,632984bd-dc81-42b6-b024-476cfd0bb2ae,61,2011,TUMOR FREE,8,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Indeterminate,5,YES,NO,,,Stage IIIA,T2N2aMX,125,TCGA-D8-A1Y3-01Z-00-DX2.B9BD14AF-52A6-4241-B3B3-03F8F5DFC8DA.svs
TCGA-AC-A6IW,,FEMALE,0,-26896,NO,21,BLACK OR AFRICAN AMERICAN,AC,A6IW,8183F0FB-2303-4D7B-BCCD-55E5031FC7DF,73,2013,TUMOR FREE,2,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,YES,NO,<10%,<10%,Stage IIA,T2N0 (i-)MX,21,TCGA-AC-A6IW-01Z-00-DX1.C4514189-E64F-4603-8970-230FA2BB77FC.svs
TCGA-D8-A1Y1,,FEMALE,0,-29474,NO,116,WHITE,D8,A1Y1,38a631a1-6875-4216-a335-ee93c90a86d6,80,2010,TUMOR FREE,22,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,,,Positive,Negative,1,YES,NO,,,Stage IIIA,T3N1aMX,116,TCGA-D8-A1Y1-01Z-00-DX2.B58DC955-F864-4E78-8B1A-8156E2F7D554.svs
TCGA-LL-A442,,FEMALE,0,-20495,NO,109,BLACK OR AFRICAN AMERICAN,LL,A442,3F56D67F-5A9C-4353-9408-E7F60EB6477B,56,2012,TUMOR FREE,4,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,YES,NO,90-99%,90-99%,Stage IIA,T2N0 (i-)MX,109,TCGA-LL-A442-01Z-00-DX1.9275EDBD-1C89-4AF3-B02B-19F613A4E083.svs
TCGA-A2-A1FW,,FEMALE,0,-22779,NO,221,WHITE,A2,A1FW,54883111-d475-4515-ba3f-fece8a71e79e,62,2010,TUMOR FREE,19,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,5,YES,NO,90-99%,,Stage IIIA,T3N2aM0,221,TCGA-A2-A1FW-01Z-00-DX1.DC2BC5D7-E57B-444E-833F-9A1B6E11DE6D.svs
TCGA-D8-A1XF,,FEMALE,0,-16787,NO,97,WHITE,D8,A1XF,6f6afd31-b5dd-48ab-b18f-6390ba18a5f0,45,2010,TUMOR FREE,8,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,,,Positive,Negative,0,YES,NO,,,Stage IIA,T2N0M0,97,TCGA-D8-A1XF-01Z-00-DX1.8B9AB4A1-DEC5-4587-B022-3077CCD220F9.svs
TCGA-EW-A1PC,,FEMALE,0,-24434,NO,187,BLACK OR AFRICAN AMERICAN,EW,A1PC,F45210D3-9E66-4F5E-BEF1-5EE5547CC893,66,2011,TUMOR FREE,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,50-59%,Stage IIB,T3N0 (i-)MX,187,TCGA-EW-A1PC-01Z-00-DX1.45369705-AD49-419F-A0F0-EC51473BBAB9.svs
TCGA-A8-A07C,,FEMALE,0,-20820,NO,580,,A8,A07C,b6633c36-7ce4-4b69-9bf6-30b64d46c66f,57,2008,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,,NO,YES,,,Stage IIA,T2N0M0,580,TCGA-A8-A07C-01Z-00-DX1.1F069BCA-D2B3-49CF-81FD-9EBA49A3439F.svs
TCGA-C8-A12V,,FEMALE,0,-20346,NO,0,ASIAN,C8,A12V,7e1673f8-5758-4963-8804-d5e39f06205b,55,2010,TUMOR FREE,5,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-C8-A12V-01Z-00-DX1.84B29360-B87B-4648-A697-B6610336C2BB.svs
TCGA-A7-A26J,TCGAFPPP,FEMALE,0,-17930,NO,68,WHITE,A7,A26J,6cb6f179-defd-4661-af0a-c353b74c0c49,49,2011,WITH TUMOR,4,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,0,YES,NO,90-99%,70-79%,Stage IIA,T2N0M0,68,TCGA-A7-A26J-01Z-00-DX1.86A92FBD-F346-4206-A1BE-0CBA1596135F.svs
TCGA-EW-A1PH,,FEMALE,0,-19073,NO,140,WHITE,EW,A1PH,4da999a0-ef41-4a0b-b1d1-446b39cc855a,52,2010,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,1,NO,YES,<10%,<10%,Stage IIA,T1cN1aM0,140,TCGA-EW-A1PH-01Z-00-DX1.77e0f907-fe59-4dc2-b582-6f10330a9c01.svs
TCGA-D8-A1JC,,FEMALE,0,-21898,NO,178,WHITE,D8,A1JC,02e6f999-24f2-4ad2-9b92-df3ee2b082e5,59,2010,TUMOR FREE,11,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,4,YES,NO,,,Stage IIIA,T2N2aM0,178,TCGA-D8-A1JC-01Z-00-DX1.16D32FE8-4D76-4EEC-9739-D394087605BC.svs
TCGA-A8-A07J,,FEMALE,0,-12965,NO,365,,A8,A07J,316625b8-a217-4829-90d1-dfd9cb7e4bc3,35,2009,TUMOR FREE,,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T2N1aM0,365,TCGA-A8-A07J-01Z-00-DX1.FE16248C-D890-4750-A9FC-5F72BE8D8B85.svs
TCGA-E2-A15I,,FEMALE,0,-16163,NO,411,WHITE,E2,A15I,64089c20-939f-48b4-ae8b-904ad0597145,44,2009,TUMOR FREE,4,Left Upper Outer QuadrantLeft Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0M0,411,TCGA-E2-A15I-01Z-00-DX1.DFF60A40-B03D-438F-A233-06132A213619.svs
TCGA-D8-A1JD,,FEMALE,0,-15166,NO,273,WHITE,D8,A1JD,530ad151-703d-4638-851f-0b5111ff318b,41,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,3,YES,NO,,,Stage IIB,T2N1aM0,273,TCGA-D8-A1JD-01Z-00-DX2.C6A7667E-25C9-48BD-A4E7-F4BB740FE589.svs
TCGA-A8-A079,,FEMALE,0,-25294,NO,274,,A8,A079,31c31cce-1b4d-4f12-922f-84f389403170,69,2007,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIB,T4bN3M0,274,TCGA-A8-A079-01Z-00-DX1.DC32BC20-A3BC-43B3-B69F-1E71E289EA34.svs
TCGA-AO-A03V,,FEMALE,0,-15284,NO,886,WHITE,AO,A03V,a6cb373a-1604-4e25-bd81-da6c3e4f06ee,41,2008,TUMOR FREE,2,Left Upper Inner QuadrantLeft,Peri (6-12 months since last menstrual period),Positive,0,Negative,,Positive,Negative,0,NO,YES,90-99%,80-89%,Stage I,T1cN0 (i-)M0,886,TCGA-AO-A03V-01Z-00-DX1.52EBCB72-0C65-4E67-B9BB-DA15494327DE.svs
TCGA-BH-A5IZ,,FEMALE,0,-18927,NO,98,BLACK OR AFRICAN AMERICAN,BH,A5IZ,A8A33BA9-0976-4E19-B0E9-FA5BA4D4EAA8,51,2012,TUMOR FREE,6,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Positive,Negative,1,YES,NO,,,Stage IIB,T2N1acM0 (i+),98,TCGA-BH-A5IZ-01Z-00-DX1.6C871030-82E1-463E-A67B-976A5F3DCDB2.svs
TCGA-D8-A1XU,,FEMALE,0,-20715,NO,150,WHITE,D8,A1XU,332148f5-f070-4c20-8eb1-4d8c0673aa52,56,2010,TUMOR FREE,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IA,T1cN0M0,150,TCGA-D8-A1XU-01Z-00-DX1.769DBC38-6F0D-425B-A904-79EBA1C119EF.svs
TCGA-AR-A1AP,,FEMALE,0,-29406,NO,1216,WHITE,AR,A1AP,9495f029-9882-4c9b-a557-b3aec9e91698,80,2007,TUMOR FREE,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,0,NO,YES,70-79%,<10%,Stage I,T1N0M0,1216,TCGA-AR-A1AP-01Z-00-DX1.F163EED5-0385-41AA-BA35-54E4910CD99E.svs
TCGA-BH-A18P,,FEMALE,1,-22222,921,NO,WHITE,BH,A18P,557cb0a3-6f1b-4faf-8296-0a15c24158f9,60,2003,WITH TUMOR,2,Left Lower Inner Quadrant,,Negative,2+,Negative,Positive,Positive,Positive,0,NO,YES,<10%,,Stage I,T1N0M0,921,TCGA-BH-A18P-01Z-00-DX1.C66642D3-BE44-4D65-B4AE-C1C3D959D22C.svs
TCGA-BH-A0BW,,FEMALE,0,-25974,NO,355,BLACK OR AFRICAN AMERICAN,BH,A0BW,5d1d00c6-fcae-479e-ae1e-de76efd41d98,71,2006,TUMOR FREE,8,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,0,NO,YES,,,Stage I,T1cN0M0,355,TCGA-BH-A0BW-01Z-00-DX1.39B0C363-46A2-4FFB-B1C5-C054A86F4A25.svs
TCGA-A8-A081,,FEMALE,0,-29555,NO,0,,A8,A081,9d876f05-5080-4c4e-9bf5-45f631d381e5,80,2008,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,0,TCGA-A8-A081-01Z-00-DX1.06D727F7-4B41-419B-A251-3D804235ACE5.svs
TCGA-E2-A573,,FEMALE,0,-17689,NO,677,BLACK OR AFRICAN AMERICAN,E2,A573,6429C443-8AC3-407F-BB9C-66420B904BBF,48,2011,TUMOR FREE,4,Right Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,,,Stage IA,T1cN0M0,677,TCGA-E2-A573-01Z-00-DX1.D6633BC2-524D-4153-952F-6B1D8D067370.svs
TCGA-E9-A1RG,,FEMALE,0,-22788,NO,35,WHITE,E9,A1RG,8744733a-7b46-43aa-bdef-64876816adbb,62,2011,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,4,YES,NO,,,Stage IIIA,T1cN2M0,35,TCGA-E9-A1RG-01Z-00-DX1.044C235A-75AE-4C7D-AC7F-56C8E64354AA.svs
TCGA-C8-A12M,,FEMALE,0,-25811,NO,0,ASIAN,C8,A12M,dd0f8e5a-383d-4f03-bb71-0e115d4e442c,70,2010,TUMOR FREE,10,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0 (i-)M0,0,TCGA-C8-A12M-01Z-00-DX1.0C5F2DED-873F-4C86-97A2-2AA76A6236DF.svs
TCGA-AO-A0J6,,FEMALE,0,-22462,NO,775,WHITE,AO,A0J6,e9f4f373-37a5-48ad-a1a0-b0d47820111a,61,2008,TUMOR FREE,4,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,775,TCGA-AO-A0J6-01Z-00-DX1.D0C003CE-E112-4375-953D-78404C9D62DA.svs
TCGA-E9-A247,,FEMALE,0,-21562,NO,13,WHITE,E9,A247,636b0a90-c8c2-4ad6-a77d-6cd428a826d1,59,2011,TUMOR FREE,10,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IA,T1cN0 (i-)M0,13,TCGA-E9-A247-01Z-00-DX1.3B2DF1CB-054A-44C4-9AD5-D8FA6D386A93.svs
TCGA-AO-A129,,FEMALE,0,-10898,NO,2923,WHITE,AO,A129,c70ee5e1-4703-4996-bb5c-f4cca0fb53ba,29,2002,TUMOR FREE,21,Left Lower Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,Negative,Negative,Negative,2,NO,YES,<10%,<10%,Stage IIB,T2N1aM0,2923,TCGA-AO-A129-01Z-00-DX1.BF485416-BF57-4F39-866B-4B1E201876FA.svs
TCGA-BH-A0AV,,FEMALE,0,-19314,NO,1180,BLACK OR AFRICAN AMERICAN,BH,A0AV,790ff5db-b7f3-4946-aaed-305f66b1dd6a,52,2008,TUMOR FREE,2,Left Upper Inner Quadrant,,Negative,,Negative,Negative,Negative,,0,NO,YES,,,Stage I,T1cN0M0,1180,TCGA-BH-A0AV-01Z-00-DX1.5A686DA4-A29D-4BA7-9BCA-B707F8755E83.svs
TCGA-A2-A3XS,,FEMALE,1,-23000,1032,NO,BLACK OR AFRICAN AMERICAN,A2,A3XS,A78B04B4-2380-4803-963E-E4E633CD69AB,62,2003,WITH TUMOR,19,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Positive,Negative,Negative,,9,NO,YES,,,Stage IIIA,T1N2aM0,1032,TCGA-A2-A3XS-01Z-00-DX1.867925C0-91D8-40A0-9FEA-25A635AC31E7.svs
TCGA-C8-A273,,FEMALE,0,,NO,6,ASIAN,C8,A273,5a5f0f48-2b13-4e78-b130-901b85d9a7f3,29,2010,TUMOR FREE,7,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,2,YES,NO,,,Stage IIB,T2N1M0,6,TCGA-C8-A273-01Z-00-DX1.6E5D581F-DF80-478D-82D1-6D6525EED1B5.svs
TCGA-BH-A0AW,,FEMALE,0,-20468,NO,622,WHITE,BH,A0AW,c5891c7a-fd24-4891-8f51-373967e4a6dd,56,2008,TUMOR FREE,12,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Positive,Positive,2,NO,YES,,,Stage IIA,T1cN1aM0,622,TCGA-BH-A0AW-01Z-00-DX1.9D50A0D2-B103-411C-831E-8520C3D50173.svs
TCGA-3C-AALJ,,FEMALE,0,-22848,NO,1228,BLACK OR AFRICAN AMERICAN,3C,AALJ,427D0648-3F77-4FFC-B52C-89855426D647,62,2011,TUMOR FREE,23,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Indeterminate,1,NO,YES,90-99%,30-39%,Stage IIB,T2N1aM0,1228,TCGA-3C-AALJ-01Z-00-DX1.777C0957-255A-42F0-9EEB-A3606BCF0C96.svs
TCGA-A8-A06N,,FEMALE,0,-24288,NO,0,,A8,A06N,3a711140-1b89-4611-9992-3861e3d0e01a,66,2009,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIB,T4bN0M0,0,TCGA-A8-A06N-01Z-00-DX1.E25E65F8-DFE0-47CF-9FAB-B82EE8E321F7.svs
TCGA-A2-A0YG,,FEMALE,0,-23058,NO,404,WHITE,A2,A0YG,c0892598-1f7b-4f23-9cd8-731f797753d5,63,2009,TUMOR FREE,18,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,14,NO,YES,90-99%,<10%,Stage IIIC,T2N3aM0,404,TCGA-A2-A0YG-01Z-00-DX1.89A39319-F880-47DE-B311-DA1F6A64B6F3.svs
TCGA-BH-A1FJ,,FEMALE,1,-24262,1927,NO,WHITE,BH,A1FJ,f6581eee-61b9-43d4-ab0d-ce5ce3ba1c74,66,1998,,35,Right Upper Outer Quadrant,,Positive,,,,Negative,,6,NO,YES,,,Stage IIIA,T3N1bM0,1927,TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3.svs
TCGA-D8-A1XA,,FEMALE,0,-23387,NO,274,WHITE,D8,A1XA,739cb132-51e9-41be-8064-311a13da0d74,64,2010,TUMOR FREE,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,,Positive,Equivocal,0,YES,NO,,,Stage IA,T1cN0M0,274,TCGA-D8-A1XA-01Z-00-DX1.36A807F0-2D35-4CE3-8A27-CC59181B1A3D.svs
TCGA-A8-A084,,FEMALE,0,-29858,NO,458,,A8,A084,3dbe99d1-e3b8-4ee2-b6a8-2e2e12c6fbe9,81,2007,WITH TUMOR,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Positive,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T2N1aM0,458,TCGA-A8-A084-01Z-00-DX1.2B52D1B8-5AD4-4BD6-ADF7-9D65B8EE2621.svs
TCGA-BH-A1EN,,FEMALE,1,-28724,2127,NO,WHITE,BH,A1EN,858652b8-c4c2-41d8-be32-fdc88e1a7bb0,78,1999,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Positive,,NO,YES,,,Stage IIA,T2NXM0,2127,TCGA-BH-A1EN-01Z-00-DX1.F535657F-E2FA-4283-87AE-7DAB663B196B.svs
TCGA-GM-A3XL,,FEMALE,0,-18171,NO,1717,BLACK OR AFRICAN AMERICAN,GM,A3XL,65CAC997-4D39-4501-85EC-4FCB328A8EB5,49,2007,TUMOR FREE,4,RightRight Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,1717,TCGA-GM-A3XL-01Z-00-DX1.CCE8AA1D-9194-4E49-9546-DBF25A35847C.svs
TCGA-C8-A278,,FEMALE,0,-22598,NO,9,ASIAN,C8,A278,65077db7-dd59-4362-9d28-d5a9154e9be0,61,2010,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,,YES,NO,,,Stage IIIA,T2N2M0,9,TCGA-C8-A278-01Z-00-DX1.188B3FE0-7B20-401A-A6B7-8F1798018162.svs
TCGA-E2-A1IG,,FEMALE,0,-16757,NO,755,WHITE,E2,A1IG,bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4,45,2009,TUMOR FREE,3,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIB,T2N1miM0,755,TCGA-E2-A1IG-01Z-00-DX1.C894EEA1-708A-4043-8C60-3BCA98AA751E.svs
TCGA-E2-A14P,,FEMALE,0,-28923,NO,487,WHITE,E2,A14P,e4fc0909-f284-4471-866d-d8967b6adcbc,79,2008,TUMOR FREE,24,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,10,NO,YES,,,Stage IIIC,T2N3M0,487,TCGA-E2-A14P-01Z-00-DX1.663B02FF-C64B-41A6-8685-FD61CD76F9C6.svs
TCGA-E9-A1RE,,FEMALE,0,-27392,NO,47,WHITE,E9,A1RE,24046547-d038-4616-b190-52ac93f4965f,74,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,9,YES,NO,,,Stage IIIA,T2N2M0,47,TCGA-E9-A1RE-01Z-00-DX1.fd100503-ba95-4af8-8e59-689b2cea145c.svs
TCGA-AN-A0XP,,FEMALE,0,-25305,NO,9,WHITE,AN,A0XP,cf0e7e4e-b857-4db5-9ae2-551a899f77be,69,2010,,19,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,,Positive,Positive,1,NO,YES,,,Stage IIIA,T2N2M0,9,TCGA-AN-A0XP-01Z-00-DX1.A4EE3970-5C1F-482E-9AED-F1E3C52A776F.svs
TCGA-E2-A1LH,,FEMALE,0,-21628,NO,2876,WHITE,E2,A1LH,d8ecba6a-9fff-4993-a799-9a8d2aea524e,59,2002,TUMOR FREE,2,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage I,T1cN0M0,2876,TCGA-E2-A1LH-01Z-00-DX1.F85384B7-1EBF-4F57-A45B-4A668B68E535.svs
TCGA-D8-A27H,,FEMALE,0,-26588,NO,19,WHITE,D8,A27H,0dca98b0-f43e-45b6-9a02-00092c78678c,72,2011,TUMOR FREE,1,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,,YES,NO,,,Stage IIA,T2N0M0,19,TCGA-D8-A27H-01Z-00-DX1.BE9DFDD4-97C5-4327-B1DA-4B34A6F267C5.svs
TCGA-A2-A04N,,FEMALE,0,-24155,NO,3153,WHITE,A2,A04N,197428f7-bd77-4c5f-8119-87157b5c35b9,66,2002,TUMOR FREE,6,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,0,NO,YES,,,Stage IA,T1cN0 (i-)M0,3153,TCGA-A2-A04N-01Z-00-DX1.9E9B7DB0-1CF1-4631-8292-A9DBCA0BD37C.svs
TCGA-D8-A27P,,FEMALE,0,-23576,NO,23,WHITE,D8,A27P,c54d5507-bba5-4a1e-8885-3c3b1eed13c1,64,2011,TUMOR FREE,1,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IA,T1cN0M0,23,TCGA-D8-A27P-01Z-00-DX1.EF426996-D0DC-4418-BEC4-F7CE3C82C869.svs
TCGA-C8-A137,,FEMALE,0,-12729,NO,34,ASIAN,C8,A137,03ab1e9f-4918-404d-b178-3a4fd929c5e8,34,2010,TUMOR FREE,2,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,,Negative,Positive,,YES,NO,,,Stage IIB,T2N1M0,34,TCGA-C8-A137-01Z-00-DX1.87F3775D-A401-4D5E-843F-8FB1D4BE97F8.svs
TCGA-AN-A0AT,,FEMALE,0,-22798,NO,10,WHITE,AN,A0AT,05506f4c-e701-4a9d-ae06-97f066aade43,62,2010,TUMOR FREE,10,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A0AT-01Z-00-DX1.DFD68CD2-C25E-47BE-BC06-8CE3C657B9FD.svs
TCGA-D8-A27M,,FEMALE,0,-21910,NO,145,WHITE,D8,A27M,ae65baeb-6b78-492a-8c63-bb7e93e83dc2,59,2011,TUMOR FREE,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,,YES,NO,,,Stage IA,T1cN0M0,145,TCGA-D8-A27M-01Z-00-DX1.3020D223-2400-4A2D-8BFE-08A5B78FE13B.svs
TCGA-A1-A0SN,,FEMALE,0,-18401,NO,1196,WHITE,A1,A0SN,0dc337fa-da8b-42c4-b9a7-fb76d81c161f,50,2007,TUMOR FREE,13,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Positive,4,NO,YES,90-99%,60-69%,Stage IIA,T1cN1MX,1196,TCGA-A1-A0SN-01Z-00-DX1.5E9B85AE-AFB7-41DC-8A1B-BD6DA39B6540.svs
TCGA-A2-A3XY,,FEMALE,0,-18059,NO,786,BLACK OR AFRICAN AMERICAN,A2,A3XY,DEBA32E4-0E68-4711-941B-3B63BD965AFB,49,2010,TUMOR FREE,16,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,Negative,3,YES,NO,,,Stage IIB,T2N1aM0,786,TCGA-A2-A3XY-01Z-00-DX1.E57FC9BF-411E-4028-AC10-8BCA5D0C8472.svs
TCGA-A8-A06P,,FEMALE,0,-23011,NO,396,,A8,A06P,5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb,63,2009,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIA,T1cN2aM0,396,TCGA-A8-A06P-01Z-00-DX1.37660D0F-1595-43C5-9D30-58D6CB93B52C.svs
TCGA-A7-A56D,,FEMALE,0,-30783,NO,177,BLACK OR AFRICAN AMERICAN,A7,A56D,F062CBD0-2426-40AC-A4BE-E74AC61FA2A7,84,2012,TUMOR FREE,8,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,YES,NO,90-99%,<10%,Stage IIA,T2N0M0,177,TCGA-A7-A56D-01Z-00-DX1.87D9CCF4-04EE-46D2-B7FC-A83561D7752C.svs
TCGA-AO-A03P,,FEMALE,0,-19724,NO,2576,BLACK OR AFRICAN AMERICAN,AO,A03P,2d4c778c-7f77-4f0a-8261-2086accf15fd,54,2003,WITH TUMOR,26,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Close,,Positive,Negative,0,NO,YES,90-99%,40-49%,Stage IIB,T2N1M0,2576,TCGA-AO-A03P-01Z-00-DX1.D34DA321-D8E3-4D68-BCE2-4A8B72B3D0AE.svs
TCGA-A2-A0CS,,FEMALE,0,-26817,NO,2298,WHITE,A2,A0CS,d071c16b-7cee-45ed-8ec9-612418143815,73,2004,TUMOR FREE,15,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,12,NO,YES,80-89%,80-89%,Stage IV,T4bN3aM1,2298,TCGA-A2-A0CS-01Z-00-DX1.3986B545-63E8-4727-BCC1-701DE947D1FB.svs
TCGA-LL-A740,,FEMALE,0,-22416,NO,137,BLACK OR AFRICAN AMERICAN,LL,A740,AA60FA8D-C374-40E0-AF2D-B007701E67E3,61,2013,TUMOR FREE,1,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,YES,NO,,,Stage IA,T1cN0 (i-)MX,137,TCGA-LL-A740-01Z-00-DX1.757D94A5-EF0F-4A0E-99A9-8809B66438DA.svs
TCGA-D8-A27K,,FEMALE,0,-17426,NO,119,WHITE,D8,A27K,7f97971b-2818-4e4b-9c9e-7c0246f9484c,47,2011,TUMOR FREE,17,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,2,YES,NO,,,Stage IIB,T2N1aM0,119,TCGA-D8-A27K-01Z-00-DX1.25AF7928-046B-45BF-BAD6-F34156203F5A.svs
TCGA-E9-A1R6,,FEMALE,0,-23347,NO,84,WHITE,E9,A1R6,4842bac3-abaa-4900-871f-f2c3ba6457f5,63,2010,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0M0,84,TCGA-E9-A1R6-01Z-00-DX1.59770592-498A-47EA-AE32-42AC1D8E99BE.svs
TCGA-E9-A1R4,,FEMALE,0,-24181,NO,29,WHITE,E9,A1R4,b7a4df9a-4e25-4550-9c10-338ca1921c2f,66,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IA,T1cN0M0,29,TCGA-E9-A1R4-01Z-00-DX1.B04D5A22-8CE5-49FD-8510-14444F46894D.svs
TCGA-E2-A1B4,,FEMALE,0,-27241,NO,911,WHITE,E2,A1B4,dbb2da92-99dd-400c-bc05-e87d7273656c,74,2008,TUMOR FREE,4,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,3,NO,YES,,,Stage IIIA,T1cN2aM0,911,TCGA-E2-A1B4-01Z-00-DX1.E585C4FB-0D3E-4160-8192-53A329648F5C.svs
TCGA-C8-A1HO,,FEMALE,0,-12715,NO,0,ASIAN,C8,A1HO,b3354b72-2637-4edc-9a95-e55801d3ac13,34,2010,TUMOR FREE,,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,,YES,NO,,,Stage IIIC,T3N3M0,0,TCGA-C8-A1HO-01Z-00-DX1.0C702CEE-C373-4D00-A706-32206D41AC17.svs
TCGA-BH-A1FB,,FEMALE,1,-21933,3669,NO,WHITE,BH,A1FB,ecab16bc-28d5-4c3a-8735-3c785bd047c4,60,2000,WITH TUMOR,15,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Negative,0,NO,YES,,,Stage IIB,T2N1bM0,3669,TCGA-BH-A1FB-01Z-00-DX1.9D778D1A-07F6-450D-B7AA-0E17B4D0A88C.svs
TCGA-E9-A229,,FEMALE,0,-13817,NO,0,WHITE,E9,A229,cea9d8f9-e18c-4947-a461-5f712e3c1e6d,37,2011,TUMOR FREE,14,Right Lower Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,0,YES,NO,,,Stage IA,T1cN0M0,0,TCGA-E9-A229-01Z-00-DX1.5B448B88-DA0C-44FF-87B3-20649A4A26FE.svs
TCGA-A8-A06U,,FEMALE,1,-29525,883,NO,,A8,A06U,6bc4c56d-aac5-49a2-9913-9538d06d898f,80,2008,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIB,T2N1aM0,883,TCGA-A8-A06U-01Z-00-DX1.56070AB9-A73E-44B8-8051-D93E8F881BBE.svs
TCGA-AO-A03T,,FEMALE,0,-15540,NO,1187,WHITE,AO,A03T,dd6b64a8-d546-4fd1-bbbd-ac9703791cae,42,2007,TUMOR FREE,12,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,0,Negative,,Positive,Negative,2,NO,YES,90-99%,60-69%,Stage IIB,T2N1aM0,1187,TCGA-AO-A03T-01Z-00-DX1.8B75E203-6DC8-4AC9-A256-6FCB818DA0DD.svs
TCGA-A8-A09E,,FEMALE,0,-26724,NO,943,,A8,A09E,dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea,73,2008,WITH TUMOR,,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Positive,Positive,Positive,,NO,YES,,,Stage IIIB,T4bN1aM0,943,TCGA-A8-A09E-01Z-00-DX1.239A8E03-49EA-4C29-AF86-FC1BD8A9DB20.svs
TCGA-BH-A0AY,,FEMALE,0,-22703,NO,777,WHITE,BH,A0AY,93ed6066-b567-4e1c-ab81-23370f9d3452,62,2008,TUMOR FREE,1,Left Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,777,TCGA-BH-A0AY-01Z-00-DX1.A1153465-D9B3-4D83-BE85-F2524B071EE5.svs
TCGA-E2-A15K,,FEMALE,0,-21514,NO,34,WHITE,E2,A15K,17c1d42c-cb84-4655-a4cd-b54bae17ecaf,58,2010,TUMOR FREE,17,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,,,Stage IIB,T2N1aM0,34,TCGA-E2-A15K-01Z-00-DX1.9F424BE2-9BFE-4DFF-8CC9-10D2DADBBEA7.svs
TCGA-A2-A25C,,FEMALE,0,-18508,NO,285,WHITE,A2,A25C,7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1,50,2010,TUMOR FREE,14,Left Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,3,YES,NO,90-99%,20-29%,Stage IIB,T2N1aM0,285,TCGA-A2-A25C-01Z-00-DX1.F8E6044A-435E-42D5-94FF-C0F572F1ED99.svs
TCGA-E2-A574,,FEMALE,0,-16195,NO,605,BLACK OR AFRICAN AMERICAN,E2,A574,029CE650-5E5A-4100-8596-CD94300E7EF5,44,2011,TUMOR FREE,4,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,605,TCGA-E2-A574-01Z-00-DX1.60341091-B118-4F20-9ADB-FB2886790B0E.svs
TCGA-BH-A1FE,,FEMALE,1,-11650,2273,NO,WHITE,BH,A1FE,4aa68586-6331-4795-b40c-859386640df6,31,1998,WITH TUMOR,12,Left,,Positive,,,,Positive,,1,NO,YES,,,Stage IIB,T2N1M0,2273,TCGA-BH-A1FE-01Z-00-DX1.8FB57ECF-350B-44E4-8612-63E8374D3C4B.svs
TCGA-OL-A66O,,FEMALE,0,-14272,NO,220,BLACK OR AFRICAN AMERICAN,OL,A66O,A45833E1-7CC9-4273-B408-620F74679A12,39,2012,TUMOR FREE,17,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Negative,Positive,,3,NO,YES,90-99%,90-99%,Stage IIB,T2N1aMX,220,TCGA-OL-A66O-01Z-00-DX1.5F1E4C60-5CE8-41B4-A94D-4AA80D9253F9.svs
TCGA-E2-A1B1,,FEMALE,0,-16603,NO,1361,WHITE,E2,A1B1,8a0ef221-8070-43fc-9d98-def90abe4871,45,2007,TUMOR FREE,6,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Equivocal,1,NO,YES,,,Stage IIB,T2N1M0,1361,TCGA-E2-A1B1-01Z-00-DX1.7C8DF153-B09B-44C7-87B8-14591E319354.svs
TCGA-BH-A0HF,,FEMALE,0,-28233,NO,727,WHITE,BH,A0HF,17ca61a2-607a-45ff-88fa-ef72e80bf891,77,2008,TUMOR FREE,2,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,90-99%,<10%,Stage IA,T1cN0 (i-)M0,727,TCGA-BH-A0HF-01Z-00-DX1.1EB2F7CE-54F4-4E41-A3CF-78209770B7CE.svs
TCGA-E9-A1RF,,FEMALE,0,-25119,NO,38,WHITE,E9,A1RF,c694615c-b1c6-499c-8058-995633ebf948,68,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,5,YES,NO,,,Stage IIIA,T2N2M0,38,TCGA-E9-A1RF-01Z-00-DX1.ee37dfd4-1431-4e80-bd7e-3e1f878273e0.svs
TCGA-A2-A0YJ,,FEMALE,0,-14448,NO,326,WHITE,A2,A0YJ,796b593f-5886-4a27-bf94-7ea8df325e1a,39,2010,TUMOR FREE,18,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,,Positive,Negative,5,NO,YES,<10%,<10%,Stage IIIA,T3N2aM0,326,TCGA-A2-A0YJ-01Z-00-DX1.8135C74E-DAA8-4C8E-AF14-A4B5B57695BE.svs
TCGA-A2-A0YI,,FEMALE,0,-22961,NO,358,WHITE,A2,A0YI,72cd1b17-d349-4551-83f7-3062ce9db865,62,2009,TUMOR FREE,3,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,60-69%,Stage I,T1cN0 (i+)M0,358,TCGA-A2-A0YI-01Z-00-DX1.1CF2EC2D-C722-467F-8832-409B823E8D8F.svs
TCGA-A2-A0ET,,FEMALE,0,-21464,NO,807,WHITE,A2,A0ET,96f23d8a-be0f-4925-ba00-805dc293414c,58,2008,TUMOR FREE,15,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,5,NO,YES,90-99%,70-79%,Stage IIIA,T2N2aM0,807,TCGA-A2-A0ET-01Z-00-DX1.41E86BB9-EA52-4615-94E7-0F09DDB094F4.svs
TCGA-BH-A204,,FEMALE,1,-29529,2534,NO,WHITE,BH,A204,05135396-df5c-49db-b34e-f4add5b65a2b,80,1996,,16,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,2,NO,YES,,,Stage IIB,T2N1bM0,2534,TCGA-BH-A204-01Z-00-DX1.9DCE8242-E862-45AB-9452-D7299110973F.svs
TCGA-A7-A13G,,FEMALE,0,-28969,NO,208,WHITE,A7,A13G,6cd9baf5-bbe0-4c1e-a87f-c53b3af22890,79,2010,TUMOR FREE,1,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,90-99%,50-59%,Stage IIA,T2N0MX,208,TCGA-A7-A13G-01Z-00-DX2.72EF429E-75A7-4D1B-AFFC-8767CB213CDA.svs
TCGA-AR-A1AY,,FEMALE,0,-23927,NO,615,WHITE,AR,A1AY,5fd9552a-c742-4388-940d-295d1107ae00,65,2008,,4,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage I,T1N0M0,615,TCGA-AR-A1AY-01Z-00-DX1.6AC0BE3B-FFC5-4EDA-9E40-B18CAAC52B81.svs
TCGA-B6-A0RL,,FEMALE,1,-22238,2469,NO,BLACK OR AFRICAN AMERICAN,B6,A0RL,5562455d-bbb8-46eb-a510-e8c6e1e26789,60,1993,TUMOR FREE,16,Left,,Positive,,Negative,,Positive,,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,2469,TCGA-B6-A0RL-01Z-00-DX1.B5B6709B-5F38-4561-A0E7-C78F97B33F22.svs
TCGA-A7-A0DA,,FEMALE,0,-22708,NO,373,WHITE,A7,A0DA,3afa1e93-1df8-4e4c-aaa4-557463f4bb77,62,2009,TUMOR FREE,1,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0 (i-)M0,373,TCGA-A7-A0DA-01Z-00-DX1.5F087009-16E9-4A07-BA24-62340E108B17.svs
TCGA-EW-A1PB,,FEMALE,0,-25770,NO,608,BLACK OR AFRICAN AMERICAN,EW,A1PB,88db1340-e4bf-451a-87c0-6e9168296f5e,70,2009,TUMOR FREE,8,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,2,NO,YES,<10%,<10%,Stage IIIA,T3N1aMX,608,TCGA-EW-A1PB-01Z-00-DX1.B2E9B88F-C371-4821-9B7B-8A63BB120D95.svs
TCGA-A8-A06T,,FEMALE,0,-27393,NO,1249,,A8,A06T,2c04a2f5-321e-4dea-8e00-268325da65cb,75,2007,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIIA,T3N1aM0,1249,TCGA-A8-A06T-01Z-00-DX1.BA8B8FC3-6169-48C1-BE1F-37F140CB4D3B.svs
TCGA-B6-A0I1,,FEMALE,1,-26902,2361,NO,BLACK OR AFRICAN AMERICAN,B6,A0I1,5DD423E8-FEAA-4568-A750-500948C41D6C,73,1998,TUMOR FREE,7,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,,0,NO,YES,,,Stage IIA,T2N0M0,2361,TCGA-B6-A0I1-01Z-00-DX1.86BEC5E4-A2D1-4039-8D08-0598FA8BCC2B.svs
TCGA-E2-A154,,FEMALE,0,-24999,NO,325,WHITE,E2,A154,24e39609-9645-43e5-960b-db5446eaea65,68,2009,TUMOR FREE,2,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage I,T1cN0M0,325,TCGA-E2-A154-01Z-00-DX1.01FC9B1A-8ECD-4467-9EDD-0B02E4AEEF72.svs
TCGA-AO-A0JL,,FEMALE,0,-21895,NO,1319,WHITE,AO,A0JL,d5d8e76e-2f2a-49bc-ba0a-d51283611b16,59,2006,TUMOR FREE,26,Left Upper Outer QuadrantLeft Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Positive,Negative,Negative,7,NO,YES,<10%,<10%,Stage IIIA,T2N2aM0,1319,TCGA-AO-A0JL-01Z-00-DX1.473CC200-221A-4777-B19E-ADC41D10FC94.svs
TCGA-A8-A09G,,FEMALE,0,-29006,NO,0,,A8,A09G,3927f736-3b5c-48c8-9d9e-83669ec44770,79,2008,TUMOR FREE,,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIIC,T3N3aM0,0,TCGA-A8-A09G-01Z-00-DX1.B834728C-DAC5-4463-961D-7E3B220905C1.svs
TCGA-EW-A1OZ,,FEMALE,0,-20664,NO,941,BLACK OR AFRICAN AMERICAN,EW,A1OZ,8f912a40-3251-4e1f-ae65-1f93d71f9881,56,2008,TUMOR FREE,4,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Positive,Positive,Equivocal,0,NO,YES,90-99%,<10%,Stage IIA,T2N0 (i-)M0,941,TCGA-EW-A1OZ-01Z-00-DX1.9639BB06-FF02-475F-A89D-773BE12721CC.svs
TCGA-GM-A2DI,,FEMALE,0,-19030,NO,1883,WHITE,GM,A2DI,66FA504C-4AE4-49AC-9355-1E063776DC0D,52,2005,TUMOR FREE,9,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,Negative,Negative,,0,NO,YES,<10%,<10%,Stage I,T1cN0 (i+)M0,1883,TCGA-GM-A2DI-01Z-00-DX1.5E9715EA-9D2B-49D0-8F1D-972CF24B1960.svs
TCGA-A1-A0SF,,FEMALE,0,-19731,NO,1463,WHITE,A1,A0SF,4b620966-b4c7-4615-bf58-ca9d3226b9bd,54,2006,TUMOR FREE,2,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0M0,1463,TCGA-A1-A0SF-01Z-00-DX1.7F252D89-EA78-419F-A969-1B7313D77499.svs
TCGA-D8-A1JP,,FEMALE,0,-26862,NO,167,WHITE,D8,A1JP,752f4773-5a12-4485-a1f6-896e148ddf4d,73,2010,,1,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,,YES,NO,,<10%,Stage IA,T1cN0M0,167,TCGA-D8-A1JP-01Z-00-DX1.B02959C4-6AAD-4ACA-9838-61D224D838E4.svs
TCGA-D8-A1Y3,,FEMALE,0,-22317,NO,125,WHITE,D8,A1Y3,632984bd-dc81-42b6-b024-476cfd0bb2ae,61,2011,TUMOR FREE,8,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Indeterminate,5,YES,NO,,,Stage IIIA,T2N2aMX,125,TCGA-D8-A1Y3-01Z-00-DX1.8AA5F695-A06C-4DEA-AD71-16254A48B218.svs
TCGA-C8-A1HI,,FEMALE,0,,NO,0,ASIAN,C8,A1HI,444374f8-9282-439c-af00-0f828edcbff3,40,2010,TUMOR FREE,6,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIIA,T2N2M0,0,TCGA-C8-A1HI-01Z-00-DX1.C6D0F8B8-55ED-477F-BAF7-AA05D0449CC8.svs
TCGA-A2-A1G1,,FEMALE,0,-31223,NO,371,WHITE,A2,A1G1,75b5529b-565a-4eba-918a-910b2f441d32,85,2010,TUMOR FREE,13,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Positive,Negative,Equivocal,1,YES,NO,,,Stage IIB,T2N1M0,371,TCGA-A2-A1G1-01Z-00-DX1.E52A474F-DE13-41CF-94D4-D00BAC46ECF4.svs
TCGA-AN-A0FJ,,FEMALE,0,-21910,NO,242,WHITE,AN,A0FJ,546248b0-22a0-4b70-a437-76fb0a238a0d,59,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Negative,1+,Negative,,Positive,Positive,8,NO,YES,10-19%,<10%,Stage IV,T2N2M1,242,TCGA-AN-A0FJ-01Z-00-DX1.97B60767-916E-4938-9D0B-E6C0FE1CB3FC.svs
TCGA-D8-A1XG,,FEMALE,0,-31748,NO,75,WHITE,D8,A1XG,de531604-bd1a-49df-96c2-6de3ae703f1d,86,2010,TUMOR FREE,2,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,2,YES,NO,,,Stage IIIB,T4bN1aM0,75,TCGA-D8-A1XG-01Z-00-DX1.0A58EF43-B97E-4111-8DC3-2F8D9BDBE7D6.svs
TCGA-A2-A3XX,,FEMALE,0,-17981,NO,1168,BLACK OR AFRICAN AMERICAN,A2,A3XX,53886143-C1C6-40E9-88E6-E4E5E0271FC8,49,2009,TUMOR FREE,1,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,1168,TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92.svs
TCGA-E2-A15T,,FEMALE,0,-24054,NO,267,WHITE,E2,A15T,e68ebfd4-3688-4caa-9e38-7764f9258c30,65,2010,TUMOR FREE,2,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,267,TCGA-E2-A15T-01Z-00-DX1.23913E37-53A8-4E11-9B64-CDD016F6D87A.svs
TCGA-EW-A6S9,,FEMALE,0,-12755,NO,463,BLACK OR AFRICAN AMERICAN,EW,A6S9,9676E46B-8F29-43CD-AB65-EB6A535CCED4,34,2013,TUMOR FREE,3,RightRight Upper Outer Quadrant,,Positive,3+,,,Positive,Positive,1,,,50-59%,,Stage IIA,T1cN1M0,463,TCGA-EW-A6S9-01Z-00-DX1.4A8CD2D4-D528-465C-82DC-9CAE35DD424B.svs
TCGA-AC-A2BK,,FEMALE,0,-28625,NO,1172,BLACK OR AFRICAN AMERICAN,AC,A2BK,6FA2A667-9C36-4526-8A58-1975E863A806,78,2006,TUMOR FREE,23,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,6,NO,YES,,,Stage IIIA,T2N2aMX,1172,TCGA-AC-A2BK-01Z-00-DX1.A3A1F275-9CDC-48BA-BB81-BCA6F02ACA94.svs
TCGA-C8-A26Y,,FEMALE,0,-32872,NO,0,ASIAN,C8,A26Y,4d51159f-ab2f-40e3-a363-847c3654431e,90,2010,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-C8-A26Y-01Z-00-DX1.166EE604-4EF3-401D-99E9-3A9711316CC4.svs
TCGA-EW-A1P8,,FEMALE,1,-21501,239,NO,WHITE,EW,A1P8,359f12f9-5c41-48a4-85bc-fd7e307bf7d8,58,2010,WITH TUMOR,15,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,14,NO,YES,<10%,<10%,Stage IIIC,T2N3bM0,239,TCGA-EW-A1P8-01Z-00-DX1.E9852193-8CDD-49EF-B49B-DA6931198F0D.svs
TCGA-BH-A0W3,,FEMALE,0,-21369,NO,180,WHITE,BH,A0W3,3c612e12-6de8-44fa-a095-805c45474821,58,2010,TUMOR FREE,4,Left Upper Inner Quadrant,Indeterminate (neither Pre or Postmenopausal),Positive,,,Negative,Positive,Equivocal,1,NO,YES,,,Stage IIA,T1cN1aM0,180,TCGA-BH-A0W3-01Z-00-DX1.38DCA2B7-1A54-4FFA-BABA-29F80974BB17.svs
TCGA-A7-A0CE,,FEMALE,0,-20863,NO,254,WHITE,A7,A0CE,9d95a65b-e41d-4f93-92d4-99dce29ff40d,57,2009,TUMOR FREE,1,Left,Indeterminate (neither Pre or Postmenopausal),Negative,2+,Negative,Negative,Negative,Equivocal,0,YES,NO,<10%,<10%,Stage IIA,T2N0 (i-)M0,254,TCGA-A7-A0CE-01Z-00-DX2.5AD1DB65-10E7-4996-AB5E-13D7851EC5FA.svs
TCGA-A2-A04V,,FEMALE,1,-14250,1920,NO,WHITE,A2,A04V,64f67506-f2df-4f0a-b7be-29b4949e986a,39,2005,WITH TUMOR,2,Right Lower Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,10-19%,Stage IIA,T2N0 (i-)M0,1920,TCGA-A2-A04V-01Z-00-DX1.EB430DDB-8FE9-4302-8829-53DBAD09E79F.svs
TCGA-BH-A203,,FEMALE,1,-28609,1174,NO,WHITE,BH,A203,b3264748-947a-43aa-b227-b294fbcc8447,78,1996,WITH TUMOR,39,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,,,,,35,NO,YES,,,Stage IIB,T2N1bM0,1174,TCGA-BH-A203-01Z-00-DX1.FAE40A13-0C4A-415F-9396-01041FF6B855.svs
TCGA-AQ-A04H,,FEMALE,0,-22539,NO,439,WHITE,AQ,A04H,83f943c7-3975-4b4f-985d-9c057741793b,61,2009,TUMOR FREE,15,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Indeterminate,4,NO,YES,90-99%,20-29%,Stage IIIA,T2N2aMX,439,TCGA-AQ-A04H-01Z-00-DX1.5AC1E459-EF27-401D-98FD-0AC16559AF17.svs
TCGA-A8-A086,,FEMALE,0,-21731,NO,396,,A8,A086,f9eb88f7-9293-46bf-ace4-a746e4ff80dc,59,2009,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T1cN1aM0,396,TCGA-A8-A086-01Z-00-DX1.E5FD8C53-2068-4018-B3C0-08EED253ACD2.svs
TCGA-A8-A07W,,FEMALE,0,-27942,NO,304,,A8,A07W,01263518-5f7c-49dc-8d7e-84b0c03a6a63,76,2009,WITH TUMOR,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Positive,Negative,Positive,Negative,,NO,YES,,,Stage IV,T2NXM1,304,TCGA-A8-A07W-01Z-00-DX1.5970CF33-D675-4AF4-800F-7182AA1A44A6.svs
TCGA-A7-A4SD,,FEMALE,0,-19131,NO,168,BLACK OR AFRICAN AMERICAN,A7,A4SD,8C09F413-E938-4F2E-A414-84F0E7FCFE41,52,2012,TUMOR FREE,6,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,YES,NO,,,Stage IIA,T2N0M0,168,TCGA-A7-A4SD-01Z-00-DX1.677152B3-17B2-42DB-AEEC-C9509ACCE831.svs
TCGA-A2-A0YC,,FEMALE,0,-21685,NO,644,WHITE,A2,A0YC,a1872011-b928-4189-ac02-e87506c20bca,59,2008,TUMOR FREE,3,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Close,Negative,Positive,,1,NO,YES,90-99%,90-99%,Stage IIB,T2N1miM0,644,TCGA-A2-A0YC-01Z-00-DX1.F01F2268-17D8-45FD-8917-FD89454D0709.svs
TCGA-AR-A0TW,,FEMALE,0,-18263,NO,739,WHITE,AR,A0TW,8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66,50,2005,,27,Right Upper Outer QuadrantRight Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,3,NO,YES,,,Stage IIIA,T3N1M0,739,TCGA-AR-A0TW-01Z-00-DX1.0C1EAE07-6BA6-4908-89E1-0133F3640174.svs
TCGA-D8-A1JH,,FEMALE,0,-20497,NO,284,WHITE,D8,A1JH,4d1bf9e6-5837-4aed-b568-92f014ed5a4b,56,2010,TUMOR FREE,9,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IA,T1cN0M0,284,TCGA-D8-A1JH-01Z-00-DX1.4A4F2502-612C-421D-9F64-444BF2C85620.svs
TCGA-A7-A0CJ,,FEMALE,0,-21014,NO,189,WHITE,A7,A0CJ,d69e59a8-b10b-46f5-b859-b6c178d90506,57,2010,TUMOR FREE,1,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Positive,,Positive,Negative,0,YES,NO,90-99%,70-79%,Stage IIA,T2N0 (i-)M0,189,TCGA-A7-A0CJ-01Z-00-DX1.E26F2F62-D688-4373-BB7B-790A06734E49.svs
TCGA-E2-A15R,,FEMALE,0,-23570,NO,330,WHITE,E2,A15R,33b7bf50-53f4-4839-aa83-9665f85671d8,64,2010,TUMOR FREE,4,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,3,NO,YES,,,Stage IIA,T1cN1aM0,330,TCGA-E2-A15R-01Z-00-DX1.B58D2D9D-05EE-4D66-8DC0-9E5C6AD2E3D3.svs
TCGA-A8-A08L,,FEMALE,1,-32842,30,NO,,A8,A08L,8bd68696-5eeb-46d7-9dc6-c39c849029a4,89,2008,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIA,T3N2aM0,30,TCGA-A8-A08L-01Z-00-DX1.0FC652B1-336D-4198-93FE-58D2214866D3.svs
TCGA-AR-A24R,,FEMALE,0,-16642,NO,1746,WHITE,AR,A24R,db62d9c7-8343-4771-84fc-146d2e307bb8,45,2006,,28,Right Upper Inner QuadrantRight Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,6,NO,YES,10-19%,10-19%,Stage IIIA,T1N2M0,1746,TCGA-AR-A24R-01Z-00-DX1.47D79205-63E7-43E6-A513-2CD10DFA53C9.svs
TCGA-D8-A1XT,,FEMALE,0,-22448,NO,193,WHITE,D8,A1XT,64975923-d032-4182-8565-59fc37127d8d,61,2010,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,3,YES,NO,,,Stage IIA,T1cN1aM0,193,TCGA-D8-A1XT-01Z-00-DX1.9E4DEEEB-AB0A-45F6-A69B-65B3E6F22D46.svs
TCGA-BH-A0EE,,FEMALE,0,-24850,NO,943,WHITE,BH,A0EE,ca76c6fc-ff30-4833-884d-3a94fe53ff17,68,2007,TUMOR FREE,1,Right Upper Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,0,NO,YES,,,Stage IIB,T3N0 (i-)M0,943,TCGA-BH-A0EE-01Z-00-DX1.872EA586-25C8-4835-A138-152DFA1EBF30.svs
TCGA-AC-A6NO,,FEMALE,0,-15996,NO,51,BLACK OR AFRICAN AMERICAN,AC,A6NO,8D9B50D1-139B-4447-AE9C-E54764D9E2A7,43,2011,TUMOR FREE,16,Right,,Positive,,Negative,,Positive,Negative,2,YES,NO,,,Stage IIB,T2N1aMX,51,TCGA-AC-A6NO-01Z-00-DX1.61B7F48C-6D6E-4C1B-B236-DD130ECBDA9D.svs
TCGA-A1-A0SI,,FEMALE,0,-19250,NO,635,WHITE,A1,A0SI,16368c32-2118-4fcf-8693-6c89995e49d8,52,2007,TUMOR FREE,23,Right,,Positive,,Negative,,Positive,Negative,1,NO,YES,50-59%,10-19%,Stage IIB,T2N1aM0,635,TCGA-A1-A0SI-01Z-00-DX1.AB717348-F964-4F29-BBE2-972B7C640432.svs
TCGA-AR-A24K,,FEMALE,0,-16961,NO,1548,WHITE,AR,A24K,599c3701-df7a-4a75-a347-fa9b510dd242,46,2004,,2,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,10-19%,10-19%,Stage IIA,T2N0M0,1548,TCGA-AR-A24K-01Z-00-DX1.3A56BAEC-484E-4F9B-BCB4-360ABF6DDB4B.svs
TCGA-C8-A12T,,FEMALE,0,,NO,0,ASIAN,C8,A12T,71229981-97c2-4ae1-a130-fe5de336b37d,43,2010,TUMOR FREE,5,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,,Positive,Positive,0,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-C8-A12T-01Z-00-DX1.EF628C26-C570-4D15-A0C0-58B2CC40ABFC.svs
TCGA-AR-A1AH,,FEMALE,0,-18991,NO,2298,WHITE,AR,A1AH,a6e11b30-3ae8-4dd1-b04c-a730c6a79746,51,2004,TUMOR FREE,9,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,1,NO,YES,10-19%,,Stage IIB,T2N1M0,2298,TCGA-AR-A1AH-01Z-00-DX1.5D5D7774-77BB-4EA0-9E8E-A8D28F70A575.svs
TCGA-A8-A08O,,FEMALE,0,-16681,NO,943,,A8,A08O,5f5964a8-8e07-4620-98f0-93d162dbc31e,45,2008,WITH TUMOR,,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Positive,Negative,Positive,Negative,,NO,YES,,,Stage IV,T2N3aM1,943,TCGA-A8-A08O-01Z-00-DX1.BC87C01D-F081-41CA-939A-875C61588E88.svs
TCGA-A7-A0DB,TCGAFPPP,FEMALE,0,-20570,NO,141,WHITE,A7,A0DB,f130f376-5801-40f9-975d-a7e2f7b5670d,56,2009,TUMOR FREE,4,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Close,,Positive,Negative,0,YES,NO,90-99%,60-69%,Stage IIA,T2N0 (i-)M0,141,TCGA-A7-A0DB-01Z-00-DX1.9CE855BC-0C37-43FB-8806-6625E176BE2E.svs
TCGA-AO-A12C,,FEMALE,0,-15469,NO,1994,WHITE,AO,A12C,71626753-cc34-4731-abc0-ae188b0964e7,42,2005,TUMOR FREE,31,Left Upper Outer QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Positive,Negative,Positive,Positive,2,NO,YES,90-99%,40-49%,Stage IIB,T2N1aM0,1994,TCGA-AO-A12C-01Z-00-DX1.F4105027-FA10-48AF-BA8F-C7A0181C4A1D.svs
TCGA-D8-A1XW,,FEMALE,0,-19478,NO,118,WHITE,D8,A1XW,887b9e5b-99db-44ac-9c30-c0dc6877b41c,53,2011,TUMOR FREE,1,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Negative,Negative,0,YES,NO,,<10%,Stage IIA,T2N0M0,118,TCGA-D8-A1XW-01Z-00-DX1.10187A1F-086B-4CD9-AC01-ADA2E435CD34.svs
TCGA-D8-A13Y,,FEMALE,0,-19028,NO,264,WHITE,D8,A13Y,17f275c1-a0d4-487d-8f02-ea279584b4cd,52,2010,TUMOR FREE,6,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,70-79%,70-79%,Stage IA,T1cN0M0,264,TCGA-D8-A13Y-01Z-00-DX1.02321E77-A11E-41A5-95FE-BB897EA5CE58.svs
TCGA-E2-A108,,FEMALE,0,-23530,NO,124,WHITE,E2,A108,4f04bd10-9902-4a23-b15d-4f4409d79499,64,2009,,27,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,4,NO,YES,,,Stage IIIA,T2N2aM0,124,TCGA-E2-A108-01Z-00-DX1.B110ED43-08A4-476A-A658-1CA75F7C0DDE.svs
TCGA-AR-A256,,FEMALE,1,-16642,2854,NO,WHITE,AR,A256,d3d545b3-457f-4389-821f-704cb24aff7f,45,2001,,5,Right Lower Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,2854,TCGA-AR-A256-01Z-00-DX1.950D4546-4BF4-4380-9877-51D86A93D755.svs
TCGA-AN-A0G0,,FEMALE,0,-20504,NO,16,WHITE,AN,A0G0,96312510-c126-485d-8109-ed81844a1dc3,56,2010,TUMOR FREE,23,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,16,TCGA-AN-A0G0-01Z-00-DX1.BE0BB5DF-DEDA-48D8-B5D8-2735C767F28F.svs
TCGA-E2-A1LA,,FEMALE,0,-21773,NO,463,,E2,A1LA,ce9e0309-9756-42d2-ae94-d91264a79498,59,2009,TUMOR FREE,35,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,,,Stage IIA,T1cN1aM0,463,TCGA-E2-A1LA-01Z-00-DX1.AE49E943-B830-4ED9-B09E-E499441BC2EC.svs
TCGA-E9-A1RB,,FEMALE,0,-14755,NO,21,WHITE,E9,A1RB,94b95984-b2fb-4e42-8887-45e7086c3179,40,2011,TUMOR FREE,10,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0M0,21,TCGA-E9-A1RB-01Z-00-DX1.845074ea-43bc-4752-9dc0-fca72d2ab5de.svs
TCGA-AN-A0XT,,FEMALE,0,-19794,NO,10,WHITE,AN,A0XT,3e25056d-d137-49f5-abaa-f68509426600,54,2010,,17,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIIA,T2N2M0,10,TCGA-AN-A0XT-01Z-00-DX1.882AF4CE-62A1-4808-9B4B-780066E5E602.svs
TCGA-AO-A126,,FEMALE,0,-14264,NO,2850,ASIAN,AO,A126,cc0902fd-a2fc-4327-929e-d4219e32e1d7,39,2002,TUMOR FREE,5,Right Upper Inner QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,0,NO,YES,10-19%,10-19%,Stage IIA,T2N0 (i-)M0,2850,TCGA-AO-A126-01Z-00-DX1.D9D6AA15-32F0-44BD-AF30-36191784FFA2.svs
TCGA-E2-A15J,,FEMALE,0,-18771,NO,464,WHITE,E2,A15J,1fef9454-b3e8-4d9d-a9aa-aa1f1a32b80c,51,2009,TUMOR FREE,12,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage I,T1cN0M0,464,TCGA-E2-A15J-01Z-00-DX1.BF7901D1-30B1-4A76-B0A5-E9B8B36EF4C9.svs
TCGA-E2-A1IN,,FEMALE,0,-22199,NO,392,WHITE,E2,A1IN,f43d622f-eed5-4933-adc6-ae9ad1e33028,60,2010,TUMOR FREE,2,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,392,TCGA-E2-A1IN-01Z-00-DX1.F63F004F-847D-41B0-BAEF-3189D4965838.svs
TCGA-BH-A0BG,,FEMALE,0,-26988,NO,756,WHITE,BH,A0BG,4f608829-ffc4-4527-886e-6bc764ab29f5,73,2008,TUMOR FREE,1,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage I,T1N0M0,756,TCGA-BH-A0BG-01Z-00-DX1.0838FB7F-8C85-4687-9F70-D136A1063383.svs
TCGA-AN-A046,,FEMALE,0,-25158,NO,10,WHITE,AN,A046,dcd5860c-7e3a-44f3-a732-fe92fe3fe300,68,2010,TUMOR FREE,19,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A046-01Z-00-DX1.C529B94F-AFE3-4701-BC98-5D6EDF7B82C0.svs
TCGA-E2-A15S,,FEMALE,0,-12671,NO,274,WHITE,E2,A15S,0f7ab21b-1fd0-45e0-9a47-17c4691eb84f,34,2010,TUMOR FREE,17,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,,,Stage IIB,T2N1M0,274,TCGA-E2-A15S-01Z-00-DX1.77CFA95F-F1AE-41BD-BAF8-BCA6F0DFA3A3.svs
TCGA-A8-A07Z,,FEMALE,0,-31351,NO,853,,A8,A07Z,a272171b-44f5-47a5-89be-7520413c01ad,85,2008,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,853,TCGA-A8-A07Z-01Z-00-DX1.713945D9-6855-456D-87FB-EF8AF8980F51.svs
TCGA-A8-A08I,,FEMALE,0,-19389,NO,365,,A8,A08I,7acf33e7-c386-45fd-8c9a-469600378687,53,2009,TUMOR FREE,,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,365,TCGA-A8-A08I-01Z-00-DX1.96A0065E-5430-40F6-835E-1A7238A79DDA.svs
TCGA-D8-A1Y2,,FEMALE,0,-26021,NO,73,WHITE,D8,A1Y2,c7d7a770-23c0-4310-ab48-1f6152dc2849,71,2011,TUMOR FREE,7,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Indeterminate,0,YES,NO,,<10%,Stage IIA,T2N0MX,73,TCGA-D8-A1Y2-01Z-00-DX1.77451A0F-00FD-44A9-A0D0-CB7A39CE74CC.svs
TCGA-A7-A13F,,FEMALE,0,-16363,NO,196,WHITE,A7,A13F,2cf68894-168b-458b-af4f-53cad72989a8,44,2010,TUMOR FREE,11,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,3,YES,NO,,,Stage IIIA,T3N1aM0,196,TCGA-A7-A13F-01Z-00-DX2.8CC23BAD-B3CC-4BBC-832A-A3879D6EF62D.svs
TCGA-A8-A09N,,FEMALE,0,-21002,NO,31,,A8,A09N,33919e92-4ea9-47e5-a6f4-36e51845d50f,57,2006,TUMOR FREE,,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIIC,T2N3aM0,31,TCGA-A8-A09N-01Z-00-DX1.A0E4EF10-5BFF-46A0-94C7-578EA3A88599.svs
TCGA-S3-AA0Z,,FEMALE,0,-23314,NO,322,BLACK OR AFRICAN AMERICAN,S3,AA0Z,CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC,63,2013,TUMOR FREE,12,LeftLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Equivocal,2,YES,NO,90-99%,<10%,Stage IIB,T2N1aM0,322,TCGA-S3-AA0Z-01Z-00-DX1.4D96156A-4067-41F2-90B8-41EF7ED794CF.svs
TCGA-C8-A12L,,FEMALE,0,-24710,NO,0,ASIAN,C8,A12L,441919eb-8c9f-478c-bda3-8de4f8295e8a,67,2010,TUMOR FREE,3,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,,Negative,Equivocal,,YES,NO,,,Stage IIA,T2N0 (i-)M0,0,TCGA-C8-A12L-01Z-00-DX1.01863BE4-F4AB-45DE-894A-46544777C519.svs
TCGA-AR-A0TX,,FEMALE,0,-23653,NO,15,,AR,A0TX,c364e81c-eb1e-4870-ab37-9c661f5f2e3d,64,2005,,25,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,3,NO,YES,<10%,,Stage IIA,T1N1M0,15,TCGA-AR-A0TX-01Z-00-DX1.5BEA4E65-8CEC-49B2-9F29-DBE53E8ED46E.svs
TCGA-AR-A0TR,,FEMALE,1,-25190,160,NO,WHITE,AR,A0TR,d1703dbd-5c93-4cf2-a4d1-0d90640882bd,68,2006,,27,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,,,Stage IIB,T2N1M0,160,TCGA-AR-A0TR-01Z-00-DX1.BBCE653F-7DD0-4830-BAD3-C06207A93853.svs
TCGA-E2-A570,,FEMALE,0,-17456,NO,549,BLACK OR AFRICAN AMERICAN,E2,A570,CDD8C046-FD97-482A-A11F-2217B321C4D1,47,2011,TUMOR FREE,7,Right Lower Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,,,Stage IB,T1cN1miM0,549,TCGA-E2-A570-01Z-00-DX1.64E5F2CA-9396-40DC-A300-04A54657BDE6.svs
TCGA-BH-A18R,,FEMALE,1,-18524,1142,NO,WHITE,BH,A18R,f6e1ec78-5ad9-4879-9b7e-262d17b166ad,50,2001,TUMOR FREE,15,Right Upper Outer Quadrant,,Negative,3+,Negative,Positive,Indeterminate,Positive,10,NO,YES,20-29%,,Stage IIA,T2bN1M0,1142,TCGA-BH-A18R-01Z-00-DX1.07E6FA7F-5072-4327-9982-A40F010B7532.svs
TCGA-BH-A1ES,,FEMALE,1,-13138,3462,NO,WHITE,BH,A1ES,51ccbf1b-7cae-44ba-991a-11eda8b8c404,35,1999,WITH TUMOR,4,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,,,Positive,Negative,1,NO,YES,,,Stage IIB,T2N1aM0,3462,TCGA-BH-A1ES-01Z-00-DX1.C54C809F-748F-4BB0-B018-A8A83A4134C0.svs
TCGA-C8-A1HN,,FEMALE,0,-20712,NO,2,ASIAN,C8,A1HN,86a18ae0-dfb1-49c3-b5c4-67ec331d6e40,56,2010,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,,Positive,Equivocal,,YES,NO,,,Stage IIA,T2N0M0,2,TCGA-C8-A1HN-01Z-00-DX1.7EBBEAB1-EBB7-456F-8848-AFE2263242B7.svs
TCGA-GM-A2DD,,FEMALE,0,-19415,NO,1309,WHITE,GM,A2DD,B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA,53,2007,TUMOR FREE,2,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,<10%,<10%,Stage I,T1cN0 (i-)M0,1309,TCGA-GM-A2DD-01Z-00-DX1.01332FF3-7488-41B7-A515-7841715DE92B.svs
TCGA-A2-A0SX,,FEMALE,0,-17774,NO,1288,WHITE,A2,A0SX,18d35983-ea6a-4b70-a209-9bef37595956,48,2007,WITH TUMOR,1,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Positive,,Negative,Negative,0,NO,YES,,,Stage IA,T1cN0 (i-)M0,1288,TCGA-A2-A0SX-01Z-00-DX1.219A994C-8974-4458-98FA-FB1F14868E04.svs
TCGA-AR-A0U0,,FEMALE,0,-26993,NO,8,WHITE,AR,A0U0,e3c336f5-c32f-4c5d-81fb-e2408ae145b2,73,2004,,4,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,,0,NO,YES,,,Stage IIB,T2N1M0,8,TCGA-AR-A0U0-01Z-00-DX1.C8BECD9F-68D9-47B1-B31E-C1C6CAE456B6.svs
TCGA-D8-A1XM,,FEMALE,0,-21056,NO,218,WHITE,D8,A1XM,92529232-8504-4541-b7e2-4df8f497c413,57,2010,TUMOR FREE,1,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IA,T1cN0M0,218,TCGA-D8-A1XM-01Z-00-DX1.5F6A140E-5D20-45F6-B76F-0F98AB27AD08.svs
TCGA-LL-A5YM,,FEMALE,0,-32478,NO,143,BLACK OR AFRICAN AMERICAN,LL,A5YM,E9A12DF9-024E-4CBC-B6BF-E4E87485FA90,88,2012,WITH TUMOR,,LeftLeft Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Positive,Positive,Equivocal,,YES,NO,90-99%,90-99%,Stage IIIB,T4bNXM0,143,TCGA-LL-A5YM-01Z-00-DX1.2B8904A9-6A45-4FFD-AF15-EB81773E5B79.svs
TCGA-AC-A7VB,,FEMALE,0,-18806,NO,74,BLACK OR AFRICAN AMERICAN,AC,A7VB,56230E4A-29CA-4F37-A0F9-730DBDFB6FA2,51,2013,TUMOR FREE,15,Right Lower Outer Quadrant,,Negative,,Negative,,Positive,,3,YES,NO,80-89%,<10%,Stage IIA,T1cN1aMX,74,TCGA-AC-A7VB-01Z-00-DX1.62D7FDB3-280D-43B2-92EA-AB810384B0B7.svs
TCGA-A8-A08B,,FEMALE,0,-19114,NO,702,,A8,A08B,d8d7a6c2-6427-4f47-968c-6c3affba4617,52,2008,TUMOR FREE,,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,702,TCGA-A8-A08B-01Z-00-DX1.416316FD-E8BF-402C-939A-08920F08A181.svs
TCGA-B6-A0I6,,FEMALE,1,-18014,991,NO,BLACK OR AFRICAN AMERICAN,B6,A0I6,045c13ef-3db7-4adf-b0a3-23338f0479f3,49,1990,WITH TUMOR,32,Left Upper Outer QuadrantLeft,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,,6,NO,YES,,,Stage IIA,T1cN1M0,991,TCGA-B6-A0I6-01Z-00-DX1.D597D207-BEB2-4CE5-B315-FE7AD6E9C30B.svs
TCGA-B6-A0RO,,FEMALE,0,-26269,NO,4929,WHITE,B6,A0RO,0b172e29-6166-4863-803d-a0a010887c11,71,1993,TUMOR FREE,17,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,2,NO,YES,,,Stage IIIB,T4N1aM0,4929,TCGA-B6-A0RO-01Z-00-DX1.3ADBFF05-92CE-41B5-BD49-CB3CE5B74CC9.svs
TCGA-E9-A1RA,,FEMALE,0,-17699,NO,29,WHITE,E9,A1RA,4b4e4ea8-6eb9-49ad-b880-c5065fe6517f,48,2011,TUMOR FREE,10,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,0,YES,NO,,,Stage IA,T1cN0M0,29,TCGA-E9-A1RA-01Z-00-DX1.E1C527C3-EDF2-442A-80FE-3E3AFBC5EF5A.svs
TCGA-E9-A22D,,FEMALE,0,-14115,NO,0,WHITE,E9,A22D,cf0a3f38-5850-44e1-8574-808bd37d84a3,38,2011,TUMOR FREE,10,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Positive,0,YES,NO,10-19%,<10%,Stage IIA,T2N0M0,0,TCGA-E9-A22D-01Z-00-DX1.b2867437-0add-4b7d-8002-fb09ed961942.svs
TCGA-E9-A22H,,FEMALE,0,-15504,NO,0,WHITE,E9,A22H,161917b8-88ad-407b-ade6-d6b98478b359,42,2011,TUMOR FREE,8,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Positive,1,YES,NO,<10%,10-19%,Stage IIB,T2N1M0,0,TCGA-E9-A22H-01Z-00-DX1.0ee39fd1-b077-40ea-bd0d-8a3db474fdd5.svs
TCGA-GM-A2DA,,FEMALE,0,-16854,NO,5909,WHITE,GM,A2DA,C07B122E-AC50-4DB2-ADD2-5617A5D0E976,46,1993,WITH TUMOR,13,Right Upper Inner QuadrantRight Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Equivocal,2,NO,YES,90-99%,50-59%,Stage IIB,T2N1bM0,5909,TCGA-GM-A2DA-01Z-00-DX1.6E409F88-F654-48C8-A753-BB054037BE16.svs
TCGA-AN-A0XS,,FEMALE,0,-23358,NO,10,WHITE,AN,A0XS,95e949d3-b1f3-46c6-9451-8fe92c99e4cf,63,2010,,11,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Negative,Negative,1,NO,YES,,,Stage IIIA,T2N2M0,10,TCGA-AN-A0XS-01Z-00-DX1.B4D4B73E-2912-4B2E-B18A-FBC35F8160D3.svs
TCGA-A2-A0EM,,FEMALE,0,-26845,NO,2758,WHITE,A2,A0EM,2fdfd287-d13c-4910-9788-73987d45908a,73,2002,TUMOR FREE,1,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,0,NO,YES,,,Stage IA,T1N0 (i-)M0,2758,TCGA-A2-A0EM-01Z-00-DX1.305CF011-7451-4880-9A5D-AB4432CF53A5.svs
TCGA-BH-A0W4,,FEMALE,0,-16911,NO,175,WHITE,BH,A0W4,0772cdbe-8b0d-452b-8df1-bd70d1306363,46,2010,TUMOR FREE,3,Left Upper Outer Quadrant,,Positive,,,,Positive,Negative,,NO,YES,,,Stage IIA,T2N0 (i-)M0,175,TCGA-BH-A0W4-01Z-00-DX1.23E017DC-15CB-4838-AC91-CFB11B932AB0.svs
TCGA-D8-A1XB,,FEMALE,0,-22976,NO,201,WHITE,D8,A1XB,d2694b09-7844-4496-865c-5d3d8cd03330,62,2010,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,YES,NO,,,Stage IIB,T2N1aM0,201,TCGA-D8-A1XB-01Z-00-DX1.DA8E2FA4-DBBA-4157-8052-B90FB3BB58F1.svs
TCGA-A2-A0T1,,FEMALE,0,-20227,NO,323,AMERICAN INDIAN OR ALASKA NATIVE,A2,A0T1,02bed00f-bef7-4fb7-b243-540354990e45,55,2009,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,10,NO,YES,<10%,<10%,Stage IIIC,T3N3M0,323,TCGA-A2-A0T1-01Z-00-DX1.CD1E9C46-18A3-466B-AA0B-24F3055FA851.svs
TCGA-B6-A0RS,,FEMALE,1,-14134,3063,NO,WHITE,B6,A0RS,9416ff9b-6f29-4554-b04d-b537a3ae3969,38,1988,WITH TUMOR,15,Left Lower Inner QuadrantLeft,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,3063,TCGA-B6-A0RS-01Z-00-DX1.F72B766D-FC49-4876-A93D-D88B05702267.svs
TCGA-B6-A0RG,,FEMALE,0,-9840,NO,2082,WHITE,B6,A0RG,9b13927c-7357-44fd-8385-92ae6a656b7d,26,1991,TUMOR FREE,19,Left,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,,0,NO,YES,,,Stage IIB,T3N0 (i-)M0,2082,TCGA-B6-A0RG-01Z-00-DX1.C83D21A0-EC61-459C-9776-EA3D91469E72.svs
TCGA-A8-A07P,,FEMALE,0,-24929,NO,334,,A8,A07P,8cccf160-93e9-48a5-9b8b-54aa50153142,68,2009,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIB,T2N1M0,334,TCGA-A8-A07P-01Z-00-DX1.2C7C75EF-EEE2-4A42-994C-A1A40850C87A.svs
TCGA-A8-A07U,,FEMALE,0,-24411,NO,303,,A8,A07U,59bf0ce4-715a-4017-bccb-c59916e78324,66,2009,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Negative,Negative,,NO,YES,,,Stage IIIA,T2N2aM0,303,TCGA-A8-A07U-01Z-00-DX1.69D356C3-C7FC-47E9-B753-BE421263343F.svs
TCGA-AR-A24V,,FEMALE,0,-19027,NO,1648,WHITE,AR,A24V,3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd,52,2006,,2,Right Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Positive,,Negative,,Positive,Negative,1,NO,YES,80-89%,<10%,Stage IIB,T2N1M0,1648,TCGA-AR-A24V-01Z-00-DX1.E749C2FE-E26B-4306-80B4-8269EEB23270.svs
TCGA-A7-A0DC,,FEMALE,0,-23294,NO,273,WHITE,A7,A0DC,cb9f5e50-f49d-4899-8895-9367afcc1015,63,2009,TUMOR FREE,3,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,0,YES,NO,90-99%,<10%,Stage IA,T1cN0 (i-)M0,273,TCGA-A7-A0DC-01Z-00-DX2.795FD529-D7C2-407D-9E8A-5DCE1EF49029.svs
TCGA-BH-A0GZ,,FEMALE,0,-22714,NO,328,WHITE,BH,A0GZ,27dfb9d4-3a2c-44bc-9acf-8f638d3f3004,62,2009,TUMOR FREE,14,Left Upper Inner QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,90-99%,80-89%,Stage IIA,T1cN1aM0,328,TCGA-BH-A0GZ-01Z-00-DX1.9AD4F493-A0A9-499D-B667-B33333FC1A51.svs
TCGA-E2-A156,,FEMALE,0,-22422,NO,481,WHITE,E2,A156,f05d314c-5ec5-4e2a-b785-9a702716f111,61,2009,TUMOR FREE,3,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,481,TCGA-E2-A156-01Z-00-DX1.CEF32B4D-A676-4230-992D-45A046E4043A.svs
TCGA-A2-A0CL,,FEMALE,0,-13556,NO,1827,BLACK OR AFRICAN AMERICAN,A2,A0CL,5c8983f2-9788-4dfa-971c-3ec457b6166e,37,2006,TUMOR FREE,14,Right Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Positive,Negative,Positive,Negative,9,NO,YES,20-29%,<10%,Stage IIIA,T3N2aM0,1827,TCGA-A2-A0CL-01Z-00-DX1.5342E971-DCD2-42C4-B4FF-E6942A95829E.svs
TCGA-E2-A1IO,,FEMALE,0,-13671,NO,498,WHITE,E2,A1IO,71fc8941-4cfb-47ea-a533-873d38f8c95c,37,2009,TUMOR FREE,1,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage I,T1cN0M0,498,TCGA-E2-A1IO-01Z-00-DX1.C812D02F-3B40-496B-9EF5-7F68ADE64962.svs
TCGA-AR-A24W,,FEMALE,0,-20123,NO,1550,WHITE,AR,A24W,67526f5a-3a30-45b2-aeab-2b21a855063e,55,2006,,22,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,3,NO,YES,,,Stage IIB,T2N1M0,1550,TCGA-AR-A24W-01Z-00-DX1.0663B4A3-6475-4981-91F0-20D2C79CBF89.svs
TCGA-EW-A1IZ,,FEMALE,0,-19706,NO,260,WHITE,EW,A1IZ,c0f88fc5-56b0-4255-bbd1-9a21ced8b37b,53,2010,TUMOR FREE,14,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,5,NO,YES,90-99%,90-99%,Stage IIIA,T2N2aMX,260,TCGA-EW-A1IZ-01Z-00-DX1.81D5544E-0A7D-4A92-A3B0-4F22CFB8BBB2.svs
TCGA-C8-A26V,,FEMALE,0,-17468,NO,9,ASIAN,C8,A26V,89414e79-7f89-42d9-8228-101b5bf2f31f,47,2010,TUMOR FREE,,Right,Peri (6-12 months since last menstrual period),Positive,,Negative,,Positive,Negative,,YES,NO,,,Stage IIIA,T3N2M0,9,TCGA-C8-A26V-01Z-00-DX1.6E86DF74-D575-4969-8142-963D9DF5208F.svs
TCGA-C8-A27A,,FEMALE,0,-17779,NO,371,ASIAN,C8,A27A,3b1f7e48-216d-47de-ba79-db350f52bff0,48,2010,TUMOR FREE,,Right Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIB,T2N1M0,371,TCGA-C8-A27A-01Z-00-DX1.0E26C46D-CD65-40F3-8976-EB4415582934.svs
TCGA-S3-A6ZF,,FEMALE,0,-23650,NO,212,BLACK OR AFRICAN AMERICAN,S3,A6ZF,FBEE40F1-D6D8-4156-8D42-36E09BB9F095,64,2013,TUMOR FREE,1,RightRight Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,YES,NO,90-99%,40-49%,Stage IIA,T2N0M0,212,TCGA-S3-A6ZF-01Z-00-DX1.E50205A0-63CA-49DE-8831-2A8916DEF403.svs
TCGA-EW-A1J6,,FEMALE,0,-25830,NO,595,WHITE,EW,A1J6,87281a89-91d2-44f7-9f80-668567ad5c72,70,2009,TUMOR FREE,3,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage I,T1cN0 (i-)M0,595,TCGA-EW-A1J6-01Z-00-DX1.F668E978-13B6-4284-9522-37C65C57A21A.svs
TCGA-PL-A8LY,,FEMALE,0,-11199,NO,8,BLACK OR AFRICAN AMERICAN,PL,A8LY,9BA11EA8-97D3-464A-90A4-EC1151BE9088,30,2013,WITH TUMOR,,RightRight Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,YES,NO,,,Stage IIB,T3N0M0,8,TCGA-PL-A8LY-01A-01-DX1.32047D5E-8A42-480A-B2B8-A56B47B949FD.svs
TCGA-E2-A572,,FEMALE,0,-26399,NO,831,BLACK OR AFRICAN AMERICAN,E2,A572,06EF6E83-5583-45B9-A0BD-EDEA68943083,72,2011,TUMOR FREE,13,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage IIIA,T2N2M0,831,TCGA-E2-A572-01Z-00-DX1.7DDF1C25-58E2-4AF9-B831-598222A4E85D.svs
TCGA-AN-A041,,FEMALE,0,-10812,NO,7,WHITE,AN,A041,316e021c-5175-4ab3-bdb6-2bf9683f657a,29,2010,,18,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,,Positive,Positive,1,NO,YES,,,Stage IIB,T2N1aM0,7,TCGA-AN-A041-01Z-00-DX1.96D3628B-FB6E-4A41-A5E8-8896B0657F1C.svs
TCGA-S3-AA12,,FEMALE,0,-30101,NO,259,BLACK OR AFRICAN AMERICAN,S3,AA12,2BCACFD1-6A45-4B96-9B80-2AD569B1AB45,82,2013,TUMOR FREE,16,LeftLeft Upper Inner QuadrantLeft Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Positive,Negative,2,YES,NO,90-99%,,Stage IIIA,T3N1aMX,259,TCGA-S3-AA12-01Z-00-DX2.4F0A4F18-41C7-4497-A7B8-5DCE610E08AD.svs
TCGA-A2-A0SU,,FEMALE,0,-24219,NO,1352,WHITE,A2,A0SU,c632675e-e8af-43cd-8744-5be3754c1c14,66,2006,TUMOR FREE,7,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,<10%,Stage IIA,T2N0 (i+)M0,1352,TCGA-A2-A0SU-01Z-00-DX1.22420EE2-4FEB-42F3-9547-4739F0F73D50.svs
TCGA-A2-A4S3,,FEMALE,0,-21762,NO,104,BLACK OR AFRICAN AMERICAN,A2,A4S3,418C11E8-2670-48D5-BBF5-95B46BFF1201,59,2012,TUMOR FREE,15,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,2,YES,NO,90-99%,90-99%,Stage IIB,T2N1aM0,104,TCGA-A2-A4S3-01Z-00-DX1.50699E65-E536-4C9B-93A7-4C9894624A29.svs
TCGA-BH-A0DT,,FEMALE,0,-15078,NO,1170,WHITE,BH,A0DT,74f31744-0aed-4633-beec-4e203315f0b7,41,2007,TUMOR FREE,18,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIA,T1cN1aM0,1170,TCGA-BH-A0DT-01Z-00-DX1.73AFCEBB-06B1-4870-ADA2-881511B1BE2D.svs
TCGA-C8-A134,,FEMALE,0,-19010,NO,14,ASIAN,C8,A134,f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e,52,2010,TUMOR FREE,7,Left,Peri (6-12 months since last menstrual period),Negative,2+,Negative,,Negative,Equivocal,,YES,NO,,,Stage IIA,T2N0M0,14,TCGA-C8-A134-01Z-00-DX1.78D10BCC-98B3-4587-897D-3E27DA28D2EB.svs
TCGA-AN-A0AK,,FEMALE,0,-27977,NO,224,WHITE,AN,A0AK,9e894662-b718-40f8-8899-b5e036cfbd76,76,2010,TUMOR FREE,11,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,,Positive,Positive,0,NO,YES,80-89%,<10%,Stage IIA,T2N0M0,224,TCGA-AN-A0AK-01Z-00-DX1.4B410152-8588-4000-870A-B31B21161015.svs
TCGA-D8-A1X5,,FEMALE,0,-29734,NO,171,WHITE,D8,A1X5,eb93df3d-9e25-4e4c-9a5d-350f296e5acf,81,2010,TUMOR FREE,16,Right Upper Outer QuadrantRight Lower Inner QuadrantRight Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,14,YES,NO,,,Stage IIIC,T2N3aMX,171,TCGA-D8-A1X5-01Z-00-DX2.E4D28EE2-9C87-4613-BD2E-89FBEF960DEE.svs
TCGA-AO-A0JI,,FEMALE,0,-20694,NO,1172,WHITE,AO,A0JI,e17c565c-9857-4df3-a352-903b53093c85,56,2007,TUMOR FREE,10,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,<10%,Stage IIA,T1cN1M0,1172,TCGA-AO-A0JI-01Z-00-DX1.4DCDA545-B7E3-49DF-AB10-963E84BEB105.svs
TCGA-C8-A130,,FEMALE,0,-19117,NO,4,ASIAN,C8,A130,8cf54607-01ce-42b0-9bd9-8627edd9f3b7,52,2010,TUMOR FREE,8,Left,Peri (6-12 months since last menstrual period),Positive,2+,Negative,,Positive,Equivocal,,YES,NO,,,Stage IIIA,T3N2M0,4,TCGA-C8-A130-01Z-00-DX1.F6810204-C35A-4461-A18A-0A117739B988.svs
TCGA-BH-A0H3,,FEMALE,0,-17152,NO,1149,WHITE,BH,A0H3,6cdc0d53-f813-4101-81e5-9bee68270536,46,2008,TUMOR FREE,2,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Negative,Positive,,0,NO,YES,,,Stage I,T1cN0M0,1149,TCGA-BH-A0H3-01Z-00-DX1.C6D4DFB9-A4FA-40B2-90EF-75294CBC4523.svs
TCGA-D8-A1XY,,FEMALE,0,-27106,NO,81,WHITE,D8,A1XY,0130d616-885e-4a6c-9d03-2f17dd692a05,74,2010,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,,,Positive,Positive,0,YES,NO,,,Stage IIA,T2N0MX,81,TCGA-D8-A1XY-01Z-00-DX2.33D96E5C-5291-4864-B282-8BACA2043586.svs
TCGA-A8-A08P,,FEMALE,0,-25598,NO,943,,A8,A08P,f947d67f-4aa2-4eb9-977e-21a5ae563613,70,2008,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIIA,T2N2aM0,943,TCGA-A8-A08P-01Z-00-DX1.431A1290-9CF4-4CE7-A9F0-13F9ADA46ADA.svs
TCGA-OL-A5D7,,FEMALE,0,-25643,NO,1416,BLACK OR AFRICAN AMERICAN,OL,A5D7,C8F39325-5382-447C-9291-A6915FC978B8,70,2009,TUMOR FREE,1,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,,NO,YES,,,Stage IIA,T2N0MX,1416,TCGA-OL-A5D7-01Z-00-DX1.A4A45393-9AE1-4370-8B92-CB85CDB04934.svs
TCGA-AR-A0TV,,FEMALE,0,-24279,NO,905,,AR,A0TV,6439621e-da61-4723-91cc-c5d87d0a4abc,66,2005,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,,Stage IIA,T2N0M0,905,TCGA-AR-A0TV-01Z-00-DX1.29AE9996-E73A-41F8-BCC9-23DEDCA5A7AC.svs
TCGA-AR-A1AW,,FEMALE,0,-23855,NO,1072,WHITE,AR,A1AW,a12fd22a-7f84-4b6e-b6d8-012e38eb73d7,65,2007,,1,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,70-79%,70-79%,Stage IIA,T2N0M0,1072,TCGA-AR-A1AW-01Z-00-DX1.E527CA46-D83F-4055-8C7E-AEFEF13C1E29.svs
TCGA-A1-A0SH,,FEMALE,0,-14595,NO,1437,WHITE,A1,A0SH,a6a863d9-b39d-4965-b47f-79a1bcf3c976,39,2006,TUMOR FREE,2,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,,90-99%,Stage IIA,T2N0 (i-)M0,1437,TCGA-A1-A0SH-01Z-00-DX1.90E71B08-E1D9-4FC2-85AC-062E56DDF17C.svs
TCGA-A8-A07E,,FEMALE,0,-29800,NO,608,,A8,A07E,853456d8-2367-404e-abc9-020fe8bbd209,81,2008,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage X,T4bN3aMX,608,TCGA-A8-A07E-01Z-00-DX1.AC684481-979A-46F9-91D7-C56CE85992F2.svs
TCGA-E2-A14S,,FEMALE,0,-23878,NO,834,WHITE,E2,A14S,c2b104ee-f914-4e79-9e1b-56bf88157472,65,2008,TUMOR FREE,2,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage I,T1cN0M0,834,TCGA-E2-A14S-01Z-00-DX1.5C332E99-7296-473A-9917-7EFC38A8251D.svs
TCGA-BH-A0B0,,FEMALE,0,-20776,NO,1428,BLACK OR AFRICAN AMERICAN,BH,A0B0,66af34ea-f471-4092-aff6-9ac9a5b75b11,56,2006,TUMOR FREE,2,Left Upper Outer Quadrant,Peri (6-12 months since last menstrual period),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,1428,TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669.svs
TCGA-A8-A07B,,FEMALE,0,-25475,NO,1004,,A8,A07B,b43e41af-1d82-4b5f-b8f1-add0510e6b86,69,2007,TUMOR FREE,,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,1004,TCGA-A8-A07B-01Z-00-DX1.950B5E4E-C5F0-4445-9F88-E8C32CDFE6DA.svs
TCGA-BH-A18V,,FEMALE,1,-17682,1556,NO,WHITE,BH,A18V,6b960b58-28e1-41c6-bd6e-7e669c6aa4ef,48,2001,,25,Right,,Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IIB,T2N1bM0,1556,TCGA-BH-A18V-01Z-00-DX1.7797760A-05CD-436E-97DA-31D6201F943B.svs
TCGA-B6-A0X1,,FEMALE,0,-17624,NO,5677,WHITE,B6,A0X1,178b2c48-c07d-422e-ae17-8bcfd996ad51,48,1994,TUMOR FREE,21,Left,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,,16,NO,YES,,,,T2N1M1,5677,TCGA-B6-A0X1-01Z-00-DX1.2A41630E-A8BF-4966-99F5-D5D8036B1759.svs
TCGA-EW-A2FR,,FEMALE,0,-21628,NO,1120,BLACK OR AFRICAN AMERICAN,EW,A2FR,AF97E043-88CB-4F99-8F8B-9BCBCCCDF842,59,2008,TUMOR FREE,21,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Positive,Negative,Equivocal,19,NO,YES,<10%,<10%,Stage IIIC,T1bN3aMX,1120,TCGA-EW-A2FR-01Z-00-DX1.FF521BBF-F5BA-4B03-9CA1-101A337F4B45.svs
TCGA-E2-A14R,,FEMALE,0,-22686,NO,845,WHITE,E2,A14R,4fba3deb-db94-44b5-a0f2-a575d270779e,62,2008,TUMOR FREE,8,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,845,TCGA-E2-A14R-01Z-00-DX1.DDE62ED5-1FC0-4B3B-A874-95C08B33AB20.svs
TCGA-E2-A1IE,,FEMALE,0,-22510,NO,983,WHITE,E2,A1IE,2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d,61,2008,TUMOR FREE,3,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,,,Stage IIB,T2N1M0,983,TCGA-E2-A1IE-01Z-00-DX1.D6BF29A7-4FBD-4F7D-B093-991FA0F49FE8.svs
TCGA-A2-A0CW,,FEMALE,0,-24541,NO,1750,WHITE,A2,A0CW,32efa6e8-6b19-480a-9d04-ace02e93318a,67,2006,TUMOR FREE,19,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,90-99%,10-19%,Stage IIB,T2N1aM0,1750,TCGA-A2-A0CW-01Z-00-DX1.8E313A22-B0E8-44CF-ADEA-8BF29BA23FFE.svs
TCGA-E2-A1LK,,FEMALE,1,-30757,266,NO,BLACK OR AFRICAN AMERICAN,E2,A1LK,1d27253f-b036-44e7-a04d-8da5bbf57419,84,2008,WITH TUMOR,15,Left Upper Outer QuadrantLeft Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,11,NO,YES,,,Stage IIIC,T4bN3aM0,266,TCGA-E2-A1LK-01Z-00-DX1.5EBAA1F4-F1B4-4938-A51F-0246621BB0ED.svs
TCGA-AO-A03R,,FEMALE,0,-20930,NO,1707,WHITE,AO,A03R,2e82e576-3095-4aee-9853-65f676647c34,57,2005,TUMOR FREE,26,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,Negative,Positive,Negative,3,NO,YES,90-99%,<10%,Stage IIB,T2N1aM0,1707,TCGA-AO-A03R-01Z-00-DX1.DC317201-7F22-4C4A-86A5-ED82C37757C8.svs
TCGA-E2-A1L7,,FEMALE,0,-14854,NO,633,WHITE,E2,A1L7,791c5768-f0f5-4ab6-86eb-998e5c4b49e3,40,2009,TUMOR FREE,20,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Negative,Negative,7,NO,YES,,,Stage IIIA,T2N2M0,633,TCGA-E2-A1L7-01Z-00-DX1.BE796CD2-2E81-44E8-8CA2-85B4D2A31B64.svs
TCGA-A2-A3Y0,,FEMALE,0,-21024,NO,859,BLACK OR AFRICAN AMERICAN,A2,A3Y0,174850B4-5EC2-462B-A890-89BD1716B3C2,57,2010,TUMOR FREE,39,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Close,,Positive,Negative,1,NO,YES,90-99%,,Stage IIB,T2N1aM0,859,TCGA-A2-A3Y0-01Z-00-DX1.A1EDDF82-FFAA-44A4-A749-7FB6F8133CC0.svs
TCGA-D8-A147,,FEMALE,0,-16736,NO,2,WHITE,D8,A147,fc18d029-9be2-4fa0-9aef-6d647dc55f0b,45,2010,,1,Right Lower Outer Quadrant,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,Negative,0,YES,NO,,,,T2N0M0,2,TCGA-D8-A147-01Z-00-DX1.159094F2-BB78-4910-B7AE-3D7CAAB1DAD9.svs
TCGA-C8-A12P,,FEMALE,0,-20332,NO,0,ASIAN,C8,A12P,abdc76db-f85e-4337-a57e-6d098789da03,55,2010,TUMOR FREE,8,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-C8-A12P-01Z-00-DX1.670B5DE8-07B0-4E4C-93FA-FA3DFFCCE50D.svs
TCGA-C8-A12K,,FEMALE,0,-29463,NO,0,ASIAN,C8,A12K,6b923e30-2ddc-407f-91b1-c202f1373fbb,80,2010,TUMOR FREE,7,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,1,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-C8-A12K-01Z-00-DX1.D71C7974-65F7-4EF0-8FFB-9F27CEC85242.svs
TCGA-BH-A0DZ,,FEMALE,0,-15980,NO,495,WHITE,BH,A0DZ,478eb8aa-50b8-4ce5-98e4-d518ede4b174,43,2009,TUMOR FREE,5,Right Upper Inner QuadrantRight Upper Outer QuadrantRight Lower Inner QuadrantRight Lower Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,,Positive,Positive,1,NO,YES,50-59%,<10%,Stage IIB,T2N1aM0,495,TCGA-BH-A0DZ-01Z-00-DX1.138BAEC2-589E-4960-B94E-DF48DDAA5490.svs
TCGA-A2-A0EO,,FEMALE,0,-19880,NO,2181,WHITE,A2,A0EO,bf88ddf5-a6d4-498c-bf7f-db9bfabff72d,54,2003,TUMOR FREE,3,Left,Peri (6-12 months since last menstrual period),Positive,1+,Close,Negative,Positive,Negative,0,NO,YES,,,Stage IA,T1N0 (i-)M0,2181,TCGA-A2-A0EO-01Z-00-DX1.D7A09E23-2CAB-4B3B-814C-BF0BA75B7589.svs
TCGA-B6-A1KI,,FEMALE,0,-23031,NO,1463,WHITE,B6,A1KI,1dafdd64-527d-4d46-bbdf-7a97774f881b,63,2003,TUMOR FREE,1,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,,,Stage I,T1cN0M0,1463,TCGA-B6-A1KI-01Z-00-DX1.EFAA08A8-02EC-4A9B-AC6B-79BF2DC5A2AA.svs
TCGA-A2-A0YT,,FEMALE,1,-20482,723,NO,WHITE,A2,A0YT,14b95463-2108-4921-afc2-e29eef52b18f,56,2008,TUMOR FREE,5,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Positive,,5,NO,YES,90-99%,<10%,Stage IIIB,T4bN2aM0,723,TCGA-A2-A0YT-01Z-00-DX1.63CA3E36-B3E4-4D3F-9F80-2703970DBE5B.svs
TCGA-AQ-A0Y5,,FEMALE,1,-25793,172,NO,WHITE,AQ,A0Y5,d0b78f3f-a198-437a-ab8c-204345d3b75d,70,2010,TUMOR FREE,17,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,5,YES,NO,70-79%,40-49%,Stage IIIA,T2N2aMX,172,TCGA-AQ-A0Y5-01Z-00-DX1.f68f5b49-30fa-4fb6-bec6-5da9f6809d02.svs
TCGA-AN-A0XU,,FEMALE,0,-20052,NO,10,WHITE,AN,A0XU,a1da9db1-db11-4f4d-a249-c738db81b87e,54,2010,,16,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A0XU-01Z-00-DX1.6B0DD0FF-A20D-4BA2-8D48-FC357BA5313F.svs
TCGA-BH-A208,,FEMALE,1,-17715,1759,NO,WHITE,BH,A208,ddcbdac6-9e43-4146-a611-d033125eba14,48,1995,TUMOR FREE,15,Left,,,,,,,,3,NO,YES,,,Stage IIB,T2N1bM0,1759,TCGA-BH-A208-01Z-00-DX1.C7A2885D-0535-4506-B06E-82BC62D6DFE9.svs
TCGA-A8-A09B,,FEMALE,0,-21520,NO,365,,A8,A09B,3828b534-908e-4953-a3fb-07d01cf49c7d,58,2009,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIB,T4bN1aM0,365,TCGA-A8-A09B-01Z-00-DX1.97CCDA89-AB73-4F05-A900-668160227B78.svs
TCGA-A8-A099,,FEMALE,0,-28063,NO,304,,A8,A099,e98b69bc-766a-485f-b5e8-9166b8d457b3,76,2009,,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,,Positive,Positive,Positive,,NO,YES,,,Stage X,T4bN3aMX,304,TCGA-A8-A099-01Z-00-DX1.B19C28B5-FEBC-49B4-A60E-E6B85BB00DD7.svs
TCGA-BH-A0H6,,FEMALE,0,-30125,NO,747,WHITE,BH,A0H6,aeb6a3a6-b57a-4c53-90e6-e833777dd2a1,82,2008,TUMOR FREE,0,Right Upper Inner QuadrantRight Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,50-59%,60-69%,Stage I,T1bNXM0,747,TCGA-BH-A0H6-01Z-00-DX1.0CF7253A-B42C-4778-B1C6-17EC78A039ED.svs
TCGA-D8-A1XK,,FEMALE,0,-20092,NO,326,WHITE,D8,A1XK,97943d87-fed7-4f14-a0a7-c5bfee64c392,55,2010,TUMOR FREE,18,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,3,YES,NO,,,Stage IIB,T2N1aMX,326,TCGA-D8-A1XK-01Z-00-DX1.41EB1BBC-F230-4E3F-8C4E-CE331CAF1935.svs
TCGA-GM-A2DM,,FEMALE,0,-21160,NO,2331,WHITE,GM,A2DM,753D5D49-3B40-4737-9D4C-B1EC29CC2692,57,2004,TUMOR FREE,2,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,40-49%,30-39%,Stage IIA,T2N0 (i-)M0,2331,TCGA-GM-A2DM-01Z-00-DX1.652038F4-C370-40EB-A545-51062783C74C.svs
TCGA-3C-AALI,,FEMALE,0,-18538,NO,3801,BLACK OR AFRICAN AMERICAN,3C,AALI,55262FCB-1B01-4480-B322-36570430C917,50,2003,TUMOR FREE,15,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Positive,1,NO,YES,<10%,<10%,Stage IIB,T2N1aM0,3801,TCGA-3C-AALI-01Z-00-DX2.CF4496E0-AB52-4F3E-BDF5-C34833B91B7C.svs
TCGA-B6-A0IB,,FEMALE,1,-23646,3941,NO,WHITE,B6,A0IB,157ec9e0-ca6e-4da1-9233-f976cf0db433,64,1992,WITH TUMOR,15,Right Upper Inner QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,8,NO,YES,,,Stage IV,T3N3M1,3941,TCGA-B6-A0IB-01Z-00-DX1.BAA1D655-1B80-49E2-B1EB-2ECC83DED989.svs
TCGA-D8-A13Y,,FEMALE,0,-19028,NO,264,WHITE,D8,A13Y,17f275c1-a0d4-487d-8f02-ea279584b4cd,52,2010,TUMOR FREE,6,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,70-79%,70-79%,Stage IA,T1cN0M0,264,TCGA-D8-A13Y-01Z-00-DX2.0043D2BB-B04D-4A44-AAB1-1CAAD97AC246.svs
TCGA-GI-A2C8,,FEMALE,0,-23103,NO,225,WHITE,GI,A2C8,33fe5833-d7a0-43d7-a03d-56985ea448a6,63,2004,,10,Right,,Positive,,Negative,Negative,Positive,Negative,0,NO,YES,90-99%,<10%,Stage IIIB,T4bN0MX,225,TCGA-GI-A2C8-01Z-00-DX1.09BD8AC9-645A-4C8B-9B36-77D833BDBA09.svs
TCGA-BH-A0DE,,FEMALE,0,-22656,NO,948,WHITE,BH,A0DE,7f0bbba1-9bc3-45db-bdda-eb3319bb15d2,62,2007,TUMOR FREE,2,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,948,TCGA-BH-A0DE-01Z-00-DX1.64A0340A-8146-48E8-AAF7-4035988B9152.svs
TCGA-AR-A254,,FEMALE,0,-18270,NO,1212,WHITE,AR,A254,6014a582-d22e-46e1-9000-c8e2fbad7acf,50,2007,,30,Left Upper Inner QuadrantLeft Lower Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,,Positive,Positive,9,NO,YES,,,Stage IIIA,T2N2M0,1212,TCGA-AR-A254-01Z-00-DX1.EA5CD008-1106-41EC-998A-04EF08EEEC9D.svs
TCGA-E9-A248,,FEMALE,0,-18684,NO,22,WHITE,E9,A248,539bbbed-43fb-4fef-9c67-6406f58b186a,51,2011,TUMOR FREE,10,Right Upper Outer Quadrant,Peri (6-12 months since last menstrual period),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0 (i-)M0,22,TCGA-E9-A248-01Z-00-DX1.C991932F-39D4-4F2C-91C3-CE12B5BAEDB1.svs
TCGA-GM-A2DB,,FEMALE,0,-22883,NO,1616,WHITE,GM,A2DB,6E6B7742-A562-490B-BB72-04A5653852E4,62,2006,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,1616,TCGA-GM-A2DB-01Z-00-DX1.9EE36AA6-2594-44C7-B05C-91A0AEC7E511.svs
TCGA-BH-A0BT,,FEMALE,0,-20625,NO,1386,WHITE,BH,A0BT,a32cb96a-78bf-456e-a6ab-2d47b2c67ad4,56,2007,TUMOR FREE,,Right Upper Inner Quadrant,,Positive,,Negative,,Positive,Negative,,NO,YES,,,Stage IIA,T1cN1miM0,1386,TCGA-BH-A0BT-01Z-00-DX1.9087B9E7-C0CD-4179-AF57-AD9255785169.svs
TCGA-A8-A097,,FEMALE,0,-23741,NO,365,,A8,A097,dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1,65,2009,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIB,T2N1M0,365,TCGA-A8-A097-01Z-00-DX1.4D06990E-E759-40F0-9106-59408CF350E5.svs
TCGA-OL-A5D8,,FEMALE,0,-14853,NO,229,BLACK OR AFRICAN AMERICAN,OL,A5D8,6D4860B2-21C6-4B7B-9093-2F32700D0612,40,2009,TUMOR FREE,2,Left Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,,Negative,Positive,,,NO,YES,90-99%,90-99%,Stage IIB,T3N0MX,229,TCGA-OL-A5D8-01Z-00-DX1.C0A75731-1DDC-4FAF-A2C5-2E2ECB23DC13.svs
TCGA-AR-A24P,,FEMALE,0,-17490,NO,26,WHITE,AR,A24P,d1fd8ed2-be13-4272-b31e-df86911db3b1,47,2005,,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,10-19%,10-19%,Stage I,T1N0M0,26,TCGA-AR-A24P-01Z-00-DX1.08BE8830-C55E-4E2B-9378-371A670C75FD.svs
TCGA-AO-A1KT,,FEMALE,0,-28660,NO,541,WHITE,AO,A1KT,1f8f87cb-8a0b-474c-97fb-c71b4fd88d97,78,2009,TUMOR FREE,5,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,90-99%,40-49%,Stage IIA,T1N1M0,541,TCGA-AO-A1KT-01Z-00-DX1.47878910-4359-4795-B0BB-FAC147C8D932.svs
TCGA-BH-A0H0,,FEMALE,0,-25223,NO,461,WHITE,BH,A0H0,96457ebf-ae88-41f4-97e5-cdc3163418aa,69,2009,TUMOR FREE,2,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,50-59%,<10%,Stage IA,T1cN0 (i-)M0,461,TCGA-BH-A0H0-01Z-00-DX1.B3B394DD-1F4E-42CA-BB51-C002E423B3D0.svs
TCGA-OL-A5RY,,FEMALE,0,-19216,NO,429,BLACK OR AFRICAN AMERICAN,OL,A5RY,8360CEC6-DAF6-41C9-9A4F-7FC03C958DCC,52,2011,WITH TUMOR,25,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Positive,Positive,Positive,,1,NO,YES,10-19%,,Stage IIA,T1cN1MX,429,TCGA-OL-A5RY-01Z-00-DX1.AE4E9D74-FC1C-4C1E-AE6D-5DF38899BBA6.svs
TCGA-D8-A1J8,,FEMALE,0,-28444,NO,256,WHITE,D8,A1J8,62d70067-ff77-4f95-8b69-f537abaf74ce,77,2010,TUMOR FREE,16,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,3,YES,NO,70-79%,70-79%,Stage IIB,T2N1aM0,256,TCGA-D8-A1J8-01Z-00-DX2.5DCB3447-548D-442C-86B1-CEF79B8689DF.svs
TCGA-AR-A0U2,,FEMALE,1,-17390,2551,NO,WHITE,AR,A0U2,9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d,47,2004,WITH TUMOR,16,Left Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,4,NO,YES,10-19%,,Stage IIIA,T2N2M0,2551,TCGA-AR-A0U2-01Z-00-DX1.03E2ADD9-F20F-44DA-93D1-D10BBD3844A5.svs
TCGA-D8-A1J9,,FEMALE,0,-17879,NO,248,WHITE,D8,A1J9,d5e9a403-88ce-40fc-bb85-80cf3f8ff6bc,48,2010,TUMOR FREE,6,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Positive,Positive,0,YES,NO,,,Stage IA,T1cN0M0,248,TCGA-D8-A1J9-01Z-00-DX2.E1C59487-9563-4501-845F-2067A0C5C59B.svs
TCGA-A2-A0T0,,FEMALE,0,-21575,NO,337,WHITE,A2,A0T0,95c53f69-0f05-4348-822a-571f3d757001,59,2009,TUMOR FREE,14,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Negative,Negative,2,NO,YES,<10%,<10%,Stage IIB,T2N1M0,337,TCGA-A2-A0T0-01Z-00-DX1.51F904DA-A4B5-4451-8AEF-58E7EF7651DB.svs
TCGA-BH-A1F8,,FEMALE,1,-32871,1,NO,WHITE,BH,A1F8,ee554215-bea2-4268-aaf9-784e68cdb969,90,1999,WITH TUMOR,13,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Positive,12,NO,YES,,,Stage IIIB,T4bN2M0,1,TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B.svs
TCGA-E2-A1L6,,FEMALE,0,-16403,NO,1312,WHITE,E2,A1L6,2e32f31f-9817-4935-b259-96c59936ee33,44,2007,TUMOR FREE,6,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,1,NO,YES,,,Stage IIA,T1cN1miM0,1312,TCGA-E2-A1L6-01Z-00-DX1.AFE87067-2BFD-42C2-9334-9DDE8AB61B49.svs
TCGA-E9-A1NE,,FEMALE,0,-10564,NO,0,WHITE,E9,A1NE,3d676bba-154b-4d22-ab59-d4d4da051b94,28,2011,TUMOR FREE,2,Right Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-E9-A1NE-01Z-00-DX1.f332124a-cdab-4ab5-82d1-4b8b7f3c9821.svs
TCGA-BH-A1F0,,FEMALE,1,-29335,785,NO,WHITE,BH,A1F0,21ef1730-e5a7-47ce-b419-d000bb59ae15,80,2000,WITH TUMOR,9,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Indeterminate,,,,Negative,Negative,1,NO,YES,,,Stage IIA,T1aN1cM0,785,TCGA-BH-A1F0-01Z-00-DX1.E1557A67-230A-4337-AEC8-158258A917FF.svs
TCGA-UU-A93S,,FEMALE,1,-23278,116,NO,BLACK OR AFRICAN AMERICAN,UU,A93S,45013972-2DFD-4F82-A076-E3E4AF1B43B8,63,2013,WITH TUMOR,,RightRight Upper Inner QuadrantRight Upper Outer QuadrantRight Lower Inner QuadrantRight Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Positive,,Negative,Positive,,YES,NO,,,Stage IV,T4dN3bM1,116,TCGA-UU-A93S-01Z-00-DX1.C4809779-DF5F-4F5D-A78C-B7F95F2D050F.svs
TCGA-E9-A1NG,,FEMALE,0,-22896,NO,0,WHITE,E9,A1NG,659b0170-e914-45ff-aa55-fcb8d3dc7b8a,62,2011,TUMOR FREE,5,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-E9-A1NG-01Z-00-DX1.30d2a611-21ad-4ba0-a03c-31f36ecb83d5.svs
TCGA-D8-A1JK,,FEMALE,0,-32872,NO,0,WHITE,D8,A1JK,56203436-8634-4fd0-96b5-ba6be9d87857,90,2010,,13,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Negative,Negative,0,YES,NO,,<10%,Stage IIA,T2N0M0,0,TCGA-D8-A1JK-01Z-00-DX1.3190C919-A403-460D-9F6C-D2AB5FD3FD05.svs
TCGA-A7-A6VW,,FEMALE,0,-17539,NO,176,BLACK OR AFRICAN AMERICAN,A7,A6VW,98E709E7-E195-4B37-9537-F6081AFFB609,48,2013,TUMOR FREE,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Close,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,176,TCGA-A7-A6VW-01Z-00-DX1.1BC4790C-DB45-4A3D-9C97-92C92C03FF60.svs
TCGA-D8-A1X6,,FEMALE,0,-29256,NO,236,WHITE,D8,A1X6,42e47f3a-dff7-41e4-8f84-146d97e8ab72,80,2010,TUMOR FREE,7,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,5,YES,NO,,,Stage IIIA,T3N2aMX,236,TCGA-D8-A1X6-01Z-00-DX1.ABF237D4-708C-46A5-AEF8-58712E5DCC04.svs
TCGA-B6-A0WW,,FEMALE,1,-21479,558,NO,BLACK OR AFRICAN AMERICAN,B6,A0WW,f02931f8-d72a-481d-b532-8b141dab115f,58,1997,WITH TUMOR,18,Right Upper Inner QuadrantRight,Indeterminate (neither Pre or Postmenopausal),Positive,,Negative,,Positive,,5,NO,YES,,,Stage X,T2N1bMX,558,TCGA-B6-A0WW-01Z-00-DX1.64048633-1D1A-4074-8C50-7641159355DB.svs
TCGA-E2-A155,,FEMALE,0,-21348,NO,553,WHITE,E2,A155,01f50abf-fc15-446e-9d07-edeecc545a32,58,2009,TUMOR FREE,15,Left Upper Inner QuadrantLeft Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,2,NO,YES,,,Stage IIB,T2N1aM0,553,TCGA-E2-A155-01Z-00-DX1.A5AF232A-61BB-4FDC-ABF9-2FE9BA461BDC.svs
TCGA-BH-A1FN,,FEMALE,1,-12525,2192,NO,WHITE,BH,A1FN,6dd0dd7b-62ff-4fd1-a99a-b265f1a91dca,34,1997,WITH TUMOR,29,Right Upper Outer Quadrant,,Positive,,,,Positive,,0,NO,YES,,,Stage IIA,T2N0M0,2192,TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7.svs
TCGA-BH-A18G,,FEMALE,0,-29820,NO,61,WHITE,BH,A18G,747083ff-0703-431b-aad4-f2adff739516,81,2010,,3,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IA,T1cN0M0,61,TCGA-BH-A18G-01Z-00-DX1.DB2B5819-CE83-4E07-BD03-2CD9CF2E246C.svs
TCGA-AO-A03L,,FEMALE,0,-12443,NO,2442,ASIAN,AO,A03L,1174f6e4-ffbe-4e59-a000-8d861c968369,34,2003,TUMOR FREE,17,Right Upper Inner QuadrantRight Upper Outer QuadrantRight Lower Inner QuadrantRight Lower Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Positive,4,NO,YES,70-79%,10-19%,Stage IIIA,T3N2M0,2442,TCGA-AO-A03L-01Z-00-DX1.DE6561A9-E6B8-4BF0-AAA8-F91C87A66037.svs
TCGA-A8-A09K,,FEMALE,0,-24960,NO,912,,A8,A09K,6f959c92-b79f-4f84-9ee5-d07d3212d52d,68,2008,TUMOR FREE,,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T1cN1M0,912,TCGA-A8-A09K-01Z-00-DX1.41B2DF5F-C0E1-43BB-BAA5-2946A9EC4650.svs
TCGA-A2-A0CT,,FEMALE,0,-25959,NO,1918,WHITE,A2,A0CT,378778d2-b331-4867-a93b-c64028c8b4c7,71,2005,TUMOR FREE,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,<10%,Stage IIA,T2N0 (i-)M0,1918,TCGA-A2-A0CT-01Z-00-DX1.A8564130-49CF-4F5B-B5AB-F4D1A10479FF.svs
TCGA-A8-A08H,,FEMALE,0,-24137,NO,0,,A8,A08H,db8d38ab-cc61-49ee-863d-40060112f2af,66,2007,TUMOR FREE,,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIA,T2N0M0,0,TCGA-A8-A08H-01Z-00-DX1.6AA6A530-3BD3-4582-9D6B-8AE3B4A73948.svs
TCGA-A8-A0A9,,FEMALE,0,-29370,NO,396,,A8,A0A9,7b605fb6-d077-401e-b870-b87ddf505f82,80,2009,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,396,TCGA-A8-A0A9-01Z-00-DX1.16524DDD-539D-4E47-9A8F-1B910D4FEC2D.svs
TCGA-A2-A04P,,FEMALE,1,-13238,548,NO,BLACK OR AFRICAN AMERICAN,A2,A04P,ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21,36,2003,WITH TUMOR,20,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Positive,Negative,Negative,,18,NO,YES,<10%,<10%,Stage IIIC,T2N3cM0,548,TCGA-A2-A04P-01Z-00-DX1.5B481E02-D269-4732-8FDD-6494E6EE2B71.svs
TCGA-BH-A18L,,FEMALE,1,-18519,811,NO,WHITE,BH,A18L,9ddc3e7b-8b54-4a83-8335-8053940f56c1,50,2003,,3,Left Upper Outer Quadrant,,Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIIA,T3N1miM0,811,TCGA-BH-A18L-01Z-00-DX1.01D6E3EF-6857-4CC6-BEA1-0BBC1A0B728F.svs
TCGA-C8-A138,,FEMALE,0,-20053,NO,7,ASIAN,C8,A138,b6c286c6-2755-419b-87d3-59c7feda9653,54,2010,TUMOR FREE,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,,Positive,Equivocal,,YES,NO,,,Stage IIIA,T2N2M0,7,TCGA-C8-A138-01Z-00-DX1.845A0680-23A4-4A58-A9C4-2EE17BDBD371.svs
TCGA-A8-A07L,,FEMALE,0,-21428,NO,518,,A8,A07L,e89a9deb-6321-4e61-b412-b4993d4277dd,58,2009,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIA,T3N1aM0,518,TCGA-A8-A07L-01Z-00-DX1.D9E1051F-724E-4E88-940A-C97005DC5BEB.svs
TCGA-C8-A27B,,FEMALE,0,-17763,NO,30,ASIAN,C8,A27B,f0d8a1fe-e313-44f1-99cc-b965cbeeff0e,48,2011,TUMOR FREE,,Left,Peri (6-12 months since last menstrual period),Negative,,Negative,,Negative,Negative,,YES,NO,,,Stage IIB,T3N0M0,30,TCGA-C8-A27B-01Z-00-DX1.5A8A14E8-6430-4147-9C71-805024E098CB.svs
TCGA-C8-A12Q,,FEMALE,0,-28733,NO,2,ASIAN,C8,A12Q,a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814,78,2010,TUMOR FREE,7,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,,YES,NO,,,Stage IIIA,T1N2M0,2,TCGA-C8-A12Q-01Z-00-DX1.CE74E5B7-FD30-4CBE-8716-ECCF2213AAC3.svs
TCGA-AN-A03Y,,FEMALE,0,-24232,NO,10,WHITE,AN,A03Y,a991644b-3ee6-4cda-acf0-e37de48a49fc,66,2010,TUMOR FREE,9,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,10,TCGA-AN-A03Y-01Z-00-DX1.074C48E5-ED69-40AE-8709-444898122BF4.svs
TCGA-AN-A0AS,,FEMALE,0,-25658,NO,10,WHITE,AN,A0AS,7c2a8440-0206-4039-8474-8d62f6c7de0c,70,2010,TUMOR FREE,9,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Positive,Negative,4,NO,YES,,,Stage IIIA,T2N2M0,10,TCGA-AN-A0AS-01Z-00-DX1.51E551E9-E5F4-4C94-9B25-71DA41109E92.svs
TCGA-A1-A0SQ,,FEMALE,0,-16458,NO,554,WHITE,A1,A0SQ,08de63a2-7b76-43c3-80dc-df748b1d81bc,45,2007,TUMOR FREE,15,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,NO,YES,90-99%,90-99%,Stage IIB,T2N1MX,554,TCGA-A1-A0SQ-01Z-00-DX1.36071264-3407-4224-BCBB-2ED00294569A.svs
TCGA-BH-A0HO,,FEMALE,0,-17710,NO,76,WHITE,BH,A0HO,8332806e-f547-4aae-89af-6d5bec831fd2,48,2009,TUMOR FREE,18,Right Upper Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,1,NO,YES,90-99%,90-99%,Stage IIA,T1cN1aM0,76,TCGA-BH-A0HO-01Z-00-DX1.D3D66547-F5D4-40F5-B737-2FECEEB35ACB.svs
TCGA-BH-A0BV,,FEMALE,0,-28699,NO,1519,WHITE,BH,A0BV,87f03d04-e651-4a6e-aea6-1c946aa46202,78,2006,TUMOR FREE,25,Right Upper Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,2,NO,YES,90-99%,50-59%,Stage IIB,T2N1aM0,1519,TCGA-BH-A0BV-01Z-00-DX1.3C9CD4F7-A001-430D-AA8D-80CAD61C344E.svs
TCGA-AR-A0TZ,,FEMALE,0,-15720,NO,2316,WHITE,AR,A0TZ,c7c34fd9-3021-45b7-b6ff-30b4196585a8,43,2004,,30,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,6,NO,YES,,,,T2N2M1,2316,TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904.svs
TCGA-E2-A56Z,,FEMALE,0,-25282,NO,219,BLACK OR AFRICAN AMERICAN,E2,A56Z,45C3975C-D333-4237-93F7-E12DC2451C38,69,2012,TUMOR FREE,16,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,1,NO,YES,10-19%,<10%,Stage IIB,T2N1aM0,219,TCGA-E2-A56Z-01Z-00-DX1.EC28E279-B869-4485-A19F-C732D4CCD374.svs
TCGA-B6-A0RN,,FEMALE,0,-22077,NO,5261,WHITE,B6,A0RN,2199b7a1-bd47-4bb5-b36a-a3e291e3e259,60,1993,TUMOR FREE,19,Right Upper Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,,0,NO,YES,,,Stage IA,T1cN0 (i-)M0,5261,TCGA-B6-A0RN-01Z-00-DX1.0D02A3FB-D694-4A5B-80C1-CF1469E29BFD.svs
TCGA-A7-A0CD,,FEMALE,0,-24242,NO,171,WHITE,A7,A0CD,09765b0a-94f6-47d2-af56-93368084ac3a,66,2009,TUMOR FREE,2,Left,Indeterminate (neither Pre or Postmenopausal),Positive,2+,Negative,Negative,Positive,Equivocal,0,YES,NO,90-99%,70-79%,Stage I,T1N0M0,171,TCGA-A7-A0CD-01Z-00-DX1.F045B9C8-049C-41BF-8432-EF89F236D34D.svs
TCGA-A8-A08X,,FEMALE,0,-15705,NO,1034,,A8,A08X,f5539207-6534-4edc-a5a5-7666b5d16ba4,43,2007,TUMOR FREE,,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,Positive,Negative,Positive,,NO,YES,,,Stage IIIC,T4dN3aM0,1034,TCGA-A8-A08X-01Z-00-DX1.01FB49CC-6B8E-4317-8C42-6B6D81187A40.svs
TCGA-A1-A0SP,,FEMALE,0,-14954,NO,584,,A1,A0SP,a9bb8159-32f0-454c-a946-b3286a52b9d5,40,2007,TUMOR FREE,3,Right,,Negative,0,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,584,TCGA-A1-A0SP-01Z-00-DX1.20D689C6-EFA5-4694-BE76-24475A89ACC0.svs
TCGA-BH-A18T,,FEMALE,1,-25674,224,NO,WHITE,BH,A18T,30ec8b1f-28c4-4f46-8a1b-a8d51e558c7d,70,2003,WITH TUMOR,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Positive,,NO,YES,,,Stage IIA,T2N0M0,224,TCGA-BH-A18T-01Z-00-DX1.90123A74-F631-4538-AB2E-4076486ADF88.svs
TCGA-AR-A1AU,,FEMALE,0,-14564,NO,1409,WHITE,AR,A1AU,36220587-1c1c-4f92-b177-3b2155e7e273,39,2007,,37,Right Upper Inner QuadrantRight Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Equivocal,4,NO,YES,70-79%,70-79%,Stage IIIA,T2N2M0,1409,TCGA-AR-A1AU-01Z-00-DX1.F06647D1-E5A3-46FE-8537-01A10A08A4EC.svs
TCGA-AN-A0AM,,FEMALE,0,-20713,NO,5,WHITE,AN,A0AM,00a2d166-78c9-4687-a195-3d6315c27574,56,2010,TUMOR FREE,20,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,5,TCGA-AN-A0AM-01Z-00-DX1.169CE39A-DD54-46D8-8D03-60B69A473CDB.svs
TCGA-A2-A0CX,,FEMALE,0,-19152,NO,1303,WHITE,A2,A0CX,c744fc13-3aca-4245-9e24-abd368cc8bef,52,2006,TUMOR FREE,2,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,3+,Negative,,Positive,Positive,0,NO,YES,,<10%,Stage IIA,T2N0 (i-)M0,1303,TCGA-A2-A0CX-01Z-00-DX1.F07C75AB-E568-45CB-B497-37C712490393.svs
TCGA-OL-A5RU,,FEMALE,0,-23108,NO,841,BLACK OR AFRICAN AMERICAN,OL,A5RU,B8A44FDF-9CB9-4123-9AB0-4BC198921FEE,63,2010,TUMOR FREE,15,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,1,NO,YES,90-99%,80-89%,Stage IIA,T1cN1MX,841,TCGA-OL-A5RU-01Z-00-DX1.A48CAF2D-9310-4611-B27D-400F3A324607.svs
TCGA-OL-A66I,,FEMALE,0,-13458,NO,714,BLACK OR AFRICAN AMERICAN,OL,A66I,35BD694D-1DD2-466F-AB27-03320614B40E,36,2008,TUMOR FREE,13,Right Upper Outer Quadrant,,Negative,,Negative,Negative,Negative,,0,NO,YES,,,Stage IIA,T1cN1miMX,714,TCGA-OL-A66I-01Z-00-DX1.8CE9DCAB-98D3-4163-94AC-1557D86C1E25.svs
TCGA-BH-A0RX,,FEMALE,0,-21857,NO,170,WHITE,BH,A0RX,e828455d-4680-41b2-8a1c-1582e3790d62,59,2010,TUMOR FREE,3,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,170,TCGA-BH-A0RX-01Z-00-DX1.B4ABAFB9-6696-4F22-9468-DA56E1AD32D3.svs
TCGA-BH-A1FL,,FEMALE,1,-25558,1673,NO,WHITE,BH,A1FL,14d1d84e-99e1-41ad-8892-3b4da3d4f948,69,1998,WITH TUMOR,22,Left Upper Outer Quadrant,,Positive,,,,Positive,,4,NO,YES,,,Stage IIB,T2N1bM0,1673,TCGA-BH-A1FL-01Z-00-DX1.D3E9F46E-9A28-4AAE-8C87-D6F1851227A3.svs
TCGA-BH-A0C7,,FEMALE,0,-17871,NO,1305,WHITE,BH,A0C7,e1119732-3e97-4259-bc69-dc4269d9496d,48,2006,TUMOR FREE,18,Left,Peri (6-12 months since last menstrual period),Negative,,Negative,Positive,Positive,,1,NO,YES,,,Stage IIB,T2N1miM0,1305,TCGA-BH-A0C7-01Z-00-DX1.C70D358E-C48F-4F69-86CE-3218E9C95837.svs
TCGA-C8-A12U,,FEMALE,0,-17045,NO,0,ASIAN,C8,A12U,97b5f490-1cd9-4833-b903-5f4c6e45670d,46,2010,TUMOR FREE,7,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-C8-A12U-01Z-00-DX1.8E90FC9F-630E-4611-A5D2-D6F11DBE81EF.svs
TCGA-BH-A0DQ,,FEMALE,0,-15533,NO,98,WHITE,BH,A0DQ,a851ca14-7bbf-455b-a054-ec03979a4247,42,2009,TUMOR FREE,25,Right Upper Inner QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,0,Negative,,Positive,Negative,1,NO,YES,60-69%,70-79%,Stage IIB,T2N1M0,98,TCGA-BH-A0DQ-01Z-00-DX1.5A98747C-52D9-45AD-BC84-934A96F069EB.svs
TCGA-AR-A0TY,,FEMALE,1,-19836,1699,NO,WHITE,AR,A0TY,da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4,54,2004,,15,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,0,NO,YES,10-19%,,Stage IIA,T2N0M0,1699,TCGA-AR-A0TY-01Z-00-DX1.089EB6B4-9921-441D-84F3-C64C97AFC3B4.svs
TCGA-A2-A0CU,,FEMALE,1,-26823,158,NO,WHITE,A2,A0CU,332423a7-8866-4ee3-b08f-3c8d7c16af80,73,2005,TUMOR FREE,1,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Close,Negative,Positive,Equivocal,0,NO,YES,90-99%,<10%,Stage IIA,T2N0 (i+)M0,158,TCGA-A2-A0CU-01Z-00-DX1.5B77D21C-A497-478B-9752-3730322AD9ED.svs
TCGA-AR-A250,,FEMALE,0,-21309,NO,1708,WHITE,AR,A250,a0963e93-b63e-4de2-86c1-81302e271d3e,58,2006,TUMOR FREE,4,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Positive,Positive,Positive,Equivocal,0,NO,YES,70-79%,,Stage IIA,T2N0M0,1708,TCGA-AR-A250-01Z-00-DX1.572A2F73-6BF5-4932-BFEF-4B8904755ACF.svs
TCGA-E2-A1LI,,FEMALE,0,-21064,NO,2750,WHITE,E2,A1LI,3558dec7-eae3-4a41-a217-266c6a4535fb,57,2003,TUMOR FREE,2,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Close,Negative,Negative,Equivocal,0,NO,YES,,,Stage IIB,T2N1M0,2750,TCGA-E2-A1LI-01Z-00-DX1.503dd2fa-23ef-4b11-8aab-301e069eaa88.svs
TCGA-BH-A1EX,,FEMALE,1,-24544,1508,NO,WHITE,BH,A1EX,7b892055-c59d-4550-8688-ad039790af3d,67,2000,WITH TUMOR,24,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,Negative,Positive,Positive,2,NO,YES,,,Stage IIB,T2N1bM0,1508,TCGA-BH-A1EX-01Z-00-DX1.16B6A817-6729-446E-9FCF-A4A333C5295D.svs
TCGA-GM-A2D9,,FEMALE,1,-25490,1812,NO,WHITE,GM,A2D9,1133B8A9-6B11-4511-B70A-F200E3B8B5DB,69,2006,WITH TUMOR,2,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,0,NO,YES,90-99%,40-49%,Stage I,T1cN0 (i-)M0,1812,TCGA-GM-A2D9-01Z-00-DX1.AF4BF2DD-05FB-400B-A1BC-6E7C9B9DDF05.svs
TCGA-S3-AA12,,FEMALE,0,-30101,NO,259,BLACK OR AFRICAN AMERICAN,S3,AA12,2BCACFD1-6A45-4B96-9B80-2AD569B1AB45,82,2013,TUMOR FREE,16,LeftLeft Upper Inner QuadrantLeft Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Positive,Negative,2,YES,NO,90-99%,,Stage IIIA,T3N1aMX,259,TCGA-S3-AA12-01Z-00-DX1.2A991B9F-E7E6-410B-B0BF-635E3CC40C7E.svs
TCGA-GM-A2DC,,FEMALE,0,-21122,NO,1628,WHITE,GM,A2DC,DD43FFD9-DA18-4AD3-ABE7-6F443C76A717,57,2006,TUMOR FREE,21,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,1,NO,YES,90-99%,90-99%,Stage IIA,T1cN1aM0,1628,TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862.svs
TCGA-D8-A146,,FEMALE,0,-20861,NO,344,WHITE,D8,A146,03da7a65-fa2f-42cb-a709-5fe8736f21d3,57,2010,,11,Right Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,,,Stage IIA,T2N0MX,344,TCGA-D8-A146-01Z-00-DX1.D93FB315-E5D7-49BA-8380-38B16B70361B.svs
TCGA-B6-A0IQ,,FEMALE,0,-14669,NO,3872,WHITE,B6,A0IQ,01eef340-598c-4205-a990-cec190ac2ca5,40,1996,TUMOR FREE,26,Left Upper Outer QuadrantLeft,Indeterminate (neither Pre or Postmenopausal),Negative,,Negative,,Negative,,1,NO,YES,,,Stage IIIA,T3N1bM0,3872,TCGA-B6-A0IQ-01Z-00-DX1.662EA039-825E-41FF-91D6-021EB0E099BD.svs
TCGA-B6-A0I2,,FEMALE,0,-16702,NO,3827,WHITE,B6,A0I2,328dfcb0-b5ae-43f2-bc87-dad0ab3df9e7,45,1995,TUMOR FREE,8,Left Upper Outer QuadrantLeft,Indeterminate (neither Pre or Postmenopausal),,,,,,,0,NO,YES,,,Stage IA,T1cN0 (i-)M0,3827,TCGA-B6-A0I2-01Z-00-DX1.885D2034-73B7-48AE-8343-631F89061C38.svs
TCGA-E2-A14Y,,FEMALE,0,-13004,NO,688,WHITE,E2,A14Y,a0576d44-9add-429b-9eeb-f7b234b7385f,35,2009,TUMOR FREE,5,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Positive,Positive,Equivocal,0,NO,YES,,,Stage IIA,T2N0M0,688,TCGA-E2-A14Y-01Z-00-DX1.804A22A3-FD8D-4C8A-A766-48D28434DE22.svs
TCGA-E9-A1R2,,FEMALE,0,-18936,NO,19,WHITE,E9,A1R2,8631969d-4ac6-4fe1-9db3-d47db604494a,51,2011,TUMOR FREE,19,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Positive,Negative,Positive,Equivocal,17,YES,NO,90-99%,,Stage IIIC,T2N3MX,19,TCGA-E9-A1R2-01Z-00-DX1.5529C856-4F4F-4F17-94A2-5CEF94A940EB.svs
TCGA-C8-A1HF,,FEMALE,0,,NO,0,ASIAN,C8,A1HF,a2453bcb-90f2-4505-949d-a89cf4bfc9b8,48,2010,TUMOR FREE,12,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,,Negative,Positive,,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-C8-A1HF-01Z-00-DX1.81EF9A57-54E1-4750-9816-5571FD18A297.svs
TCGA-AR-A1AS,,FEMALE,0,-20028,NO,1150,ASIAN,AR,A1AS,7d681cc6-689d-41c8-9e84-e13733089ec9,54,2007,,17,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,NO,YES,70-79%,70-79%,Stage IIB,T2N1M0,1150,TCGA-AR-A1AS-01Z-00-DX1.72979519-0A90-42AD-9F23-1991F75C8CE7.svs
TCGA-B6-A0IO,,FEMALE,0,-24322,NO,3350,WHITE,B6,A0IO,04af44fc-c487-4005-b3cb-cb64815824a2,66,2001,TUMOR FREE,17,Left,Indeterminate (neither Pre or Postmenopausal),Indeterminate,,Negative,,Positive,,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,3350,TCGA-B6-A0IO-01Z-00-DX1.D8898C30-4016-4983-9359-5C1507C01715.svs
TCGA-BH-A0E7,,FEMALE,0,-29115,NO,1363,WHITE,BH,A0E7,d3b9d925-ae04-4721-8bfc-50b41225bc74,79,2006,TUMOR FREE,17,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,NO,YES,50-59%,60-69%,Stage IIB,T2N1aM0,1363,TCGA-BH-A0E7-01Z-00-DX1.7FEE54C4-3795-403C-85B9-FF932BE56788.svs
TCGA-D8-A1XF,,FEMALE,0,-16787,NO,97,WHITE,D8,A1XF,6f6afd31-b5dd-48ab-b18f-6390ba18a5f0,45,2010,TUMOR FREE,8,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,,,Positive,Negative,0,YES,NO,,,Stage IIA,T2N0M0,97,TCGA-D8-A1XF-01Z-00-DX2.1460E522-5B87-4690-8B6B-3183C5D282D6.svs
TCGA-A8-A08R,,FEMALE,0,-19298,NO,30,,A8,A08R,6412854a-f874-469e-9d1f-8bd3ae5bd41d,52,2008,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,,NO,YES,,,Stage IIB,T2N1aM0,30,TCGA-A8-A08R-01Z-00-DX1.72FBD9A3-5EB9-4855-89EB-697883C2EA9B.svs
TCGA-AN-A0FT,,FEMALE,0,-23300,NO,183,WHITE,AN,A0FT,baf5e81f-2322-41ec-9053-b9559a7993bc,63,2010,TUMOR FREE,7,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,1,NO,YES,90-99%,90-99%,Stage IIB,T2N1M0,183,TCGA-AN-A0FT-01Z-00-DX1.6F263AB3-FB1D-4056-AEC2-4F163017324F.svs
TCGA-E2-A152,,FEMALE,0,-20705,NO,588,WHITE,E2,A152,a8015490-9740-45c9-8bd2-eb6d1beefc2e,56,2009,WITH TUMOR,3,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Positive,Positive,0,NO,YES,,,Stage I,T1cN0M0,588,TCGA-E2-A152-01Z-00-DX1.B0860DEB-D34B-4C5D-97F5-C1C646437424.svs
TCGA-PL-A8LZ,,FEMALE,0,-10869,NO,120,BLACK OR AFRICAN AMERICAN,PL,A8LZ,9087585F-E792-4F33-BAAA-56FFE0F745BE,29,2013,TUMOR FREE,,LeftLeft Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,,,,,,YES,NO,,,Stage IIIB,T4bN2M0,120,TCGA-PL-A8LZ-01A-01-DX1.B9F233EE-06DD-4C14-A392-D2937C7C0868.svs
TCGA-BH-A0B9,,FEMALE,0,-16310,NO,1572,WHITE,BH,A0B9,5a57dc25-d252-4b22-b192-4de630d7002f,44,2006,TUMOR FREE,1,Right Lower Inner QuadrantRight Lower Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,0,Negative,,Negative,Negative,0,NO,YES,,,Stage IA,T1cN0 (i-)M0,1572,TCGA-BH-A0B9-01Z-00-DX1.C23ADB4C-52D4-4DFD-B8E3-156E43F0E645.svs
TCGA-EW-A3U0,,FEMALE,0,-22520,NO,229,BLACK OR AFRICAN AMERICAN,EW,A3U0,D9DC3B59-613D-469E-8B4F-6C5A557EB26A,61,2011,TUMOR FREE,25,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,1,YES,NO,,,Stage IIIA,T3N1aM0,229,TCGA-EW-A3U0-01Z-00-DX1.526F60F9-D1EB-4613-B428-18A1FC0BAAE2.svs
TCGA-E9-A1N8,,FEMALE,0,-17652,NO,0,WHITE,E9,A1N8,ac075bc0-1b59-4557-beea-541694faee03,48,2010,TUMOR FREE,8,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-E9-A1N8-01Z-00-DX1.1243AB1C-75A3-4A5E-9674-53992E6DD377.svs
TCGA-A7-A4SF,,FEMALE,0,-19985,NO,369,BLACK OR AFRICAN AMERICAN,A7,A4SF,D81594D9-DD6A-45C3-8BAD-61960611D78D,54,2012,TUMOR FREE,2,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Positive,,Positive,Positive,0,YES,NO,90-99%,,Stage IIA,T2N0M0,369,TCGA-A7-A4SF-01Z-00-DX1.CDCFD4BC-4363-4CF2-95F5-4922E04C3B9D.svs
TCGA-AR-A0U1,,FEMALE,0,-13467,NO,2134,WHITE,AR,A0U1,17d9e646-6ab3-40b3-a0bc-2c834d3c3213,36,2004,,31,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,1,NO,YES,,,Stage IIB,T2N1M0,2134,TCGA-AR-A0U1-01Z-00-DX1.276433E7-E841-42D2-AF21-762F2FEA3B9B.svs
TCGA-BH-A0HY,,FEMALE,0,-22179,NO,868,WHITE,BH,A0HY,844ad251-3ee4-42f6-ad00-59a7a1670eea,60,2009,TUMOR FREE,3,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Positive,0,NO,YES,,,Stage I,T1cN0M0,868,TCGA-BH-A0HY-01Z-00-DX1.D7A1BF42-F268-4220-B71B-354CE2AF32D8.svs
TCGA-B6-A1KN,,FEMALE,0,-21183,NO,3330,WHITE,B6,A1KN,271404de-24e8-43f6-806b-fb510c1124c4,57,1998,TUMOR FREE,30,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,,24,NO,YES,,,Stage IIIB,T4bN1M0,3330,TCGA-B6-A1KN-01Z-00-DX1.E769FD65-E5CE-4CA4-8BBE-6FC54A2ED870.svs
TCGA-D8-A1X6,,FEMALE,0,-29256,NO,236,WHITE,D8,A1X6,42e47f3a-dff7-41e4-8f84-146d97e8ab72,80,2010,TUMOR FREE,7,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,5,YES,NO,,,Stage IIIA,T3N2aMX,236,TCGA-D8-A1X6-01Z-00-DX2.F36D68F2-70C3-4E0E-ABE6-6969170BA6DC.svs
TCGA-D8-A1Y0,,FEMALE,0,-24083,NO,167,WHITE,D8,A1Y0,ced2c048-b047-43ff-b0e7-cd7ad480850c,65,2010,TUMOR FREE,15,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,,,Positive,Negative,9,YES,NO,,,Stage IIIA,T1cN2aMX,167,TCGA-D8-A1Y0-01Z-00-DX2.7C25E941-12A6-46CE-B1A5-488D08E35684.svs
TCGA-BH-A0DV,,FEMALE,0,-19781,NO,1374,WHITE,BH,A0DV,96b9c7db-1be1-4b60-b47c-26b654c3d64c,54,2007,TUMOR FREE,9,Left Upper Inner QuadrantLeft Lower Inner QuadrantLeft Lower Outer QuadrantLeft,Peri (6-12 months since last menstrual period),Positive,,Negative,,Positive,Negative,9,NO,YES,,,Stage IIIA,T2N2aM0,1374,TCGA-BH-A0DV-01Z-00-DX1.2F0B5FB3-40F0-4D27-BFAC-390FB9A42B39.svs
TCGA-C8-A26X,,FEMALE,0,-21463,NO,11,ASIAN,C8,A26X,70ab4f23-23c4-409f-a5cc-18a010c3a24e,58,2010,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,,YES,NO,,,Stage IIA,T1N1M0,11,TCGA-C8-A26X-01Z-00-DX1.FBD86F91-BAD7-4484-8D50-202340FBF242.svs
TCGA-EW-A1P7,,FEMALE,0,-21750,NO,635,WHITE,EW,A1P7,01674b2c-5cf2-478f-84a1-f69c39f47bd4,59,2009,TUMOR FREE,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,635,TCGA-EW-A1P7-01Z-00-DX1.97575C9F-C318-45A5-A4B7-1A902B93FA3F.svs
TCGA-A8-A06Y,,FEMALE,0,-24442,NO,791,,A8,A06Y,515b1400-e896-4f2a-81bd-70895441a0bd,66,2008,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T2N0M0,791,TCGA-A8-A06Y-01Z-00-DX1.3BC58446-524E-43F3-AAE6-FBC4AA543E66.svs
TCGA-A8-A07R,,FEMALE,0,-29251,NO,273,,A8,A07R,72e486b8-a866-4916-b2e4-8b4bb5dcd92d,80,2009,,,Left Upper Outer Quadrant,,Negative,2+,Positive,,Negative,Positive,,NO,YES,,,Stage IIIC,T2N3aM0,273,TCGA-A8-A07R-01Z-00-DX1.D716752E-86AF-468B-A905-A7894B978F22.svs
TCGA-BH-A0BS,,FEMALE,0,-20374,NO,1641,WHITE,BH,A0BS,2b22db1d-54a1-4b9e-a86e-a174cf51d95c,55,2007,TUMOR FREE,11,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,0,NO,YES,,,Stage IIIA,T3N1cM0,1641,TCGA-BH-A0BS-01Z-00-DX1.FEE32127-4D0B-4560-A39C-4EAA5B189B70.svs
TCGA-AO-A03N,,FEMALE,0,-21816,NO,1645,WHITE,AO,A03N,9435447e-d65f-408b-863b-6576b1d652dd,59,2006,WITH TUMOR,19,Left Upper Inner QuadrantLeft Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,2,NO,YES,70-79%,<10%,Stage IIB,T2N1aM0,1645,TCGA-AO-A03N-01Z-00-DX1.79A8816D-961F-4D79-90B4-341919297A90.svs
TCGA-AO-A0JA,,FEMALE,0,-13307,NO,346,BLACK OR AFRICAN AMERICAN,AO,A0JA,86b7b206-8e69-432d-acc9-bccce710955e,36,2009,WITH TUMOR,11,Right Upper Inner QuadrantRight Lower Inner QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,11,NO,YES,90-99%,<10%,Stage IIIC,T2N3M0,346,TCGA-AO-A0JA-01Z-00-DX1.E3DDBAAF-6FFA-40BE-83FF-942857CFED5D.svs
TCGA-E9-A1ND,,FEMALE,0,-27400,NO,0,WHITE,E9,A1ND,f06f09f3-8133-4a92-ac86-fbe64295e0d8,75,2011,TUMOR FREE,11,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Positive,1,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-E9-A1ND-01Z-00-DX1.5C2F5250-A3B2-4B97-9E11-56CF3C7CA2DB.svs
TCGA-B6-A0RH,,FEMALE,0,-18759,NO,5749,BLACK OR AFRICAN AMERICAN,B6,A0RH,c3148e68-1739-4334-abda-1dcbc2166846,51,1991,TUMOR FREE,23,Left Lower Inner Quadrant,Indeterminate (neither Pre or Postmenopausal),Positive,,Positive,,Positive,,0,NO,YES,,,Stage IIA,T2N0 (i-)M0,5749,TCGA-B6-A0RH-01Z-00-DX1.33DB5CF9-AC87-435B-A8AF-C4F84BEF15F1.svs
TCGA-E2-A14Q,,FEMALE,0,-18507,NO,974,WHITE,E2,A14Q,303a1d77-a37a-4966-a4a4-9981d99ba1b4,50,2008,TUMOR FREE,7,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,1,NO,YES,,,Stage IIB,T2N1miM0,974,TCGA-E2-A14Q-01Z-00-DX1.C19BA7FD-D986-4E3B-9A79-F3531A78F05D.svs
TCGA-C8-A1HE,,FEMALE,0,,NO,0,ASIAN,C8,A1HE,b26d41cd-393b-4cd4-8925-a9488f7de576,59,2010,TUMOR FREE,5,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,,Positive,Equivocal,,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-C8-A1HE-01Z-00-DX1.83A5D816-E3A6-46B8-B1B8-B31486EB686E.svs
TCGA-S3-AA14,,FEMALE,0,-17352,NO,218,BLACK OR AFRICAN AMERICAN,S3,AA14,929ACC67-B8BF-4F65-9110-380E44AB66B7,47,2013,TUMOR FREE,4,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,0,YES,NO,70-79%,70-79%,Stage I,T1N0 (i+)cM0 (i+),218,TCGA-S3-AA14-01Z-00-DX1.000A865F-19E6-4018-9352-BFA54EF0CE31.svs
TCGA-E9-A1RD,,FEMALE,0,-24719,NO,20,WHITE,E9,A1RD,5fe3c51f-65e2-4da6-8924-a6fae17c022d,67,2011,TUMOR FREE,10,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0M0,20,TCGA-E9-A1RD-01Z-00-DX1.34083668-cbd2-4610-b857-d50ee9f3e5bd.svs
TCGA-A7-A13D,TCGAFPPP,FEMALE,0,-17070,NO,267,BLACK OR AFRICAN AMERICAN,A7,A13D,8785012f-f73e-4d68-87cf-1d804af32782,46,2010,TUMOR FREE,4,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Close,Negative,Negative,Equivocal,0,YES,NO,<10%,<10%,Stage IIA,T2N0 (i-)M0,267,TCGA-A7-A13D-01Z-00-DX2.8165A362-6A08-4BFD-9428-7EEB6C59D7F1.svs
TCGA-A2-A1FX,,FEMALE,0,-22344,NO,935,WHITE,A2,A1FX,ac6d3ba9-f84f-4657-aa85-4d66fb7c09da,61,2008,TUMOR FREE,24,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Positive,Negative,Positive,,6,NO,YES,70-79%,60-69%,Stage IIIA,T3N2aM0,935,TCGA-A2-A1FX-01Z-00-DX1.35B93F3A-9959-4D72-A702-08B27563D24F.svs
TCGA-BH-A0BC,,FEMALE,0,-21949,NO,974,WHITE,BH,A0BC,327a2395-85c8-42e1-9638-8e037a1723ed,60,2007,TUMOR FREE,18,Right Upper Inner QuadrantRight Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,12,NO,YES,90-99%,30-39%,Stage IIIC,T2N3M0,974,TCGA-BH-A0BC-01Z-00-DX1.7A91831D-9625-49FC-B783-C633F80F898C.svs
TCGA-AN-A0XN,,FEMALE,0,-25029,NO,10,WHITE,AN,A0XN,4e3699da-4367-4a43-9d66-a117d3ad460d,68,2010,TUMOR FREE,15,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Negative,Negative,1,NO,YES,,,Stage IIIA,T2N2M0,10,TCGA-AN-A0XN-01Z-00-DX1.A8EB9F62-236E-4C59-A206-DF0C7654AC30.svs
TCGA-B6-A0I9,,FEMALE,1,-22798,362,NO,WHITE,B6,A0I9,44954053-0b93-4577-a436-42777e442300,62,1992,WITH TUMOR,,Left Lower Outer QuadrantLeft,Indeterminate (neither Pre or Postmenopausal),Positive,,,,Indeterminate,,,NO,YES,,,Stage IV,T3NXM1,362,TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497.svs
TCGA-A2-A0YE,,FEMALE,0,-17727,NO,253,WHITE,A2,A0YE,84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33,48,2010,TUMOR FREE,19,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Negative,Negative,1,NO,YES,<10%,<10%,Stage IIB,T2N1aM0,253,TCGA-A2-A0YE-01Z-00-DX1.8A2E3094-5755-42BC-969D-7F0A2ECA0F39.svs
TCGA-AR-A0TQ,,FEMALE,0,-9873,NO,1500,WHITE,AR,A0TQ,5dc1bee9-c44d-4fdc-9ae5-83426c4d6880,27,2006,TUMOR FREE,15,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,Positive,Positive,Equivocal,2,NO,YES,10-19%,,Stage IIIA,T3N1M0,1500,TCGA-AR-A0TQ-01Z-00-DX1.2BEA298C-6B3D-4133-ADBC-769E62CEFFA0.svs
TCGA-C8-A274,,FEMALE,0,-23337,NO,1,ASIAN,C8,A274,dbcad60f-86c7-41e3-b0ae-baa39c9f83dd,63,2010,TUMOR FREE,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0M0,1,TCGA-C8-A274-01Z-00-DX1.B667DAB1-C944-4285-A312-5E4DDAE0EE78.svs
TCGA-AR-A251,,FEMALE,0,-18771,NO,1374,WHITE,AR,A251,8c51bbcb-7c8d-47ad-9193-70ca157c6900,51,2006,,7,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Positive,Negative,Positive,Equivocal,4,NO,YES,,,Stage IIIA,T2N2M0,1374,TCGA-AR-A251-01Z-00-DX1.E91E357A-3AD4-4F79-A698-05F0B21A37EC.svs
TCGA-EW-A1PF,,FEMALE,0,-18384,NO,140,WHITE,EW,A1PF,848773a3-2f4a-4186-ab3f-de667129accf,50,2010,TUMOR FREE,11,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IA,T1cN0M0,140,TCGA-EW-A1PF-01Z-00-DX1.9420D058-65CE-4DF8-815F-EB407003096E.svs
TCGA-AR-A252,,FEMALE,0,-18611,NO,1236,WHITE,AR,A252,4d0fec97-e024-4608-a0cc-426a3decc7b1,50,2007,,4,Left Upper Outer QuadrantLeft Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,0,NO,YES,70-79%,,Stage I,T1N0M0,1236,TCGA-AR-A252-01Z-00-DX1.2E7EE069-A0B8-489B-A2F0-3175FB58F468.svs
TCGA-BH-A0B6,,FEMALE,0,-17346,NO,1732,WHITE,BH,A0B6,FA4E082A-D213-412E-8D91-842A6F4BEF12,47,2006,TUMOR FREE,4,Left Upper Outer Quadrant,,Positive,,Negative,,Positive,Positive,0,NO,YES,,,Stage I,T1cN0M0,1732,TCGA-BH-A0B6-01Z-00-DX1.4D982935-F600-4F37-ABB5-13AF74F4FDC4.svs
TCGA-EW-A6SD,,FEMALE,0,-12006,NO,1010,BLACK OR AFRICAN AMERICAN,EW,A6SD,42378DBC-A123-4CF9-8502-165E89FDA271,32,2012,TUMOR FREE,31,LeftLeft Upper Outer Quadrant,,Negative,3+,Negative,,Negative,,2,YES,NO,<10%,<10%,Stage IIB,T2N1aM0,1010,TCGA-EW-A6SD-01Z-00-DX1.32D8240E-2076-492B-BB95-300A9FCA96E7.svs
TCGA-B6-A0WS,,FEMALE,1,-21230,2965,NO,BLACK OR AFRICAN AMERICAN,B6,A0WS,197741de-a098-4f04-bb37-8ea8b3bb39bc,58,1996,TUMOR FREE,,Left Upper Outer QuadrantLeft,Indeterminate (neither Pre or Postmenopausal),Positive,,Positive,,Positive,,,NO,YES,,,Stage X,T1cNXMX,2965,TCGA-B6-A0WS-01Z-00-DX1.020ED7BF-9497-4F13-AA07-FE0E839F9A06.svs
TCGA-BH-A1EW,,FEMALE,1,-14090,1694,NO,WHITE,BH,A1EW,9d166970-07c8-4ca3-9cfa-ed0049df9ecc,38,1999,WITH TUMOR,16,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,,,Negative,Negative,1,NO,YES,,,Stage IIA,T2N1bM0,1694,TCGA-BH-A1EW-01Z-00-DX1.A6A5F9C5-FB97-4DA3-A1EA-1F84BC006681.svs
TCGA-BH-A0HW,,FEMALE,0,-22962,NO,1561,ASIAN,BH,A0HW,29fdc464-f216-4828-b456-829f71436e27,62,2006,TUMOR FREE,2,Left Lower Inner QuadrantLeft Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,<10%,Stage IA,T1cN0 (i-)M0,1561,TCGA-BH-A0HW-01Z-00-DX1.44DCCE00-133F-4469-A4DA-5057C011B4AC.svs
TCGA-OL-A5RX,,FEMALE,0,-18942,NO,513,BLACK OR AFRICAN AMERICAN,OL,A5RX,43C0BEC6-6FAC-47B1-83CB-200A15A932BE,51,2011,TUMOR FREE,4,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Negative,Positive,,,NO,YES,90-99%,90-99%,Stage IA,T1cN0MX,513,TCGA-OL-A5RX-01Z-00-DX1.15A0D4F4-2744-4D44-8883-27FF83D9C824.svs
TCGA-AN-A0XW,,FEMALE,0,-13208,NO,170,WHITE,AN,A0XW,39de7761-e762-4811-b95c-8216b79ae06b,36,2010,,14,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Negative,Positive,Positive,1,NO,YES,90-99%,90-99%,Stage IIIA,T2N2M0,170,TCGA-AN-A0XW-01Z-00-DX1.811E11E7-FA67-46BB-9BC6-1FD0106B789D.svs
TCGA-A8-A092,,FEMALE,0,-17807,NO,487,,A8,A092,38a8b734-9acc-42f9-b5b7-e51b0dfc6504,48,2008,TUMOR FREE,,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIIA,T2N2aM0,487,TCGA-A8-A092-01Z-00-DX1.2A55EA0C-47CD-426B-9697-F2B761730585.svs
TCGA-C8-A1HM,,FEMALE,0,-27063,NO,6,ASIAN,C8,A1HM,8b525ec6-d24b-49d4-bfcb-b354de4dae7c,74,2010,TUMOR FREE,,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0M0,6,TCGA-C8-A1HM-01Z-00-DX1.F93C3F56-3AA6-4D38-B51E-4694CBEA3830.svs
TCGA-E2-A1II,,FEMALE,0,-18788,NO,850,WHITE,E2,A1II,0fe1419e-a005-407c-8ae7-15c4c1579539,51,2008,TUMOR FREE,5,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Negative,Negative,0,NO,YES,,,Stage I,T1cN0M0,850,TCGA-E2-A1II-01Z-00-DX1.7F782477-0F92-4C57-8735-A1E3F95A6B94.svs
TCGA-EW-A1J1,,FEMALE,0,-14122,NO,282,WHITE,EW,A1J1,ed6cef77-1bd9-4e3b-b576-550a91e4253a,38,2010,TUMOR FREE,17,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,1,NO,YES,90-99%,90-99%,Stage IIB,T2N1aM0,282,TCGA-EW-A1J1-01Z-00-DX1.FFC2D5DB-E6D0-4143-A1E7-0A2027846C8C.svs
TCGA-B6-A0WT,,FEMALE,0,-22362,NO,5396,WHITE,B6,A0WT,d7195183-9fe4-4b17-bcfd-9367d2e539ce,61,1995,TUMOR FREE,15,Left Lower Inner QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,,1,NO,YES,,,Stage IIB,T2N1M0,5396,TCGA-B6-A0WT-01Z-00-DX1.7ED21DA2-A3D8-4DCA-9742-963879A658D8.svs
TCGA-BH-A0EB,,FEMALE,0,-25259,NO,745,WHITE,BH,A0EB,ec6930e5-2d83-435a-9a57-a2c5c22caf02,69,2008,TUMOR FREE,4,Right Lower Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,40-49%,Stage IA,T1cN0 (i-)M0,745,TCGA-BH-A0EB-01Z-00-DX1.70D7BBA0-214D-4D1A-933C-7CFCDA5416A3.svs
TCGA-D8-A1XZ,,FEMALE,0,-29916,NO,121,WHITE,D8,A1XZ,2c90d5e3-ac8c-4c86-a06f-42ccc064eb49,81,2010,TUMOR FREE,14,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,6,YES,NO,,,Stage IIIA,T1cN2aMX,121,TCGA-D8-A1XZ-01Z-00-DX2.73D59546-C003-4DED-80D5-866E7055EC79.svs
TCGA-BH-A0HQ,,FEMALE,0,-20719,NO,1121,WHITE,BH,A0HQ,f31c21b6-0f7f-435b-9e24-97c909755c36,56,2007,TUMOR FREE,4,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0 (i+)M0,1121,TCGA-BH-A0HQ-01Z-00-DX1.0921FCEF-20A2-4D4B-A198-91AF9F6C814C.svs
TCGA-BH-A18U,,FEMALE,1,-26426,1563,NO,WHITE,BH,A18U,233b02f3-c4f0-4a67-9db5-e68d5cdaccb6,72,2003,TUMOR FREE,16,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,9,NO,YES,,,Stage IIIA,T2N2aM0,1563,TCGA-BH-A18U-01Z-00-DX1.63940315-59BC-462B-87A8-2BBB33C9503E.svs
TCGA-A2-A3XT,,FEMALE,0,-16649,NO,2238,BLACK OR AFRICAN AMERICAN,A2,A3XT,C72CB184-462D-4009-9CDB-848782FF8A76,45,2006,TUMOR FREE,13,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,Negative,Negative,Negative,1,NO,YES,,,Stage IIB,T2N1aM0,2238,TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C.svs
TCGA-AO-A1KR,,FEMALE,0,-18900,NO,2141,WHITE,AO,A1KR,b7f74ae1-6f58-447c-be50-a7666eb19d9a,51,2005,TUMOR FREE,4,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,Negative,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,2141,TCGA-AO-A1KR-01Z-00-DX1.BFB2E69B-E23C-4542-9CBF-EDD040B985AC.svs
TCGA-BH-A0W7,,FEMALE,0,-17996,NO,558,WHITE,BH,A0W7,9f80649b-a249-4fb5-97ad-059a30e13fea,49,2008,TUMOR FREE,2,Left Upper Outer Quadrant,,Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0 (i-)M0,558,TCGA-BH-A0W7-01Z-00-DX1.93F11232-A1FB-4682-B744-3531D4DF11AF.svs
TCGA-OL-A5D6,,FEMALE,0,-26052,NO,385,BLACK OR AFRICAN AMERICAN,OL,A5D6,C3A981C7-F148-4252-BD50-AF8A49EC0DF8,71,2009,TUMOR FREE,2,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,,NO,YES,,,Stage IIA,T2N0MX,385,TCGA-OL-A5D6-01Z-00-DX1.6B11331B-4A0D-4E13-B054-A5C7A6FC3AAC.svs
TCGA-A2-A3XV,,FEMALE,0,-16971,NO,428,BLACK OR AFRICAN AMERICAN,A2,A3XV,189E1F27-7738-413A-A4D4-97D41D592A13,46,2011,TUMOR FREE,4,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,Positive,Positive,Equivocal,0,YES,NO,<10%,,Stage IIA,T2N0M0,428,TCGA-A2-A3XV-01Z-00-DX1.4B58B7CD-B3F6-4C31-863F-924D291EF17C.svs
TCGA-D8-A1JM,,FEMALE,0,-21602,NO,238,WHITE,D8,A1JM,3e775c99-ceda-4246-8d6f-0f58ca5097c8,59,2010,TUMOR FREE,11,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,3,YES,NO,<10%,,Stage IIB,T2N1aM0,238,TCGA-D8-A1JM-01Z-00-DX1.3CD15BC8-08B3-4BEE-9FD7-A8BEED33268E.svs
TCGA-EW-A1OV,,FEMALE,0,-20764,NO,523,WHITE,EW,A1OV,ac68d219-5670-4ddd-8df6-8aa7ad59e5c7,56,2009,TUMOR FREE,6,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Close,Negative,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIB,T2N1miMX,523,TCGA-EW-A1OV-01Z-00-DX1.93698123-5B34-4163-848B-2D75A5F7B001.svs
TCGA-BH-A0BM,,FEMALE,0,-20049,NO,1117,WHITE,BH,A0BM,c2aeee6c-ba10-4cf9-b560-c739580f7bf3,54,2007,TUMOR FREE,24,Right Upper Inner QuadrantRight Upper Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,,Positive,Negative,3,NO,YES,,,Stage IIB,T2N1aM0,1117,TCGA-BH-A0BM-01Z-00-DX1.8BD324F2-60F5-4F59-AF2D-533A5FB230BF.svs
TCGA-A2-A0ER,,FEMALE,0,-23021,NO,1903,WHITE,A2,A0ER,7455d832-ad66-40df-85d7-3a7051c4498d,63,2005,TUMOR FREE,14,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Negative,Positive,Equivocal,1,NO,YES,90-99%,80-89%,Stage IB,T1cN1miM0,1903,TCGA-A2-A0ER-01Z-00-DX1.18123C1B-A0CC-4957-9373-5FFAB985C2E8.svs
TCGA-AC-A23C,,FEMALE,0,-22751,NO,29,WHITE,AC,A23C,dfd0b7ba-c7d3-498e-b455-346301865452,62,2010,,1,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Positive,Positive,Positive,1,NO,YES,90-99%,50-59%,Stage IIB,T2N1MX,29,TCGA-AC-A23C-01Z-00-DX1.0E67C785-83D3-49AF-B600-FB5B909AE6ED.svs
TCGA-C8-A135,,FEMALE,0,-23667,NO,13,ASIAN,C8,A135,33cea538-4c3f-470a-972d-257c43241ab4,64,2010,TUMOR FREE,3,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,1,YES,NO,,,Stage IIB,T2N1M0,13,TCGA-C8-A135-01Z-00-DX1.B69A605E-B577-4F43-9471-2C95312B05D9.svs
TCGA-AR-A1AJ,,FEMALE,0,-30489,NO,1605,WHITE,AR,A1AJ,23e7a78a-1d56-4ad1-9bb4-72ec0178aff2,83,2005,TUMOR FREE,8,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,0,NO,YES,10-19%,,Stage I,T1N0M0,1605,TCGA-AR-A1AJ-01Z-00-DX1.34B9FCF0-74D8-4328-9B5A-698AD57EDA85.svs
TCGA-AO-A0JD,,FEMALE,0,-21831,NO,1813,WHITE,AO,A0JD,0a229f95-0ea1-4d63-953e-74f5ec2f3028,59,2005,TUMOR FREE,27,Left Upper Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,3,NO,YES,90-99%,40-49%,Stage IIIA,T3N1aM0,1813,TCGA-AO-A0JD-01Z-00-DX1.52E3DCE8-32E3-45C0-AB54-7FA0A2F3F722.svs
TCGA-BH-A0EA,,FEMALE,1,-26548,991,NO,WHITE,BH,A0EA,1f601832-eee3-48fb-acf5-80c4a454f26e,72,2008,TUMOR FREE,4,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,2,NO,YES,,,Stage IIA,T1cN1aM0,991,TCGA-BH-A0EA-01Z-00-DX1.85FF2B48-2AF7-4C15-A7E6-FCA68CAB76C7.svs
TCGA-E2-A150,,FEMALE,0,-17580,NO,591,WHITE,E2,A150,4ac693e9-10f3-46b3-9d46-df3af7b0d259,48,2009,TUMOR FREE,2,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,0,NO,YES,,,Stage IIA,T2N0M0,591,TCGA-E2-A150-01Z-00-DX1.55643D23-83E6-4058-8EA5-18AAA8547839.svs
TCGA-AO-A0JM,,FEMALE,0,-14653,NO,1826,,AO,A0JM,44bec761-b603-49c0-8634-f6bfe0319bb1,40,2005,TUMOR FREE,23,Right Lower Inner QuadrantRight Lower Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,Positive,Positive,Positive,2,NO,YES,90-99%,<10%,Stage IIB,T2N1M0,1826,TCGA-AO-A0JM-01Z-00-DX1.94E75EFD-E5F5-4DF8-93A0-ED94CB4D203A.svs
TCGA-S3-AA15,,FEMALE,0,-18659,NO,209,BLACK OR AFRICAN AMERICAN,S3,AA15,E783E518-C1E5-4EAC-8EAF-E2D65CCD9692,51,2013,TUMOR FREE,13,RightRight Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,2,YES,NO,,,Stage IIB,T2N1acM0 (i+),209,TCGA-S3-AA15-01Z-00-DX1.A2456A4A-E6E8-4429-8F09-B997AA497BB0.svs
TCGA-A8-A06R,,FEMALE,0,-25477,NO,547,,A8,A06R,f3ba71f9-25f3-4784-bf2d-3aa522a0cba8,69,2007,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIB,T2N1aM0,547,TCGA-A8-A06R-01Z-00-DX1.41476D0D-BA72-4FB8-B143-9EB679F26D28.svs
TCGA-BH-A0B8,,FEMALE,0,-23380,NO,1569,WHITE,BH,A0B8,d3a75976-67d3-40fa-9f6f-cf2a3d7b773c,64,2006,TUMOR FREE,2,Right Upper Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,90-99%,30-39%,Stage I,T1bN0 (i-)M0,1569,TCGA-BH-A0B8-01Z-00-DX1.380ABAE9-EA83-4E9B-BFB2-6476A86C1ADD.svs
TCGA-BH-A18N,,FEMALE,1,-32404,468,NO,WHITE,BH,A18N,665dd3d3-779c-4abd-b5d7-13342340451d,88,2001,,26,Left,,Positive,,Negative,,Positive,Negative,2,NO,YES,,,Stage IIA,T2N1bM0,468,TCGA-BH-A18N-01Z-00-DX1.FE0E24A1-8AE9-4021-B9C7-B408EE0DE329.svs
TCGA-A2-A0T7,,FEMALE,0,-18756,NO,397,WHITE,A2,A0T7,43d5632e-7272-4aad-9496-7f5a99671223,51,2009,TUMOR FREE,2,Right Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Positive,,Positive,Negative,0,NO,YES,90-99%,70-79%,Stage IIA,T2N0 (i+)M0,397,TCGA-A2-A0T7-01Z-00-DX1.EA4DF9B5-8D04-4BCC-9ECB-CB8CB8ACBE1C.svs
TCGA-A8-A07G,,FEMALE,0,-23926,NO,577,,A8,A07G,8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa,65,2009,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIA,T1cN1aM0,577,TCGA-A8-A07G-01Z-00-DX1.37E8A762-8141-4BE6-935A-B3DCB712BB4A.svs
TCGA-BH-A18M,,FEMALE,1,-14532,2207,NO,WHITE,BH,A18M,f63722c1-a0bb-4bf9-8a10-1d76a8e1a0ba,39,2001,,6,Left Upper Inner Quadrant,,Positive,,Negative,Positive,Positive,Positive,4,NO,YES,,,Stage IIIA,T3N1M0,2207,TCGA-BH-A18M-01Z-00-DX1.56E6935A-62CB-4CBE-BDCA-60DA56422CE0.svs
TCGA-D8-A1XD,,FEMALE,0,-13510,NO,155,WHITE,D8,A1XD,c4699748-f01d-4b30-9c74-1ca77fb84ac1,36,2010,TUMOR FREE,18,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,6,YES,NO,,,Stage IIIA,T1cN2aM0,155,TCGA-D8-A1XD-01Z-00-DX1.E500D561-1F49-4F08-99AE-E8345F21B406.svs
TCGA-A8-A06X,,FEMALE,1,-28338,943,NO,,A8,A06X,70931617-b3df-4a12-8e3f-2b2307602f48,77,2006,TUMOR FREE,,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIB,T3N0M0,943,TCGA-A8-A06X-01Z-00-DX1.21F19EDD-ABCB-4398-B210-D795BB7A34E3.svs
TCGA-C8-A1HG,,FEMALE,0,,NO,0,ASIAN,C8,A1HG,0c23c380-363c-474d-b64c-b47f612a8225,50,2010,TUMOR FREE,,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-C8-A1HG-01Z-00-DX1.F2AB6D0F-4D6B-491F-915B-92E838E79D67.svs
TCGA-D8-A1XW,,FEMALE,0,-19478,NO,118,WHITE,D8,A1XW,887b9e5b-99db-44ac-9c30-c0dc6877b41c,53,2011,TUMOR FREE,1,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Negative,Negative,0,YES,NO,,<10%,Stage IIA,T2N0M0,118,TCGA-D8-A1XW-01Z-00-DX2.9849E503-BE3E-417C-ABE8-93A39583DDE0.svs
TCGA-E2-A15O,,FEMALE,0,-32583,NO,289,BLACK OR AFRICAN AMERICAN,E2,A15O,eafa45a4-2fd1-4fa3-860c-9d52ed382b7d,89,2010,TUMOR FREE,,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,,NO,YES,,,Stage I,T1cNXM0,289,TCGA-E2-A15O-01Z-00-DX1.4D0F3975-93EA-4DC2-AD0C-A76A24C3AE0C.svs
TCGA-A2-A04X,,FEMALE,0,-12642,NO,1349,WHITE,A2,A04X,733a2a0f-b37a-4b81-b49e-3c0f30d1eb37,34,2006,TUMOR FREE,3,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,Positive,Positive,Positive,0,NO,YES,80-89%,50-59%,Stage IIA,T2N0 (i-)M0,1349,TCGA-A2-A04X-01Z-00-DX1.E01A4522-67B3-4FEF-BD6B-99DFED9E7C85.svs
TCGA-AR-A24N,,FEMALE,0,-19989,NO,2074,WHITE,AR,A24N,30047d32-0833-4aca-98d1-3b9ab7122863,54,2005,,4,Left Upper Inner Quadrant,Peri (6-12 months since last menstrual period),Positive,2+,Negative,Negative,Positive,Equivocal,0,NO,YES,10-19%,10-19%,Stage I,T1N0M0,2074,TCGA-AR-A24N-01Z-00-DX1.563E9160-9E09-4E3F-8CE9-FFED0AA52927.svs
TCGA-BH-A0E1,,FEMALE,0,-19192,NO,477,WHITE,BH,A0E1,606fbc6a-b41b-441d-9401-51e54912bf5e,52,2009,TUMOR FREE,17,Left Upper Inner QuadrantLeft,Peri (6-12 months since last menstrual period),Positive,2+,Negative,Negative,Positive,Equivocal,2,NO,YES,70-79%,50-59%,Stage IIB,T2N1M0,477,TCGA-BH-A0E1-01Z-00-DX1.257EB36A-1008-4890-927B-204EF05DBE90.svs
TCGA-OL-A66L,,FEMALE,0,-26186,NO,945,BLACK OR AFRICAN AMERICAN,OL,A66L,AF0ACAA9-A61C-4E57-BC0D-453AD5BF193A,71,2010,TUMOR FREE,2,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,,NO,YES,90-99%,90-99%,Stage IA,T1cN0MX,945,TCGA-OL-A66L-01Z-00-DX1.E01BA275-57A5-49DF-9376-1AD0BDFFF7E2.svs
TCGA-BH-A0DX,,FEMALE,0,-22833,NO,1442,WHITE,BH,A0DX,035cb359-eac3-484a-9e88-3ddc739440a3,62,2007,TUMOR FREE,11,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1bN0M0,1442,TCGA-BH-A0DX-01Z-00-DX1.45C27E71-9A0A-400E-93A9-5CE7780F3C5E.svs
TCGA-E9-A1N6,,FEMALE,0,-19327,NO,0,WHITE,E9,A1N6,955d4263-61f7-42e8-8a6e-772a0d6c209d,52,2010,TUMOR FREE,10,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Positive,2,YES,NO,,,Stage IIB,T2N1M0,0,TCGA-E9-A1N6-01Z-00-DX1.C0E8FFDC-2614-4DBF-B51E-4646A3919911.svs
TCGA-BH-A18F,,FEMALE,0,-18594,NO,268,WHITE,BH,A18F,bfd49783-1767-469b-9d79-7822301c5efc,50,2010,TUMOR FREE,1,Right Lower Outer Quadrant,Peri (6-12 months since last menstrual period),Positive,,Negative,,Positive,Negative,0,NO,YES,70-79%,40-49%,Stage IIA,T2N0M0,268,TCGA-BH-A18F-01Z-00-DX1.81A81589-2D77-4CD6-BD34-76E292AA031D.svs
TCGA-AN-A0FK,,FEMALE,0,-32462,NO,213,WHITE,AN,A0FK,2f4cbedf-ed7e-45a2-bf34-f1d1e696bdde,88,2010,TUMOR FREE,7,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Positive,0,NO,YES,90-99%,90-99%,Stage IIIB,T4N0M0,213,TCGA-AN-A0FK-01Z-00-DX1.8966A1D5-CE3A-4B08-A1F6-E613BEB1ABD1.svs
TCGA-EW-A1P3,,FEMALE,0,-17637,NO,987,WHITE,EW,A1P3,1ff85ada-3cdd-4afb-b311-2c7befb52702,48,2008,TUMOR FREE,4,Right Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0MX,987,TCGA-EW-A1P3-01Z-00-DX1.EF69B964-57D6-4F8E-A183-A3022AF6E835.svs
TCGA-D8-A27N,,FEMALE,0,-13243,NO,146,WHITE,D8,A27N,d5be2ab3-f748-480d-954b-385cf01b4c81,36,2011,TUMOR FREE,19,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,3+,Negative,,Positive,Positive,4,YES,NO,,,Stage IIIA,T2N2aM0,146,TCGA-D8-A27N-01Z-00-DX2.EB803DEC-438B-43A9-B906-FD7C3B9A0138.svs
TCGA-BH-A0BZ,,FEMALE,0,-21856,NO,1492,WHITE,BH,A0BZ,4a032bad-e726-48f2-8f39-e3acc109cc91,59,2007,TUMOR FREE,23,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIIA,T3N1aM0,1492,TCGA-BH-A0BZ-01Z-00-DX1.45EB3E93-A871-49C6-9EAE-90D98AE01913.svs
TCGA-E9-A226,,FEMALE,0,-16511,NO,16,WHITE,E9,A226,dd67408e-46ba-4573-9415-d4814e9f84de,45,2011,TUMOR FREE,10,Left Lower Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),,,Negative,,,,6,YES,NO,,,Stage IIIA,T2N2M0,16,TCGA-E9-A226-01Z-00-DX1.14f1f4c7-4e6e-4574-af20-60d2ab511b2a.svs
TCGA-A2-A0D3,,FEMALE,0,-15524,NO,736,WHITE,A2,A0D3,4a16429b-884f-4c95-8683-feeedf0d6a55,42,2008,TUMOR FREE,1,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IA,T1cN0 (i-)M0,736,TCGA-A2-A0D3-01Z-00-DX1.D18CE1C0-291D-41C1-8F71-2A0551F8C661.svs
TCGA-AR-A255,,FEMALE,0,-22809,NO,1059,WHITE,AR,A255,e8f3cc64-5e15-4f4d-b73e-5c9b250a664c,62,2007,,2,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,0,NO,YES,,,Stage I,T1N0M0,1059,TCGA-AR-A255-01Z-00-DX1.E67C081D-50C9-451C-814B-F097B2671300.svs
TCGA-D8-A1JD,,FEMALE,0,-15166,NO,273,WHITE,D8,A1JD,530ad151-703d-4638-851f-0b5111ff318b,41,2010,TUMOR FREE,14,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,,Positive,Negative,3,YES,NO,,,Stage IIB,T2N1aM0,273,TCGA-D8-A1JD-01Z-00-DX1.6D215B14-DD90-4635-8645-AF06EBD9BA3F.svs
TCGA-GM-A2DF,,FEMALE,0,-19614,NO,1299,BLACK OR AFRICAN AMERICAN,GM,A2DF,D6F7AFC0-1558-43AD-ACB1-2B5311ED2264,53,2007,TUMOR FREE,32,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Negative,Negative,Negative,1,NO,YES,<10%,<10%,Stage IIA,T1cN1aM0,1299,TCGA-GM-A2DF-01Z-00-DX1.CD0BE6D7-2DB3-4193-84CC-F9BE7BF18CC2.svs
TCGA-D8-A1J8,,FEMALE,0,-28444,NO,256,WHITE,D8,A1J8,62d70067-ff77-4f95-8b69-f537abaf74ce,77,2010,TUMOR FREE,16,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,3,YES,NO,70-79%,70-79%,Stage IIB,T2N1aM0,256,TCGA-D8-A1J8-01Z-00-DX1.EADAB43A-87C6-47FA-9120-25B69E23366D.svs
TCGA-BH-A202,,FEMALE,0,-22052,NO,22,WHITE,BH,A202,e7a00d67-2c26-4d1f-bd17-35f659e88bc1,60,2011,,4,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Positive,0,NO,YES,,,Stage II,T2N0M0,22,TCGA-BH-A202-01Z-00-DX1.8CECDB74-5E6F-4CE8-B52C-A89E574F38FB.svs
TCGA-E9-A22E,,FEMALE,0,-20574,NO,0,WHITE,E9,A22E,64d4dfae-8d91-464b-adc3-80ba7caf54ae,56,2011,TUMOR FREE,10,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Positive,4,YES,NO,10-19%,<10%,Stage IIIA,T2N2M0,0,TCGA-E9-A22E-01Z-00-DX1.3d5b1ba6-466f-4852-b1fc-bc29ef3be9a2.svs
TCGA-AC-A23H,,FEMALE,0,-32873,NO,0,WHITE,AC,A23H,7dcf550c-90ce-4f63-aecd-0e46897e2a3e,90,2009,TUMOR FREE,,Right Upper Inner QuadrantRight Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Positive,Positive,Positive,,NO,YES,10-19%,,Stage IIA,T2NXM0,0,TCGA-AC-A23H-01Z-00-DX1.8E0AE339-1047-4CA5-BFC5-37A3B10FD8B5.svs
TCGA-D8-A27L,,FEMALE,0,-18025,NO,126,WHITE,D8,A27L,6020d1b4-ee20-4cc9-82a3-340b5e3122f1,49,2011,TUMOR FREE,16,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,2,YES,NO,,,Stage IIIA,T1cN2aM0,126,TCGA-D8-A27L-01Z-00-DX1.6572593C-B015-4F9A-8C9B-B634CAA0D3B4.svs
TCGA-E2-A1B0,,FEMALE,0,-18346,NO,1271,WHITE,E2,A1B0,996bd3f0-d767-4eff-9c82-99fcb5a3006a,50,2007,TUMOR FREE,28,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Negative,,Negative,Positive,6,NO,YES,,,Stage IIIA,T2N2M0,1271,TCGA-E2-A1B0-01Z-00-DX1.4C50EC91-A62A-450E-88C0-7DCAB8E9724C.svs
TCGA-A2-A0D0,,FEMALE,0,-22115,NO,643,BLACK OR AFRICAN AMERICAN,A2,A0D0,324bcba2-f6a4-45a6-807c-215bdffcca21,60,2008,TUMOR FREE,8,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Negative,Negative,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,643,TCGA-A2-A0D0-01Z-00-DX1.4FF6B8E5-703B-400F-920A-104F56E0F874.svs
TCGA-BH-A1F6,,FEMALE,1,-18691,2965,NO,WHITE,BH,A1F6,ad18820b-a804-49c0-ba8a-86c09fa6bce2,51,1996,,6,Left,,Negative,,,,Negative,Negative,6,NO,YES,,,,T4dN2aMX,2965,TCGA-BH-A1F6-01Z-00-DX1.E83F0DC0-EA2C-4641-81B0-8702B9C5D579.svs
TCGA-AC-A8OQ,,FEMALE,0,-26535,NO,34,BLACK OR AFRICAN AMERICAN,AC,A8OQ,DFAABD03-2D40-4422-B210-CAF112FF4229,72,2011,TUMOR FREE,2,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Indeterminate,1,YES,NO,,,Stage IIB,T2N1aMX,34,TCGA-AC-A8OQ-01Z-00-DX1.15946A44-711C-4765-AB46-5CFB7BD11E42.svs
TCGA-EW-A1P5,,FEMALE,0,-28177,NO,365,WHITE,EW,A1P5,53d0af48-d7ea-42c9-8695-c614b89b415b,77,2010,TUMOR FREE,40,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,Negative,3,NO,YES,90-99%,90-99%,Stage IIB,T2N1aM0,365,TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B.svs
TCGA-A2-A3XU,,FEMALE,1,-13046,912,NO,BLACK OR AFRICAN AMERICAN,A2,A3XU,A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6,35,2006,WITH TUMOR,12,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Negative,Negative,,3,NO,YES,,,Stage IIB,T2N1miM0,912,TCGA-A2-A3XU-01Z-00-DX1.174A92D4-50B2-4A59-AD31-D5EC5BBF2F65.svs
TCGA-A8-A08T,,FEMALE,0,-23560,NO,2830,,A8,A08T,32bc7cc4-d185-4594-bbee-4b96410be512,64,2002,WITH TUMOR,,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Positive,Positive,Positive,Positive,,NO,YES,,,Stage IV,T2N1aM1,2830,TCGA-A8-A08T-01Z-00-DX1.ABA1ABF2-DDB1-4E31-89DC-0F7821311D11.svs
TCGA-E2-A10C,,FEMALE,0,-19849,NO,854,WHITE,E2,A10C,9ac44381-5d43-4f63-aa3f-7703bfc923c9,54,2008,TUMOR FREE,13,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,1,NO,YES,,,Stage IIB,T2N1aM0,854,TCGA-E2-A10C-01Z-00-DX1.29A2B20B-29C6-4491-ADAB-0584C772EF25.svs
TCGA-OL-A5RZ,,FEMALE,0,-21038,NO,313,BLACK OR AFRICAN AMERICAN,OL,A5RZ,7E8713BD-0B17-4F09-9696-BC29707D862B,57,2012,TUMOR FREE,3,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,Positive,Positive,,,NO,YES,30-39%,<10%,Stage IA,T1bN0MX,313,TCGA-OL-A5RZ-01Z-00-DX1.6394C05E-1C34-4F4B-8859-F5E961E7EFF9.svs
TCGA-D8-A1X9,,FEMALE,0,-24417,NO,380,WHITE,D8,A1X9,34a74805-300c-4773-ab59-2085fcc2e6cc,66,2010,TUMOR FREE,23,Left Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,Negative,Positive,Indeterminate,3,YES,NO,,,Stage IIB,T2N1aM0,380,TCGA-D8-A1X9-01Z-00-DX1.28CE7849-EEC5-4ABB-A319-A977A1FD3CD1.svs
TCGA-A8-A09A,,FEMALE,0,-14883,NO,304,,A8,A09A,b205bba0-1870-4458-9088-8817e20389fe,40,2009,WITH TUMOR,,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Positive,Negative,Positive,Negative,,NO,YES,,,Stage X,T2NXM0,304,TCGA-A8-A09A-01Z-00-DX1.78773A6C-BA8A-46BE-AC2A-9C6FDAB45622.svs
TCGA-D8-A1JB,,FEMALE,0,-19822,NO,365,WHITE,D8,A1JB,dd96a9c7-899c-47cd-a0f9-b149ed07a5d6,54,2010,TUMOR FREE,8,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Positive,Positive,Equivocal,1,YES,NO,,,Stage IIB,T2N1aM0,365,TCGA-D8-A1JB-01Z-00-DX1.6CF48257-066C-4B8C-91AA-30A6B4AD4307.svs
TCGA-D8-A27F,,FEMALE,0,-14731,NO,106,WHITE,D8,A27F,1549dc64-3dab-43fc-96e9-b07d520957e1,40,2010,TUMOR FREE,11,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,106,TCGA-D8-A27F-01Z-00-DX1.C1A87F27-49F1-46BA-B2E2-A89293F7FD0C.svs
TCGA-BH-A0AU,,FEMALE,0,-16688,NO,746,WHITE,BH,A0AU,360d1d6d-cf3e-4c78-b36f-ef5e3160aa6b,45,2008,TUMOR FREE,2,Left Upper Inner Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Negative,Positive,Positive,0,NO,YES,,,Stage IIA,T2N0M0,746,TCGA-BH-A0AU-01Z-00-DX1.E852F218-B15C-4CF8-8FD0-F284043834C4.svs
TCGA-BH-A201,,FEMALE,0,-23423,NO,210,WHITE,BH,A201,3bf81a9f-abb4-4495-a514-fd3865e13a03,64,2011,TUMOR FREE,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,,,Positive,Negative,0,NO,YES,,,Stage IA,T1N0M0,210,TCGA-BH-A201-01Z-00-DX1.6D6E3224-50A0-45A2-B231-EEF27CA7EFD2.svs
TCGA-B6-A1KC,,FEMALE,0,-24791,NO,1326,WHITE,B6,A1KC,1502c7d7-1535-4e56-9f34-30623acd50d5,67,2003,TUMOR FREE,2,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIB,T2N1M0,1326,TCGA-B6-A1KC-01Z-00-DX1.4DD3E48B-F434-499F-9FF1-0FFD2883A375.svs
TCGA-BH-A0BF,,FEMALE,0,-20691,NO,782,WHITE,BH,A0BF,e6b79d7a-ed6b-459a-b040-d142616e7ab4,56,2009,TUMOR FREE,3,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,1,NO,YES,,,Stage IIB,T2N1miM0,782,TCGA-BH-A0BF-01Z-00-DX1.934DF984-9054-4B20-B85B-9CF94B8DC3D4.svs
TCGA-E2-A14V,,FEMALE,0,-19643,NO,748,WHITE,E2,A14V,3144f1fb-4342-4079-bfe8-940da4bfd88e,53,2008,TUMOR FREE,24,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,3,NO,YES,,,Stage IIB,T2N1M0,748,TCGA-E2-A14V-01Z-00-DX1.D6274B5E-644C-478C-817F-B8BB9262D6F4.svs
TCGA-A8-A075,,FEMALE,0,-15369,NO,518,,A8,A075,7861a5f2-8910-4bcb-9c34-f79c5acd6e21,42,2009,TUMOR FREE,,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Positive,Positive,Positive,,NO,YES,,,Stage IIB,T2N1aM0,518,TCGA-A8-A075-01Z-00-DX1.8E06AF51-951F-48E8-934E-42A455F65E5F.svs
TCGA-A8-A07F,,FEMALE,0,-23742,NO,577,,A8,A07F,5d688049-f271-40ef-813a-d37240ffe21c,65,2009,TUMOR FREE,,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T2N1aM0,577,TCGA-A8-A07F-01Z-00-DX1.E6FE5B3A-A412-4E7B-A710-7DFD3596F4E3.svs
TCGA-BH-A0BQ,,FEMALE,0,-14494,NO,827,WHITE,BH,A0BQ,b3bb8fd6-ee54-4813-b042-2bbe70115382,39,2007,TUMOR FREE,2,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,,Positive,Positive,0,NO,YES,,,Stage I,T1cN0M0,827,TCGA-BH-A0BQ-01Z-00-DX1.F5C6386B-BB2C-49DF-B3B8-6C4B80D060D4.svs
TCGA-C8-A26Z,,FEMALE,0,,NO,4,ASIAN,C8,A26Z,dc11b1c7-1f00-4813-b4b5-ecf776b2eb37,59,2010,TUMOR FREE,,Right Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,,YES,NO,,,Stage IIA,T2N0M0,4,TCGA-C8-A26Z-01Z-00-DX1.1A15D951-F3BD-4024-91DD-E7633C09A837.svs
TCGA-BH-A1EV,,FEMALE,1,-16504,365,NO,WHITE,BH,A1EV,417dea5f-f68e-4dab-940e-43ae8c67e5e6,45,1999,WITH TUMOR,10,Left,,Positive,,,,Positive,Positive,3,NO,YES,,,Stage IIIA,T3N1bM0,365,TCGA-BH-A1EV-01Z-00-DX1.106CF220-1D7D-40DD-88B2-A7F00B758F8F.svs
TCGA-A7-A2KD,,FEMALE,0,-19563,NO,182,BLACK OR AFRICAN AMERICAN,A7,A2KD,92654F8D-5137-4FFD-AAA3-5AE38EB88226,53,2011,,10,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,3+,Negative,,Positive,Positive,8,YES,NO,90-99%,90-99%,Stage IIIA,T2N2aMX,182,TCGA-A7-A2KD-01Z-00-DX1.BFF2DFC8-1D95-4DC2-98FC-5BD7D7C6CDF5.svs
TCGA-LL-A5YP,,FEMALE,0,-18041,NO,99,BLACK OR AFRICAN AMERICAN,LL,A5YP,6D24E675-2FA4-4102-861F-7516650B3049,49,2013,,12,RightRight Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,Positive,Positive,Negative,2,YES,NO,<10%,<10%,Stage IIB,T2N1aM0,99,TCGA-LL-A5YP-01Z-00-DX1.ADA978DF-6625-4C4D-AE0C-F589B2BA4897.svs
TCGA-A2-A0CP,,FEMALE,0,-22133,NO,2495,WHITE,A2,A0CP,fe15c48b-116d-461e-9b40-68514730fd18,60,2003,TUMOR FREE,2,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,Negative,Positive,,0,NO,YES,90-99%,90-99%,Stage IA,T1cN0 (i-)M0,2495,TCGA-A2-A0CP-01Z-00-DX1.ECFD263C-BB17-4ADA-8F2C-654C2AA4C45F.svs
TCGA-A2-A0CZ,,FEMALE,0,-17026,NO,1339,WHITE,A2,A0CZ,9f93ea0a-1687-44e0-9e8a-eeb4097d471c,46,2007,TUMOR FREE,2,Right Upper Inner Quadrant,Peri (6-12 months since last menstrual period),Positive,1+,Positive,Negative,Positive,Negative,0,NO,YES,90-99%,20-29%,Stage IIA,T2N0 (i-)M0,1339,TCGA-A2-A0CZ-01Z-00-DX1.A433A414-4F1B-4F99-8FD9-E64803F5E042.svs
TCGA-E2-A1LL,,FEMALE,0,-27028,NO,1014,BLACK OR AFRICAN AMERICAN,E2,A1LL,2a84997d-ccee-4f46-bea2-752534f26416,73,2008,TUMOR FREE,44,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,5,NO,YES,,,Stage IIIA,T3N2aMX,1014,TCGA-E2-A1LL-01Z-00-DX1.D1AA1613-902C-4579-9612-48A76042B0AE.svs
TCGA-D8-A1XR,,FEMALE,0,-20488,NO,168,WHITE,D8,A1XR,70f34c5c-3671-44c8-9469-99f9786efec1,56,2010,TUMOR FREE,7,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,2,YES,NO,,,Stage IIB,T2N1aM0,168,TCGA-D8-A1XR-01Z-00-DX1.7F443346-C564-47B6-9736-6944230CAF46.svs
TCGA-E9-A22G,,FEMALE,0,-17300,NO,0,WHITE,E9,A22G,56033839-35d5-4d72-8b8c-400cb345263d,47,2011,TUMOR FREE,6,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Positive,0,YES,NO,,,Stage IIA,T2N0M0,0,TCGA-E9-A22G-01Z-00-DX1.2b47e321-7910-40ec-ad1c-c4e08ed26334.svs
TCGA-EW-A2FS,,FEMALE,0,-15302,NO,1173,BLACK OR AFRICAN AMERICAN,EW,A2FS,D34471A1-B367-4F8A-B35A-C5901C4F5503,41,2008,TUMOR FREE,8,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Positive,Negative,1,NO,YES,90-99%,<10%,Stage IIB,T2N1miMX,1173,TCGA-EW-A2FS-01Z-00-DX1.A01C9183-2AC8-456A-B5A6-85C5BB0361D8.svs
TCGA-AO-A0JE,,FEMALE,0,-19516,NO,1966,BLACK OR AFRICAN AMERICAN,AO,A0JE,36fe6152-f61e-4948-9ccc-23ac01a9d77d,53,2005,TUMOR FREE,29,Right Lower Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Positive,Positive,Negative,Positive,8,NO,YES,<10%,<10%,Stage IIIA,T2N2aM0,1966,TCGA-AO-A0JE-01Z-00-DX1.82D33053-E305-47D8-9B02-B55511EBB06D.svs
TCGA-A7-A6VX,,FEMALE,0,-25066,NO,169,BLACK OR AFRICAN AMERICAN,A7,A6VX,7EEA2B6E-771F-44C0-9350-38F45C8DBE87,68,2013,TUMOR FREE,2,LeftLeft Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,YES,NO,90-99%,,Stage IIA,T2N0M0,169,TCGA-A7-A6VX-01Z-00-DX1.F74DA243-C65A-4997-BCA0-F1C89675978C.svs
TCGA-BH-A0HA,,FEMALE,0,-11379,NO,856,WHITE,BH,A0HA,e666081b-caaf-4e8b-9446-807be71201a5,31,2008,TUMOR FREE,4,Right,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Negative,Positive,,0,NO,YES,,,Stage I,T1cN0 (i-)M0,856,TCGA-BH-A0HA-01Z-00-DX1.5A2F5C86-E1E7-445D-A4E3-29980FA37708.svs
TCGA-A2-A04U,,FEMALE,0,-17474,NO,671,WHITE,A2,A04U,1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9,47,2004,TUMOR FREE,3,Right,Peri (6-12 months since last menstrual period),Negative,1+,Negative,Positive,Negative,Negative,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i+)M0,671,TCGA-A2-A04U-01Z-00-DX1.06D17357-46A8-4DC3-A22B-2F4EB6EE3F79.svs
TCGA-A2-A0T2,,FEMALE,1,-24235,255,NO,WHITE,A2,A0T2,128d198e-9b22-427c-90db-3714455f3a17,66,2009,WITH TUMOR,14,Right,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,0,Close,,Negative,Negative,10,NO,YES,<10%,<10%,Stage IV,T3N3M1,255,TCGA-A2-A0T2-01Z-00-DX1.29A5C4C8-6AE8-44EE-98C2-ACBCBFBE9D60.svs
TCGA-D8-A1XZ,,FEMALE,0,-29916,NO,121,WHITE,D8,A1XZ,2c90d5e3-ac8c-4c86-a06f-42ccc064eb49,81,2010,TUMOR FREE,14,Right Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Positive,Negative,6,YES,NO,,,Stage IIIA,T1cN2aMX,121,TCGA-D8-A1XZ-01Z-00-DX1.8E51A61D-B01C-4A52-8F5D-44D2ABCA46FC.svs
TCGA-A2-A25E,,FEMALE,0,-12601,NO,2511,BLACK OR AFRICAN AMERICAN,A2,A25E,ba89cb4f-cd63-47b1-9550-76fdaff89f2e,34,2004,TUMOR FREE,10,Left Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,2+,Negative,Equivocal,Positive,Equivocal,6,NO,YES,80-89%,60-69%,Stage IIIA,T2N2aM0,2511,TCGA-A2-A25E-01Z-00-DX1.46D1950B-0BAF-4A44-B58F-CD738E74CB27.svs
TCGA-A8-A09D,,FEMALE,0,-17440,NO,396,,A8,A09D,36449392-de76-4ee9-bc09-627a07e18727,47,2007,TUMOR FREE,,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage IIB,T2N1M0,396,TCGA-A8-A09D-01Z-00-DX1.66312A8A-88BA-4B58-96DF-1A7AC39F9E4A.svs
TCGA-AO-A0J2,,FEMALE,0,-15324,NO,585,WHITE,AO,A0J2,d2f2560c-ec80-4fea-9474-c47a2e85ea95,41,2008,TUMOR FREE,5,Left Lower Inner QuadrantLeft,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,<10%,<10%,Stage IA,T1cN0 (i-)M0,585,TCGA-AO-A0J2-01Z-00-DX1.7C9FEC7B-6040-4C58-9563-D10C0D7AC72E.svs
TCGA-E2-A1IU,,FEMALE,0,-22279,NO,127,WHITE,E2,A1IU,001cef41-ff86-4d3f-a140-a647ac4b10a1,60,2010,TUMOR FREE,11,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage IA,T1cN0 (mol+)M0,127,TCGA-E2-A1IU-01Z-00-DX1.E2F24814-24BA-4158-8841-F27A8E100589.svs
TCGA-E2-A14T,,FEMALE,0,-19237,NO,890,WHITE,E2,A14T,e0929c47-cff3-4518-a188-8764af01073a,52,2008,TUMOR FREE,7,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,Negative,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,890,TCGA-E2-A14T-01Z-00-DX1.61B4C988-6D75-447B-A5F4-9DE92CEACC9F.svs
TCGA-BH-A0BR,,FEMALE,0,-21622,NO,1633,WHITE,BH,A0BR,3ecb0147-276d-486c-9af0-ce437c24ba83,59,2007,TUMOR FREE,3,Left Lower Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,,,Stage I,T1cN0M0,1633,TCGA-BH-A0BR-01Z-00-DX1.F7912887-8AE9-4391-9B83-9AC7B4FF38EF.svs
TCGA-BH-A0W5,,FEMALE,0,-28304,NO,543,WHITE,BH,A0W5,da9c10ea-c13f-4d88-8b94-a0cbc106d036,77,2008,TUMOR FREE,11,Left,,Positive,,Negative,Equivocal,Positive,Equivocal,1,NO,YES,,,Stage IIA,T1cN1aM0,543,TCGA-BH-A0W5-01Z-00-DX1.84EA3913-667B-4694-A0F0-E629CAC615C8.svs
TCGA-A7-A13E,TCGAFPPP,FEMALE,0,-22690,NO,287,WHITE,A7,A13E,8c7e74e0-71ef-49b8-9217-94b8ef740ef9,62,2010,TUMOR FREE,12,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Positive,Equivocal,2,YES,NO,20-29%,<10%,Stage IIB,T2N1MX,287,TCGA-A7-A13E-01Z-00-DX1.891954FF-316A-4562-AA14-429631944F22.svs
TCGA-AR-A24S,,FEMALE,0,-22587,NO,1888,WHITE,AR,A24S,074e8b06-3929-4896-9263-3b80ad6a355b,61,2006,,4,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,0,NO,YES,70-79%,,Stage I,T1N0M0,1888,TCGA-AR-A24S-01Z-00-DX1.317C3B19-0D0F-4315-AC2D-C741F09DD775.svs
TCGA-A8-A095,,FEMALE,0,-16742,NO,1277,,A8,A095,29df128d-ace2-40cf-88ee-3f6f2170f159,45,2007,TUMOR FREE,,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,,NO,YES,,,Stage I,T1cN0M0,1277,TCGA-A8-A095-01Z-00-DX1.97072E53-7323-4836-9D58-22B7C346A7CE.svs
TCGA-AC-A5XU,,FEMALE,0,-27191,NO,9,BLACK OR AFRICAN AMERICAN,AC,A5XU,97677FD7-8523-48C5-A8CE-614FD4010551,74,2013,TUMOR FREE,2,Left Upper Outer Quadrant,,Positive,,Negative,,Positive,Negative,0,YES,NO,90-99%,60-69%,Stage IIB,T3N0 (i-)MX,9,TCGA-AC-A5XU-01Z-00-DX1.1AEEFAAF-0906-4086-8022-13B689FAB9F5.svs
TCGA-AN-A0FL,,FEMALE,0,-22805,NO,231,WHITE,AN,A0FL,baf1207d-7d1a-4cad-ba58-62c26be2415e,62,2010,TUMOR FREE,8,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Positive,0,NO,YES,<10%,<10%,Stage IIA,T2N0M0,231,TCGA-AN-A0FL-01Z-00-DX1.20A041C6-A306-4599-A7D1-65032A252AA9.svs
TCGA-A7-A6VV,,FEMALE,0,-18695,NO,181,BLACK OR AFRICAN AMERICAN,A7,A6VV,57AF5C72-0D60-4A6B-B1B4-EC6DAB90F80F,51,2013,TUMOR FREE,5,Right,Peri (6-12 months since last menstrual period),Negative,,Negative,,Negative,Negative,0,YES,NO,,,Stage IIA,T2N0M0,181,TCGA-A7-A6VV-01Z-00-DX2.4C2BF8C1-CC84-4A6E-BC0F-430BC8BE6B26.svs
TCGA-A2-A0EQ,,FEMALE,0,-23543,NO,2053,BLACK OR AFRICAN AMERICAN,A2,A0EQ,2192c1db-4718-4254-ba42-3ae7f30ad5a8,64,2004,TUMOR FREE,2,Left,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,3+,Positive,Negative,Negative,Positive,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,2053,TCGA-A2-A0EQ-01Z-00-DX1.5FCD8890-4594-4BE2-93B1-B8F698BFD2A0.svs
TCGA-E9-A1RH,,FEMALE,0,-23224,NO,14,WHITE,E9,A1RH,408cb583-6dc3-4698-8bd2-e284042bd5ef,63,2011,TUMOR FREE,10,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,0,YES,NO,,,Stage IIA,T2N0M0,14,TCGA-E9-A1RH-01Z-00-DX1.CC9CEDCC-7BF2-4C96-A0F1-C98071DA2CD3.svs
TCGA-E2-A15E,,FEMALE,0,-14894,NO,518,WHITE,E2,A15E,0a2a3529-f645-4967-9a58-89ee20b8bb62,40,2009,TUMOR FREE,9,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,,Negative,Positive,Positive,,1,NO,YES,,,Stage IIA,T1cN1aM0,518,TCGA-E2-A15E-06Z-00-DX1.D394A007-91A2-4445-9B4A-1629EE684A51.svs
TCGA-E2-A158,,FEMALE,0,-15903,NO,450,WHITE,E2,A158,a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb,43,2009,TUMOR FREE,2,Left Upper Inner QuadrantLeft Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,1+,Negative,,Negative,Negative,1,NO,YES,,,Stage IIA,T1cN1miM0,450,TCGA-E2-A158-01Z-00-DX1.994C60FE-E651-4224-95E7-4669834F2338.svs
TCGA-AO-A0JC,,FEMALE,0,-23404,NO,1547,WHITE,AO,A0JC,03565036-b6d3-432f-8d9a-7099818e0788,64,2006,TUMOR FREE,12,Right Upper Outer QuadrantRight Lower Outer QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,0,Negative,,Positive,Negative,0,NO,YES,90-99%,50-59%,Stage IIA,T2N0 (i-)M0,1547,TCGA-AO-A0JC-01Z-00-DX1.C8DD421B-9799-4FE7-9224-5EAC6ED1028E.svs
TCGA-BH-A0HI,,FEMALE,0,-28644,NO,620,WHITE,BH,A0HI,e0375a8b-a135-4103-a59d-39063fcf4a6f,78,2008,TUMOR FREE,1,Right Upper Inner QuadrantRight Lower Inner QuadrantRight,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,1+,Negative,,Positive,Negative,0,NO,YES,50-59%,40-49%,Stage IA,T1cN0 (i-)M0,620,TCGA-BH-A0HI-01Z-00-DX1.89DB9F79-0DCC-4C65-831E-96AE026C2C4E.svs
TCGA-A2-A04T,,FEMALE,0,-22707,NO,1950,WHITE,A2,A04T,b58ad350-5140-4fa8-bc2c-24bca8395f3a,62,2004,TUMOR FREE,3,Left Upper Inner Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,NO,YES,<10%,<10%,Stage IIA,T2N0 (i-)M0,1950,TCGA-A2-A04T-01Z-00-DX1.71444266-BD56-4183-9603-C7AC20C9DA1E.svs
TCGA-AO-A12A,,FEMALE,0,-17420,NO,2755,WHITE,AO,A12A,99927651-34be-4795-893a-128d8a1fdb30,47,2003,TUMOR FREE,27,Right Upper Outer QuadrantRight,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Close,Negative,Positive,Negative,0,NO,YES,90-99%,90-99%,Stage IIA,T2N0 (i+)M0,2755,TCGA-AO-A12A-01Z-00-DX1.4E9609A7-9AAD-40A8-8344-8369DF998006.svs
TCGA-EW-A1PE,,FEMALE,0,-20694,NO,107,WHITE,EW,A1PE,f3b86c02-09a5-4e97-aa7a-86f13f7cda4b,56,2011,TUMOR FREE,23,Left Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,1,NO,YES,90-99%,90-99%,Stage IIA,T1cN1aM0,107,TCGA-EW-A1PE-01Z-00-DX1.8EF56824-0B37-4AD1-AF3E-7988FCBEF773.svs
TCGA-D8-A13Z,,FEMALE,0,-18942,NO,210,WHITE,D8,A13Z,5a17dcd9-5ced-4a69-8069-23c7fd0649d1,51,2010,,11,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,9,YES,NO,,,,T2N2aM0,210,TCGA-D8-A13Z-01Z-00-DX1.517140BB-D34C-42F8-952C-340EF16D382F.svs
TCGA-D8-A1XQ,,FEMALE,0,-25345,NO,177,WHITE,D8,A1XQ,3886b4fb-ba22-4a50-b11a-a6893951f170,69,2010,TUMOR FREE,7,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,1+,Negative,,Negative,Negative,0,YES,NO,,<10%,Stage IIA,T2N0M0,177,TCGA-D8-A1XQ-01Z-00-DX1.1A17A5C7-F14B-4AD2-AD5F-D3400D86A366.svs
TCGA-E2-A159,,FEMALE,0,-18621,NO,515,WHITE,E2,A159,d7308344-5bab-4073-bb4f-4d8cd8d7bd17,50,2009,TUMOR FREE,4,Left Lower Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,Negative,Negative,,0,NO,YES,,,Stage IIA,T2N0M0,515,TCGA-E2-A159-01Z-00-DX1.C8DC3356-CAE9-4E7A-AEFF-ABB4BE38192B.svs
TCGA-BH-A18J,,FEMALE,1,-20678,612,NO,WHITE,BH,A18J,cc074b7f-d3b2-4880-902e-bf10e667b665,56,2000,WITH TUMOR,,Right,,Positive,,Negative,,Positive,Negative,,NO,YES,40-49%,30-39%,Stage IV,T4bN2M1,612,TCGA-BH-A18J-01Z-00-DX1.AE20ADB6-050C-405D-BF17-1EE4A1A4979A.svs
TCGA-A7-A6VY,,FEMALE,0,-17640,NO,125,BLACK OR AFRICAN AMERICAN,A7,A6VY,E8EA576B-EB16-44F7-B241-DAEFC1375388,48,2013,TUMOR FREE,14,RightRight Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,,Negative,,Negative,Negative,2,YES,NO,,,Stage IIB,T2N1M0,125,TCGA-A7-A6VY-01Z-00-DX1.38D4EBD7-40B0-4EE3-960A-1F00E8F83ADB.svs
TCGA-A2-A1G4,,FEMALE,0,-25966,NO,372,WHITE,A2,A1G4,e3b555aa-7f0a-49c6-9b13-182c61a144c1,71,2010,TUMOR FREE,15,Right Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,2,YES,NO,90-99%,90-99%,Stage IIIA,T3N1aM0,372,TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2.svs
TCGA-D8-A1JI,,FEMALE,0,-20072,NO,21,WHITE,D8,A1JI,baf2afc8-f16c-488f-947c-efc9083c6bef,54,2010,TUMOR FREE,22,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,,Negative,,Positive,Negative,2,YES,NO,,,Stage IIA,T1cN1aMX,21,TCGA-D8-A1JI-01Z-00-DX2.E688E270-26C9-43EC-BC26-86BF8B74A31D.svs
TCGA-D8-A142,,FEMALE,0,-27313,NO,61,WHITE,D8,A142,ccb22ecc-6e18-44b8-ad48-6ab51314b16e,74,2010,TUMOR FREE,14,Left Lower Outer QuadrantLeft,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Negative,2+,Negative,Negative,Negative,Equivocal,0,YES,NO,,,Stage IIB,T3N0M0,61,TCGA-D8-A142-01Z-00-DX1.F6D58989-9120-40C9-918D-6B1650C1A8E8.svs
TCGA-E9-A24A,,FEMALE,0,-25370,NO,11,WHITE,E9,A24A,9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6,69,2011,TUMOR FREE,10,Right Upper Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),,,Negative,,,,1,YES,NO,,,Stage IIA,T1cN1M0,11,TCGA-E9-A24A-01Z-00-DX1.F0342837-5750-4172-B60D-5F902E2A02FD.svs
TCGA-A2-A0D4,,FEMALE,0,-13805,NO,496,BLACK OR AFRICAN AMERICAN,A2,A0D4,75113445-d2d6-44a0-866c-c9175e6d214b,37,2009,TUMOR FREE,23,Left,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Positive,1+,Negative,Negative,Positive,Negative,1,NO,YES,90-99%,10-19%,Stage IIB,T2N1aM0,496,TCGA-A2-A0D4-01Z-00-DX1.35E43827-DABC-4685-A62A-333672923349.svs
TCGA-BH-A0DG,,FEMALE,0,-11204,NO,713,BLACK OR AFRICAN AMERICAN,BH,A0DG,0bc5744c-5fa3-45bb-87d0-70a02068b392,30,2007,TUMOR FREE,3,Right Upper Outer Quadrant,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Negative,,Negative,,Positive,Negative,0,NO,YES,,,Stage IIA,T2N0M0,713,TCGA-BH-A0DG-01Z-00-DX1.D3C4F57F-608F-46AA-A978-B558117C9DFB.svs
TCGA-S3-AA17,,FEMALE,0,-23642,NO,119,BLACK OR AFRICAN AMERICAN,S3,AA17,49A2FD48-744D-4D88-B9B4-8C778D4F48FD,64,2013,TUMOR FREE,2,RightRight Lower Outer Quadrant,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),Positive,2+,Negative,Negative,Positive,Equivocal,0,YES,NO,90-99%,70-79%,Stage IIB,T2N1micM0 (i+),119,TCGA-S3-AA17-01Z-00-DX1.9B7DC02E-ECB2-4403-A894-F418AD452E49.svs
